10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission File Number: 1-11442

CHART INDUSTRIES, INC.

(Exact name of registrant as specified in its charter)

Delaware	34-1712937
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

3055 Torrington Drive, Ball Ground, Georgia 30107

(Address of principal executive offices) (ZIP Code)

(770) 721-8800

(Registrant's telephone number, including area code)

NOT APPLICABLE

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01	GTLS	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes  x   No  o 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	x	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     Yes  ☐     No  x

As of April 19, 2021, there were 36,348,534 outstanding shares of the Company’s common stock, par value $0.01 per share.

CHART INDUSTRIES, INC.

INDEX

Part I. Financial Information
Item 1. Financial Statements	Page
Condensed Consolidated Balance Sheets	3
Condensed Consolidated Statements of Income and Comprehensive Income	5
Condensed Consolidated Statements of Cash Flows	6
Condensed Consolidated Statements of Equity	7
Notes to the Unaudited Condensed Consolidated Financial Statements	8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	28
Item 3. Quantitative and Qualitative Disclosures About Market Risk	37
Item 4. Controls and Procedures	38
Part II. Other Information
Item 1. Legal Proceedings	40
Item 1A. Risk Factors	40
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	40
Item 4. Mine Safety Disclosures	40
Item 6. Exhibits	41
Signatures	42

2

PART I. FINANCIAL INFORMATION

Item 1.Financial Statements

CHART INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(Dollars in millions, except per share amounts)

	March 31, 2021		December 31, 2020
ASSETS
Current Assets
Cash and cash equivalents	$	114.9	$	125.1
Accounts receivable, less allowances of $7.9 and $8.4, respectively	186.4		200.8
Inventories, net	279.9		248.4
Unbilled contract revenue	74.6		79.4
Prepaid expenses	26.4		20.0
Other current assets	31.6		29.3
Total Current Assets	713.8		703.0
Property, plant, and equipment, net	409.3		414.5
Goodwill	911.3		865.9
Identifiable intangible assets, net	481.4		493.1
Investments	119.9		78.9
Other assets	16.6		15.1
TOTAL ASSETS	$	2,652.3	$	2,570.5
LIABILITIES AND EQUITY
Current Liabilities
Accounts payable	$	151.8	$	140.1
Customer advances and billings in excess of contract revenue	106.3		118.9
Accrued salaries, wages, and benefits	27.3		39.7
Accrued income taxes	46.0		46.5
Current portion of warranty reserve	10.3		11.0
Current convertible notes	255.2		220.9
Operating lease liabilities, current	5.1		5.1
Other current liabilities	58.3		52.6
Total Current Liabilities	660.3		634.8
Long-term debt	303.1		221.6
Long-term deferred tax liabilities	49.9		60.2
Accrued pension liabilities	9.1		9.6
Operating lease liabilities, non-current	22.7		23.6
Other long-term liabilities	41.2		41.4
Total Liabilities	1,086.3		991.2

3

Equity
Common stock, par value $0.01 per share – 150,000,000 shares authorized, 36,347,850 and 36,185,829 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively	0.4		0.4
Additional paid-in capital	750.0		780.8
Treasury stock; 760,782 shares at March 31, 2021	(19.3)		(19.3)
Retained earnings	844.7		808.4
Accumulated other comprehensive (loss) income	(16.8)		2.4
Total Chart Industries, Inc. Shareholders’ Equity	1,559.0		1,572.7
Noncontrolling interests	7.0		6.6
Total Equity	1,566.0		1,579.3
TOTAL LIABILITIES AND EQUITY	$	2,652.3	$	2,570.5

See accompanying notes to these unaudited condensed consolidated financial statements.

4

CHART INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

(UNAUDITED)

(Dollars and shares in millions, except per share amounts)

	Three Months Ended March 31,
	2021		2020
Sales	$	288.5	$	301.9
Cost of sales	204.6		219.6
Gross profit	83.9		82.3
Selling, general, and administrative expenses	46.2		52.5
Amortization expense	8.8		14.0
Operating expenses	55.0		66.5
Operating income	28.9		15.8
Interest expense, net	2.0		7.2
Unrealized (gain) loss on investments in equity securities	(3.3)		4.8
Financing costs amortization	1.2		1.0
Foreign currency (gain) loss and other	(0.2)		0.3
Income from continuing operations before income taxes	29.2		2.5
Income tax expense	3.1		0.4
Net income from continuing operations	26.1		2.1
Income from discontinued operations, net of tax	—		6.4
Net income	26.1		8.5
Less: Income attributable to noncontrolling interests of continuing operations, net of taxes	0.5		—
Net income attributable to Chart Industries, Inc.	$	25.6	$	8.5
Net income attributable to Chart Industries, Inc.
Income from continuing operations	$	25.6	$	2.1
Income from discontinued operations, net of tax	—		6.4
Net income attributable to Chart Industries, Inc.	$	25.6	$	8.5
Basic earnings per common share attributable to Chart Industries, Inc.:
Income from continuing operations	$	0.72	$	0.06
Income from discontinued operations	—		0.18
Net income attributable to Chart Industries, Inc.	$	0.72	$	0.24
Diluted earnings per common share attributable to Chart Industries, Inc.
Income from continuing operations	$	0.63	$	0.06
Income from discontinued operations	—		0.18
Net income attributable to Chart Industries, Inc.	$	0.63	$	0.24
Weighted-average number of common shares outstanding:
Basic	35.55		35.77
Diluted	40.62		36.01
Comprehensive income (loss), net of taxes	$	6.9	$	(1.4)
Less: Comprehensive income attributable to noncontrolling interests, net of taxes	0.5		—
Comprehensive income (loss) attributable to Chart Industries, Inc., net of taxes	$	6.4	$	(1.4)

See accompanying notes to these unaudited condensed consolidated financial statements.

5

CHART INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(Dollars in millions)

	Three Months Ended March 31,
	2021		2020
OPERATING ACTIVITIES
Net income	$	26.1	$	8.5
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	19.5		23.9
Interest accretion of convertible notes discount	—		1.9
Employee share-based compensation expense	3.4		2.9
Financing costs amortization	1.2		1.0
Unrealized foreign currency transaction gain	(4.6)		—
Unrealized (gain) loss on investments in equity securities	(3.3)		4.8
Other non-cash operating activities	1.9		3.2
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	13.6		7.5
Inventories	(36.3)		(16.1)
Unbilled contract revenues and other assets	(6.8)		8.4
Accounts payable and other liabilities	4.1		(17.0)
Customer advances and billings in excess of contract revenue	(10.5)		(3.5)
Net Cash Provided By Operating Activities	8.3		25.5
INVESTING ACTIVITIES
Acquisition of businesses, net of cash acquired	(55.0)		—
Investments	(40.0)		—
Capital expenditures	(11.5)		(10.3)
Government grants	0.2		0.1
Net Cash Used In Investing Activities	(106.3)		(10.2)
FINANCING ACTIVITIES
Borrowings on revolving credit facilities	187.7		64.5
Repayments on revolving credit facilities	(102.5)		(84.7)
Repayments on term loan	—		(2.8)
Proceeds from exercise of stock options	5.6		2.0
Common stock repurchases from share-based compensation plans	(3.0)		(1.7)
Common stock repurchases	—		(19.3)
Net Cash Provided By (Used In) Financing Activities	87.8		(42.0)
Effect of exchange rate changes on cash and cash equivalents	—		(3.0)
Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents (1)	(10.2)		(29.7)
Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period	126.1		120.0
CASH, CASH EQUIVALENTS, RESTRICTED CASH, AND RESTRICTED CASH EQUIVALENTS AT END OF PERIOD (2)	$	115.9	$	90.3

(1)Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents represents cash flows of consolidated operations for all periods presented. For cash flows of discontinued operations, refer to Note 2, “Discontinued Operations.”

(2)Includes restricted cash and restricted cash equivalents of $1.0 in other assets for each of the periods presented. For further information regarding restricted cash and restricted cash equivalents balances, refer to Note 9, “Debt and Credit Arrangements.”

See accompanying notes to these unaudited condensed consolidated financial statements.

6

CHART INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)

(Dollars in millions)

	Common Stock			Additional Paid-in Capital						Accumulated Other Comprehensive Income (Loss)		Non-controlling Interests
	Shares Outstanding	Amount				Treasury Stock		Retained Earnings						Total Equity
Balance at December 31, 2020	36.19	$	0.4	$	780.8	$	(19.3)	$	808.4	$	2.4	$	6.6	$	1,579.3
Net income	—	—		—		—		25.6		—		0.5		26.1
Cumulative effect of change in accounting principle (1)	—	—		(36.9)		—		10.7		—		—		(26.2)
Other comprehensive loss	—	—		—		—		—		(19.2)		—		(19.2)
Share-based compensation expense	—	—		3.4		—		—		—		—		3.4
Common stock issued from share-based compensation plans	0.18	—		5.6		—		—		—		—		5.6
Common stock repurchases from share-based compensation plans	(0.02)	—		(3.0)		—		—		—		—		(3.0)
Dividend distribution to noncontrolling interest	—	—		—		—		—		—		—		—
Other	—	—		0.1		—		—		—		(0.1)		—
Balance at March 31, 2021	36.35	$	0.4	$	750.0	$	(19.3)	$	844.7	$	(16.8)	$	7.0	$	1,566.0

	Common Stock			Additional Paid-in Capital						Accumulated Other Comprehensive Loss		Non-controlling Interests
	Shares Outstanding	Amount				Treasury Stock		Retained Earnings						Total Equity
Balance as of December 31, 2019	35.80	$	0.4	$	762.8	$	—	$	500.3	$	(35.9)	$	4.8	$	1,232.4
Net income	—	—		—		—		8.5		—		—		8.5
Other comprehensive loss	—	—		—		—		—		(9.9)		—		(9.9)
Share-based compensation expense	—	—		2.9		—		—		—		—		2.9
Common stock issued from share-based compensation plans	0.16	—		2.0		—		—		—		—		2.0
Common stock repurchases (2)	—	—		—		(19.3)		—		—		—		(19.3)
Common stock repurchases from share-based compensation plans	(0.01)	—		(1.7)		—		—		—		—		(1.7)
Balance at March 31, 2020	35.95	$	0.4	$	766.0	$	(19.3)	$	508.8	$	(45.8)	$	4.8	$	1,214.9

_______________

(1)Refer to Note 1, “ Basis of Preparation” for discussion regarding the cumulative effect of change in accounting principle.

(2)Includes $19.3 in shares repurchased through our share repurchase program. On March 11, 2021, the share repurchase program expired with no further repurchases. Refer to Note 1, “Basis of Preparation” for further information.

See accompanying notes to these unaudited condensed consolidated financial statements.

7

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts)

NOTE 1 — Basis of Preparation

The accompanying unaudited condensed consolidated financial statements of Chart Industries, Inc. and its consolidated subsidiaries (herein referred to as the “Company,” “Chart,” “we,” “us,” or “our”) have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for annual financial statements. These financial statements should be read in conjunction with the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2020. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021.

Nature of Operations: We are a leading independent global manufacturer of highly engineered equipment servicing multiple applications in the Clean Energy and Industrial Gas markets. Our unique product portfolio is used in every phase of the liquid gas supply chain, including upfront engineering, service and repair. Being at the forefront of the clean energy transition, Chart is a leading provider of technology, equipment and services related to liquefied natural gas, hydrogen, biogas and CO2 Capture amongst other applications. We are committed to excellence in environmental, social and corporate governance (ESG) issues both for our company as well as our customers. With over 25 global locations from the United States to Asia, Australia, India, Europe and South America, we maintain accountability and transparency to our team members, suppliers, customers and communities.

Principles of Consolidation: The unaudited condensed consolidated financial statements include the accounts of Chart Industries, Inc. and its subsidiaries. Intercompany accounts and transactions are eliminated in consolidation.

Reclassifications: As discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, on October 1, 2020, we closed on the sale of our cryobiological products business to Cryoport, Inc. (CYRX) (refer to Note 2, “Discontinued Operations” for further information). Furthermore, we reorganized our reporting structure such that the composition of our reportable segments changed effective October 1, 2020 (refer to Note 3, “Reportable Segments” for further information). As such, certain reclassifications have been made to the statement of income and comprehensive income for the three months ended March 31, 2020 and certain notes to the unaudited condensed consolidated financial statements in order to conform to the 2021 presentation.

Use of Estimates: The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. These estimates may also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions. While our production has been considered “essential” in all locations we operate in, we have experienced, and may again experience in the future, temporary facility closures while awaiting appropriate government approvals in certain jurisdictions. The Covid-19 outbreak could also disrupt our supply chain and materially adversely impact our ability to secure supplies for our facilities, which could materially adversely affect our operations. There may also be long-term effects on our customers in and the economies of affected countries. As a result of these uncertainties, actual results could differ from those estimates and assumptions. If the economy or markets in which we operate remain weak or deteriorate further, our business, financial condition and results of operations may be materially and adversely impacted.

Share Repurchase Program: As discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, on March 11, 2020, our Board of Directors authorized a share repurchase program for up to $75 million of the Company’s common stock over the next twelve months through various means, including open market transactions, block purchases, privately negotiated transactions or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. During the first quarter of 2020, we repurchased 0.76 shares of our common stock at an average price of $25.40 per share for a total purchase price of $19.3. We suspended the program on March 20, 2020 (the “Suspension Date”) in light of uncertainty resulting from the Covid-19 pandemic and the desire to conserve cash resources. On March 11, 2021, the share repurchase program expired with no further repurchases since the Suspension Date.

Recently Issued Accounting Standards (Not Yet Adopted): In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” and in January 2021, the FASB subsequently issued ASU 2021-01,

8

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

“Reference Rate Reform (Topic 848): Scope.” ASU 2020-04 and the subsequent modifications are identified as Accounting Standards Codification (“ASC”) 848 (“ASC 848”). ASC 848 simplifies the accounting for modifying contracts (including those in hedging relationships) that refer to LIBOR and other interbank offered rates that are expected to be discontinued due to reference rate reform. The amendments in ASC 848 are effective for all entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments for contract modifications by Topic or Industry Subtopic as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020, up to the date that the financial statements are available to be issued. Once elected for a Topic or an Industry Subtopic, the amendments in ASC 848 must be applied prospectively for all eligible contract modifications for that Topic or Industry Subtopic. We expect application of the amendments to impact accounting for our senior secured revolving credit facility due June 2024. We are currently assessing the effect ASC 848 will have on our financial position, results of operations, and disclosures.

Recently Adopted Accounting Standards: In August 2020, the FASB issued ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entities Own Equity (Subtopic 815-40).” This ASU simplifies accounting for convertible instruments by eliminating two of the three models in ASC 470-20 that require separating embedded conversion features from convertible instruments. The guidance is effective for fiscal years beginning after December 15, 2021. We adopted this guidance effective January 1, 2021 under the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods.

As a result of the adoption of ASU 2020-06, our convertible notes due November 2024 are no longer bifurcated into separate liability and equity components in our March 31, 2021 condensed consolidated balance sheet. Rather, the $258.8 principal amount of our convertible notes due November 2024 was classified as a liability only in our March 31, 2021 condensed consolidated balance sheet. Upon adoption of ASU 2020-06, we recorded an adjustment to the convertible notes liability component, equity component (additional paid-in-capital) and retained earnings. This adjustment was calculated based on the carrying amount of the convertible notes as if it had always been treated as a liability only. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, i.e. as if debt issuance costs had always been treated as a contra liability only. Lastly, we derecognized deferred income taxes associated with the convertible notes debt discount and adjusted deferred incomes taxes relative to unamortized debt issuance costs associated with our convertible notes due November 2024.

Interest expense related to the accretion of our convertible notes due November 2024 is no longer recognized. Interest accretion of convertible notes discount and net income from continuing operations attributable to Chart Industries, Inc. for the three months ended March 31, 2021 would have been $2.0 and $24.0, respectively, without the adoption of ASU 2020-06. As such, net income from continuing operations attributable to Chart Industries, Inc. per common share (both basic and diluted) for the three months ended March 31, 2021 is $0.04 higher due to the effect of adoption of ASU 2020-06. As further described in Note 9, “Debt and Credit Arrangements,” on December 31, 2020, we amended the Indenture governing our convertible notes due November 2024 to eliminate share settlement thus leaving us with two settlement options: (1) cash settlement or (2) cash for par and any combination of cash and shares for the excess settlement amount above the $258.8 principal amount of our convertible notes due November 2024. ASU 2020-06 requires usage of the if-converted method to compute diluted earnings per share for our convertible notes due November 2024, however, based on the terms of the amended Indenture and the cessation of interest accretion expense recognition from the transition at adoption, the if-converted method was modified such that interest expense is no longer added to the numerator, and the denominator only includes incremental shares that would be issued upon conversion.

9

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

Impacts on Financial Statements

The following table summarizes the cumulative effect of the changes to our condensed consolidated balance sheet as of December 31, 2020 from the adoption of ASU 2020-06:

	Balance at December 31, 2020		Adjustments due to ASU 2020-06 adoption		Balance at January 1, 2021
Liabilities
Accrued income taxes	$	46.5	$	(0.2)	$	46.3
Current convertible notes (1)	220.9		34.0		254.9
Long-term deferred tax liabilities	60.2		(7.6)		52.6
Equity
Additional paid-in-capital	$	780.8	$	(36.9)	$	743.9
Retained earnings	808.4		10.7		819.1

_______________

(1)Current convertible notes is presented net of unamortized discount and debt issuance costs of $34.8 and $3.1, respectively at December 31, 2020. Current convertible notes is presented net of unamortized debt issuance costs of $3.9 at January 1, 2021.

In January 2020, the FASB issued ASU 2020-01, “Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815).” This ASU clarifies the interactions between the measurement alternative in Topic 321, the equity method of accounting in Topic 323 and the application of guidance for certain forward contracts and purchased options that upon settlement or exercise would be accounted for under the equity method of accounting in Topic 815. This guidance is effective for fiscal years ending after December 15, 2020. We adopted this guidance effective January 1, 2021. The adoption of this guidance did not have a material impact on our financial position, results of operations or disclosures.

10

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

NOTE 2 — Discontinued Operations

As discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, on October 1, 2020, we closed on the sale of our cryobiological products business to Cryoport, Inc. (NASDAQ: CYRX) (the “Cryobiological Divestiture”). Our cryobiological products business asset group met the criteria to be held for sale. Furthermore, we determined that the assets held for sale qualified for discontinued operations. As such, the financial results of the cryobiological products business are reflected in our unaudited condensed consolidated statements of income and comprehensive income as discontinued operations for all prior periods presented.

Summarized Financial Information of Discontinued Operations

The following table represents income from discontinued operations, net of tax:

	Three Months Ended March 31, 2020
Sales	$	19.2
Cost of sales	10.1
Selling, general and administrative expenses	1.4
Operating income (1)	7.7
Income before income taxes from discontinued operations	7.7
Income tax expense	1.3
Income from discontinued operations, net of tax	$	6.4

________________

(1)Includes depreciation expense of $0.3 for the three months ended March 31, 2020.

The following table represents a summary of cash flows related to discontinued operations:

	Three Months Ended March 31, 2020
Net cash provided by (used in):
Operating activities	$	7.2
Investing activities	(0.1)
Net cash provided by discontinued operations	$	7.1

NOTE 3 — Reportable Segments

As reported in our Annual Report on Form 10-K for the year ended December 31, 2020, the structure of our internal organization is divided into the following four reportable segments, which are also our operating segments: Cryo Tank Solutions, Heat Transfer Systems, Specialty Products and Repair, Service & Leasing.

Our Cryo Tank Solutions segment, which has principal operations in the United States, Europe and Asia, supplies bulk, microbulk and mobile equipment used in the storage, distribution, vaporization, and application of industrial gases. Our Heat Transfer Systems segment, which has principal operations in the United States, Europe and India, supplies mission critical engineered equipment and systems used in the separation, liquefaction, and purification of hydrocarbon and industrial gases that span gas-to-liquid applications. Our Specialty Products segment with locations globally supplies products used in our specialty market applications including hydrogen, HLNG vehicle tanks, food and beverage, space exploration, lasers, cannabis and water treatment, amongst others. Our Repair, Service & Leasing segment, which includes repair and service centers globally, provides installation, service, repair, maintenance, and refurbishment of cryogenic products as well as global equipment leasing solutions.

Corporate includes operating expenses for executive management, accounting, tax, treasury, corporate development, human resources, information technology, investor relations, legal, internal audit and risk management. Corporate support functions are not currently allocated to the segments. All prior period amounts presented in the tables below have been reclassified based on our current reportable segments.

11

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

We evaluate performance and allocate resources based on operating income as determined in our condensed consolidated statements of income and comprehensive income.

Segment Financial Information

	Three Months Ended March 31, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	103.9	$	69.2	$	77.3	$	41.4	$	(3.3)	$	—	$	288.5
Depreciation and amortization expense	3.9		9.5		3.1		2.6		—		0.4		19.5
Operating income (loss) (1) (2)	15.6		3.9		17.9		8.3		—		(16.8)		28.9

	Three Months Ended March 31, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	98.0	$	112.9	$	52.9	$	40.7	$	(2.6)	$	—	$	301.9
Depreciation and amortization expense	4.4		14.1		1.4		3.3		—		0.4		23.6
Operating income (loss) (1)	11.6		5.5		13.8		4.6		—		(19.7)		15.8

_______________

(1)Restructuring costs for the:

•three months ended March 31, 2021 were $0.7 ($0.3 - Cryo Tank Solutions, $0.4 - Heat Transfer Systems).

•three months ended March 31, 2020 were $5.2 ($1.8 - Cryo Tank Solutions, $2.8 - Heat Transfer Systems, $0.6 - Corporate ).

(2)Includes acquisition-related contingent consideration adjustments of $0.8 in our Specialty Products segment for the three months ended March 31, 2021.

Sales by Geography

	Three Months Ended March 31, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	41.1	$	46.3	$	26.1	$	29.0	$	(1.7)	$	140.8
Europe, Middle East, Africa and India	37.7		7.8		45.6		10.5		(1.0)		100.6
Asia-Pacific	24.2		14.8		5.6		1.8		(0.6)		45.8
Rest of the World	0.9		0.3		—		0.1		—		1.3
Total	$	103.9	$	69.2	$	77.3	$	41.4	$	(3.3)	$	288.5

	Three Months Ended March 31, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	40.6	$	82.2	$	24.9	$	32.1	$	(1.3)	$	178.5
Europe, Middle East, Africa and India	34.3		9.5		25.6		6.7		(0.7)		75.4
Asia-Pacific	20.1		20.9		2.2		1.7		(0.5)		44.4
Rest of the World	3.0		0.3		0.2		0.2		(0.1)		3.6
Total	$	98.0	$	112.9	$	52.9	$	40.7	$	(2.6)	$	301.9

12

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

Total Assets

Corporate assets mainly include cash and cash equivalents and long-term deferred income taxes as well as certain corporate-specific property, plant and equipment, net and certain investments. Our allocation methodology for property, plant and equipment, net of the reportable segments differs from our allocation method of depreciation expense of a reportable segment and therefore, depreciation expense does not entirely align with the related depreciable assets of the reportable segments. Furthermore, since finite-lived intangible assets are excluded from total assets of reportable segments while amortization expense is allocated to each of our reportable segments, amortization expense by segment inherently does not align with the related amortizable intangible assets of the reportable segments.

	March 31, 2021		December 31, 2020
Cryo Tank Solutions	$	392.0	$	399.2
Heat Transfer Systems	230.1		247.2
Specialty Products	216.3		178.3
Repair, Service & Leasing	145.7		142.6
Total assets of reportable segments	984.1		967.3
Goodwill (1)	911.3		865.9
Identifiable intangible assets, net (1)	481.4		493.1
Corporate	275.5		244.2
Total	$	2,652.3	$	2,570.5

_______________

(1)See Note 8, “Goodwill and Intangible Assets,” for further information related to goodwill and identifiable intangible assets, net.

NOTE 4 — Revenue

Disaggregation of Revenue

The following tables represent a disaggregation of revenue by timing of revenue along with the reportable segment for each category:

	Three Months Ended March 31, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	98.7	$	5.6	$	61.9	$	26.7	$	(2.9)	$	190.0
Over time	5.2		63.6		15.4		14.7		(0.4)		98.5
Total	$	103.9	$	69.2	$	77.3	$	41.4	$	(3.3)	$	288.5

	Three Months Ended March 31, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	89.8	$	7.1	$	38.8	$	28.0	$	(1.5)	$	162.2
Over time	8.2		105.8		14.1		12.7		(1.1)		139.7
Total	$	98.0	$	112.9	$	52.9	$	40.7	$	(2.6)	$	301.9

Refer to Note 3, “Reportable Segments,” for a table of revenue by reportable segment disaggregated by geography.

13

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

Contract Balances

The following table represents changes in our contract assets and contract liabilities balances:

	March 31, 2021		December 31, 2020		Year-to-date Change ($)		Year-to-date Change (%)
Contract assets
Accounts receivable, net of allowances	$	186.4	$	200.8	$	(14.4)	(7.2)	%
Unbilled contract revenue	74.6		79.4		(4.8)		(6.0)	%
Contract liabilities
Customer advances and billings in excess of contract revenue	$	106.3	$	118.9	$	(12.6)	(10.6)	%
Long-term deferred revenue	0.2		1.9		(1.7)		(89.5)	%

Revenue recognized for the three months ended March 31, 2021 and 2020, that was included in the contract liabilities balance at the beginning of each year was $52.5 and $17.1, respectively. The amount of revenue recognized during the three months ended March 31, 2021 from performance obligations satisfied or partially satisfied in previous periods as a result of changes in the estimates of variable consideration related to long-term contracts, was not significant.

Remaining Performance Obligations

Remaining performance obligations represent the transaction price of firm signed purchase orders or other written contractual commitments from customers for which work has not been performed, or is partially completed, and excludes unexercised contract options and potential orders. As of March 31, 2021, the estimated revenue expected to be recognized in the future related to remaining performance obligations was $934.1. We expect to recognize revenue on approximately 76% of the remaining performance obligations over the next 12 months and with the remaining over the next few years thereafter.

14

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

NOTE 5 — Investments

Investments in equity securities

We measure certain of our investments in equity securities at fair value on a recurring basis. Furthermore, we categorize these investments in equity securities according to the fair value hierarchy as defined in Note 2, “Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended December 31, 2020. Mark-to-market fair value adjustments in these investments in equity securities are classified as unrealized (gain) loss on investments in equity securities in our condensed consolidated statements of income and comprehensive income.

For certain other investments in equity securities that are not measured at fair value on a recurring basis, we measure such investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.

The following table summarizes the components of our investments in equity securities:

	Investments in Equity Securities, Level 1 (1)		Investments in Equity Securities, Level 2 (2)		Subtotal		Investments in Equity Securities, All Others (3) (4) (5)		Investments in Equity Securities, Total
Balance at December 31, 2020	$	53.8	$	4.1	$	57.9	$	15.7	$	73.6
New investments	—		—		—		40.0		40.0
(Decrease) increase in fair value of investments in equity securities	(2.6)		5.9		3.3		—		3.3
Foreign currency translation adjustments	(2.4)		—		(2.4)		0.1		(2.3)
Balance at March 31, 2021	$	48.8	$	10.0	$	58.8	$	55.8	$	114.6

_______________

(1)Represents our investment in McPhy (Euronext Paris: MCPHY - ISIN; FR001742329), which was 41.6 million euros ($48.8) and 39.8 million euros ($53.8) at March 31, 2021 and December 31, 2020, respectively. For the three months ended March 31, 2021, we recognized an unrealized loss of $2.6. For additional information see Note 6, “Investments” in our Annual Report on Form 10-K for the year ended December 31, 2020.

(2)Represents our investment in Stabilis Energy, Inc. (“Stabilis”), which was $10.0 and $4.1 at March 31, 2021 and December 31, 2020, respectively. For the three months ended March 31, 2021, we recognized an unrealized gain of $5.9. For additional information see Note 6, “Investments” in our Annual Report on Form 10-K for the year ended December 31, 2020.

(3)Represents our investment in HTEC Hydrogen Technology & Energy Corporation (“HTEC”), which was CAD 20.0 million at both March 31, 2021 and December 31, 2020 (equivalent to $15.8 and $15.7 at March 31, 2021 and December 31, 2020, respectively). For additional information see Note 6, “Investments” in our Annual Report on Form 10-K for the year ended December 31, 2020.

(4)During the first quarter of 2021, we completed an investment in Svante Inc. (“Svante”) in the amount of $15.0 for under 10% of its capital stock on a fully diluted basis. This investment was measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. As of March 31, 2021, the value of the investment was $15.0. Svante offers companies in emissions-intensive industries a commercially viable way to capture large-scale CO2 emissions from existing infrastructure, either for safe storage or to be recycled for further industrial use in a closed loop.

(5)During the first quarter of 2021, we completed an investment in Transform Materials LLC (“Transform Materials”) in the amount of $25.0 for approximately 5% of its equity. This investment was measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. As of March 31, 2021, the value of the investment was $25.0. Transform Materials is a sustainable chemical technology company that uses microwave plasma to convert natural gas into acetylene and hydrogen. Its highly selective, cost-effective, net-carbon-negative process converts the methane in natural gas into high-value products suitable for direct use or downstream reactions.

15

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

Equity method accounting investments

Our equity investments accounted for under the equity method of accounting include a 50% ownership interest in a joint venture with Hudson Products de Mexico S.A. de CV which totaled $2.8 at both March 31, 2021 and December 31, 2020. This investment is operated and managed by our joint venture partner and as such, we do not have control over the joint venture and therefore it is not consolidated. Additionally, we have a 25% ownership interest in Liberty LNG, which was valued at $2.2 and $2.1 at March 31, 2021 and December 31, 2020, respectively. Our equity in earnings from these equity method accounting investments were not material for the periods presented.

NOTE 6 — Leases

As of March 31, 2021 and December 31, 2020, operating right-of-use (“ROU”) assets and lease liabilities were $28.0 and $27.7 ($5.1 of which was current) and $29.0 and $28.7 ($5.1 of which was current), respectively. The weighted-average remaining term for lease contracts was 5.6 years at March 31, 2021, with maturity dates ranging from April 2021 to February 2029. The weighted-average discount rate was 2.3% at March 31, 2021. ROU assets are classified as property, plant and equipment, net in the condensed consolidated balance sheets.

We incurred $3.0 and $2.9 of rental expense under operating leases for the three months ended March 31, 2021 and 2020, respectively. Certain operating leases contain rent escalation clauses and lease concessions that require additional rental payments in the later years of the term. Rent expense for these types of leases is recognized on a straight-line basis over the minimum lease term. Adjustments for straight-line rental expense for the respective periods was not material and as such, the majority of expense recognized was reflected in cash provided by operating activities for the respective periods. This expense consisted primarily of payments for base rent on building and equipment leases. Payments related to short-term lease costs and taxes and variable service charges on leased properties were immaterial. In addition, we have the right, but no obligation, to renew certain leases for various renewal terms.

The following table summarizes future minimum lease payments for non-cancelable operating leases as of March 31, 2021:

2021	$	5.4
2022	6.2
2023	5.6
2024	5.1
2025	4.3
Thereafter (1)	3.5
Total future minimum lease payments	$	30.1

_______________

(1)     As of March 31, 2021, future minimum lease payments for non-cancelable operating leases for period subsequent to 2024 relate to seven leased facilities.

NOTE 7 — Inventories

The following table summarizes the components of inventory:

	March 31, 2021		December 31, 2020
Raw materials and supplies	$	140.6	$	124.7
Work in process	57.8		57.8
Finished goods	81.5		65.9
Total inventories, net	$	279.9	$	248.4

The allowance for excess and obsolete inventory balance at both March 31, 2021 and December 31, 2020 was $9.7.

16

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

NOTE 8 — Goodwill and Intangible Assets

Goodwill

The following table represents the changes in goodwill by segment:

	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Consolidated
Balance at December 31, 2020	$	93.2	$	435.2	$	172.4	$	165.1	$	865.9
Goodwill acquired during the period (1)	—		—		52.1		—		52.1
Foreign currency translation adjustments	(4.8)		(2.6)		—		—		(7.4)
Purchase price adjustment (1)	—		—		0.7		—		0.7
Balance at March 31, 2021	$	88.4	$	432.6	$	225.2	$	165.1	$	911.3

_______________

(1)During the first quarter of 2021, we recorded a purchase price adjustment that increased goodwill by $0.7 in Specialty Products related to the Cryogenic Gas Technologies, Inc. acquisition. For further information regarding goodwill acquired and the purchase price adjustment during the period refer to Note 11, “Business Combinations.”

Amounts included in accumulated goodwill impairment loss at both March 31, 2021 and December 31, 2020 were $129.0 ($23.5 - Cryo Tank Solutions, $49.3 - Heat Transfer Systems, $35.8 - Specialty Products, $20.4 - Repair, Service & Leasing).

Intangible Assets

The following table displays the gross carrying amount and accumulated amortization for finite-lived intangible assets and indefinite-lived intangible assets (exclusive of goodwill) (1):

		March 31, 2021				December 31, 2020
	Weighted-average Estimated Useful Life	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Finite-lived intangible assets:
Customer relationships	13 years	$	300.2	$	(65.0)	$	302.5	$	(59.9)
Unpatented technology	12 years	110.8		(24.2)		110.4		(22.3)
Patents and other	6 years	5.6		(0.4)		8.4		(1.8)
Trademarks and trade names	11 years	3.3		(1.6)		3.6		(1.4)
Land use rights	50 years	11.0		(1.4)		11.1		(1.4)
Total finite-lived intangible assets	13 years	430.9		(92.6)		436.0		(86.8)
Indefinite-lived intangible assets:
Trademarks and trade names		143.1		—		143.9		—
Total intangible assets		$	574.0	$	(92.6)	$	579.9	$	(86.8)

_______________

(1)Amounts include the impact of foreign currency translation. Fully amortized or impaired amounts are written off.

Amortization expense for intangible assets subject to amortization was $8.8 and $14.0 for the three months ended March 31, 2021 and 2020, respectively. We estimate amortization expense to be recognized during the next five years as follows:

For the Year Ending December 31,
2021	$	35.7
2022	34.6
2023	34.4
2024	34.1
2025	33.2

17

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

Government Grants

We received certain government grants related to land use rights for capacity expansion in China (“China Government Grants”). China Government Grants are generally recorded in other current liabilities and other long-term liabilities in the unaudited condensed consolidated balance sheets and generally recognized into income over the useful life of the associated assets (10 to 50 years).

China Government Grants are presented in our unaudited condensed consolidated balance sheets as follows:

	March 31, 2021		December 31, 2020
Current	$	0.5	$	0.5
Long-term	7.1		7.3
Total China Government Grants	$	7.6	$	7.8

NOTE 9 — Debt and Credit Arrangements

Summary of Outstanding Borrowings

The following table represents the components of our borrowings:

	March 31, 2021		December 31, 2020
Senior secured revolving credit facility and term loan:
Term loan due June 2024 (1)	$	103.1	$	103.1
Senior secured revolving credit facility due June 2024 (2) (3)	204.7		123.5
Unamortized debt issuance costs	(4.7)		(5.0)
Senior secured revolving credit facility and term loan, net of debt issuance costs	303.1		221.6
Convertible notes due November 2024:
Principal amount	258.8		258.8
Unamortized discount (4)	—		(34.8)
Unamortized debt issuance costs	(3.6)		(3.1)
Convertible notes due November 2024, net of unamortized discount and debt issuance costs	255.2		220.9
Foreign facilities	—		—
Total debt, net of unamortized discount and debt issuance costs	558.3		442.5
Less: current maturities	255.2		220.9
Long-term debt	$	303.1	$	221.6

_______________

(1)As of March 31, 2021, there were $103.1 in borrowings outstanding under the term loan due June 2024, which is due at maturity, bearing an interest rate of 2.0% (2.5% as of December 31, 2020).

(2)The senior secured revolving credit facility due 2024 includes $100.0 sub limit for letters of credit, a $250.0 sub limit for discretionary letters of credit and $50.0 sub limit for swingline loans. As of March 31, 2021, there were $204.7 in borrowings outstanding under the senior secured revolving credit facility due 2024 bearing a weighted-average interest rate of 1.8% (2.1% as of December 31, 2020) and $53.1 in letters of credit and bank guarantees outstanding supported by the senior secured revolving credit facility due 2024. As of March 31, 2021, the senior secured revolving credit facility due 2024 had availability of $292.2.

18

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

(3)A portion of borrowings outstanding under our senior secured revolving credit facility due 2024 are denominated in euros (“EUR Revolver Borrowings”). As of both March 31, 2021 and December 31, 2020, EUR Revolver Borrowings outstanding were EUR 71.5 million (equivalent to $83.8 and $87.7 at March 31, 2021 and December 31, 2020, respectively). During the three months ended March 31, 2021, we recognized an unrealized foreign currency gain of $3.9 relative to the translation of the EUR Revolver Borrowings outstanding during the reporting period. This unrealized foreign currency gain is classified as foreign currency (gain) loss and other in the condensed consolidated statement of income for the three months ended March 31, 2021.

(4)We derecognized the debt discount associated with the convertible notes due November 2024 upon adoption of ASU 2020-06 on January 1, 2021.

Senior Secured Revolving Credit Facility and Term Loan

On June 14, 2019, we entered into the Fourth Amended and Restated Credit Agreement, which includes a senior secured revolving credit facility (the “SSRCF”) and a term loan (together, the “2024 Credit Facilities”). The 2024 Credit Facilities mature on June 14, 2024.

•The SSRCF has a borrowing capacity of $550.0.

•The principal amount of the term loan is $450.0.

•The 2024 Credit Facilities bear interest at a base rate margin determined on a leveraged-based scale which ranges from 25 to 150 basis points for alternative base rate loans and 125 to 250 basis points for LIBOR loans.

•Interest and fees are payable on a quarterly basis (or if earlier, at the end of each interest period for LIBOR loans).

Significant financial covenants for the 2024 Credit Facilities include financial maintenance covenants that, as of the last day of any fiscal quarter ending on and after June 30, 2019, (i) require the ratio of the amount of Chart and its subsidiaries’ consolidated total net indebtedness to consolidated EBITDA to be less than specified maximum ratio levels and (ii) require the ratio of the amount of Chart and its subsidiaries’ consolidated EBITDA to consolidated cash interest expense to be greater than a specified minimum ratio level. The 2024 Credit Facilities include a number of other customary covenants including, but not limited to, restrictions on our ability to incur additional indebtedness, create liens or other encumbrances, sell assets, enter into sale and lease-back transactions, make certain payments, investments, loans, advances or guarantees, make acquisitions and engage in mergers or consolidations and pay dividends or distributions. At March 31, 2021, we were in compliance with all covenants.

The 2024 Credit Facilities also contain customary events of default. If such an event of default occurs, the lenders thereunder would be entitled to take various actions, including the acceleration of amounts due and all actions permitted to be taken by a secured creditor. The 2024 Credit Facilities are guaranteed by Chart and substantially all of its U.S. subsidiaries and secured by substantially all of the assets of Chart and our U.S. subsidiaries and 65% of the capital stock of our material non-U.S. subsidiaries (as defined by the Fourth Amended and Restated Credit Agreement) that are owned by U.S. subsidiaries.

On September 28, 2020 and April 20, 2020, we amended our 2024 Credit Facilities. The amendments, among other things, (i) reduce the LIBO Screen Rate (as defined in the Credit Agreement) floor by half, effectively reducing all interest payable by Chart (ii) provide Chart with further flexibility to complete divestitures at its discretion by changing the “catch-all” permitted divestiture basket from a small annual cap to a more substantial life-of the-facility cap, (iii) adjust the pricing grid in order to accommodate potentially higher leverage ratios, (iv) adjust factoring related definitions and other related provisions to provide Chart with greater flexibility to enter into such arrangements in the future, (v) incorporate a “cash hoarding” prevention covenant and (vi) incorporate various amendments to reflect interest rate floor and other changes to the Loan Syndications and Trading Association and Loan Market Association market standards for credit agreements. The terms and conditions under the 2024 Credit Facilities are otherwise substantially the same as those prior to the amendments. We recorded $1.9 in deferred debt issuance costs related to these amendments which are being amortized over the remaining term of the 2024 Credit Facilities.

We recorded $6.1 in deferred debt issuance costs in conjunction with the 2024 Credit Facilities, which is included in long-term debt in the unaudited condensed consolidated balance sheet at March 31, 2021, associated with the term loan, which is being amortized over its five-year term beginning in July 2019.

We paid $11.9 in deferred debt issuance costs related to the SSRCF. Deferred debt issuance costs are presented in other assets in the unaudited condensed consolidated balance sheets and are being amortized over the term of the SSRCF. At March 31, 2021, unamortized debt issuance costs associated with the SSRCF were $7.3.

19

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

The following table summarizes interest expense and financing costs amortization related to the 2024 Credit Facilities:

	Three Months Ended March 31,
	2021		2020
Interest expense, term loan due June 2024	$	0.6	$	4.2
Interest expense, senior secured revolving credit facility due June 2024	0.7		0.6
Interest expense, senior secured revolving credit facility and term loan due June 2024	$	1.3	$	4.8
Financing costs amortization, senior secured revolving credit facility and term loan due 2024	$	1.0	$	0.8

2024 Convertible Notes

On November 6, 2017, we issued 1.00% Convertible Senior Subordinated Notes due November 2024 (the “2024 Notes”) in the aggregate principal amount of $258.8, pursuant to an Indenture, dated as of such date (the “Indenture”). On December 31, 2020, we entered into the First Supplemental Indenture (the “Supplemental Indenture”) to the Indenture, between Chart and Wells Fargo Bank, National Association, as trustee, governing the 2024 Notes. Pursuant to the Supplemental Indenture, Chart irrevocably elected (i) to eliminate Chart’s option to elect Physical Settlement (as defined in the Indenture) on any conversion of 2024 Notes that occurs on or after the date of the Supplemental Indenture and (ii) that, with respect to any Combination Settlement (as defined in the Indenture) for a conversion of 2024 Notes, the Specified Dollar Amount (as defined in the Indenture) that will be settled in cash per $1,000 principal amount of the Notes shall be no lower than $1,000. The 2024 Notes bear interest at an annual rate of 1.00%, payable on May 15 and November 15 of each year, beginning on May 15, 2018, and will mature on November 15, 2024 unless earlier converted or repurchased.

The 2024 Notes are senior subordinated unsecured obligations of the Company and are not guaranteed by any of our subsidiaries. The 2024 Notes are senior in right of payment to our future subordinated debt, equal in right of payment with the Company’s future senior subordinated debt and are subordinated in right of payment to our existing and future senior indebtedness, including indebtedness under our existing credit agreement.

Prior to December 31, 2020, a conversion of the 2024 Notes could have been settled in cash, shares of our common stock or a combination of cash and shares of our common stock, at our election (subject to, and in accordance with, the settlement provisions of the Indenture). After December 31, 2020, a conversion of the 2024 Notes may be settled in either (1) cash or (2) cash for the principal amount of the 2024 Notes and any combination of cash and shares for the excess settlement amount above the principal amount of the 2024 Notes, at our election (subject to, and in accordance with, the settlement provisions of the Indenture and Supplemental Indenture). The initial conversion rate for the 2024 Notes is 17.0285 shares of common stock (subject to adjustment as provided for in the Indenture) per $1,000 principal amount of the 2024 Notes, which is equal to an initial conversion price of approximately $58.725 per share, representing a conversion premium of approximately 35% above the closing price of our common stock of $43.50 per share on October 31, 2017. In addition, following certain corporate events that occur prior to the maturity date as described in the Indenture, we will pay a make-whole premium by increasing the conversion rate for a holder who elects to convert its 2024 Notes in connection with such a corporate event in certain circumstances. For purposes of calculating earnings per share, if the average market price of our common stock exceeds the applicable conversion price during the periods reported, shares contingently issuable under the 2024 Notes will have a dilutive effect with respect to our common stock. Since our closing common stock price of $142.35 at the end of the period exceeded the conversion price of $58.725, the if-converted value exceeded the principal amount of the 2024 Notes by approximately $368.5 at March 31, 2021. As described below, we entered into convertible note hedge transactions, which are expected to reduce the potential dilution with respect to our common stock upon conversion of the 2024 Notes.

Holders of the 2024 Notes may convert their 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding August 15, 2024 only under the following circumstances: (1) during any fiscal quarter commencing after December 31, 2017 (and only during such fiscal quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price for the 2024 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Notes for each trading day of such measurement period was less than 97% of the product of the last reported sale price of our common stock and the applicable conversion rate for the 2024 Notes on each such

20

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

trading day; or (3) upon the occurrence of specified corporate events described in the Indenture. On or after August 15, 2024 until the close of business on the second scheduled trading day immediately preceding November 15, 2024, holders may convert their 2024 Notes at the option of the holder regardless of the foregoing circumstances.

As of April 1, 2021, the 2024 Notes continue to be convertible at the option of the shareholders. This conversion right, which will remain available until June 30, 2021, was triggered since the closing price of our common stock was greater than or equal to $76.3425 (130% of the conversion price of the 2024 Notes) for at least 20 trading days during the last 30 trading days ending on March 31, 2021. Since the holders of the 2024 Notes could potentially convert their 2024 Notes at their option during the three month period subsequent to March 31, 2021, the $258.8 principal amount of the 2024 Notes was classified as a current liability in the consolidated balance sheet at March 31, 2021. As of December 31, 2020, the 2024 Notes were convertible at the option of the holders, and the liability component of the 2024 Notes was classified as a current liability. We will reassess the convertibility of the 2024 Notes and the related balance sheet classification on a quarterly basis. There have been no conversions as of the date of this filing.

Prior to the adoption of ASU 2020-06, we allocated the gross proceeds of the 2024 Notes between the liability and equity components of the 2024 Notes. The initial liability component of $200.1, which was recorded as long-term debt, represented the fair value of similar debt instruments that have no conversion rights. The initial equity component of $58.7, which was recorded as additional paid-in capital, represented the debt discount and was calculated as the difference between the fair value of the liability component and gross proceeds of the 2024 Notes. The liability component was recognized at the present value of its associated cash flows using a 4.8% straight-debt rate and was being accreted to interest expense over the term of the 2024 Notes.

After the adoption of ASU 2020-06, our convertible notes due November 2024 are no longer bifurcated into separate liability and equity components in our March 31, 2021 condensed consolidated balance sheet. Rather, the $258.8 principal amount of our convertible notes due November 2024 was classified as a liability only in our March 31, 2021 condensed consolidated balance sheet. Upon adoption of ASU 2020-06 and transition, we recorded an adjustment to the convertible notes liability component, equity component (additional paid-in-capital) and retained earnings. This adjustment was calculated based on the carrying amount of the convertible notes as if it had always been treated as a liability only. Refer to Note 1, “Basis of Preparation” for further discussion.

Prior to the adoption of ASU 2020-06, we recorded $5.3 in deferred debt issuance costs associated with the 2024 Notes, which was being amortized over the term of the 2024 Notes using the effective interest method. We also recorded $1.5 in equity issuance costs, which was recorded as a reduction to additional paid-in capital. After the adoption of ASU 2020-06, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, i.e. as if debt issuance costs had always been treated as a contra liability only. We amortize the adjusted unamortized debt issuance costs balance over the term of the 2024 Notes using the effective interest method. Refer to Note 1, “Basis of Preparation” for further discussion. Furthermore, interest expense related to the accretion of our convertible notes due November 2024 is no longer recognized.

The following table summarizes interest accretion of the 2024 Notes discount, 1.0% contractual interest coupon and financing costs amortization associated with the 2024 Notes:

	Three Months Ended March 31,
	2021		2020
2024 Notes, interest accretion of convertible notes discount	$	—	$	1.9
2024 Notes, 1.0% contractual interest coupon	0.6		0.6
2024 Notes, total interest expense	$	0.6	$	2.5
2024 Notes, financing costs amortization	$	0.2	$	0.2

Convertible Note Hedge and Warrant Transactions Associated with the 2024 Notes

In connection with the pricing of the 2024 Notes, we entered into convertible note hedge transactions (the “Note Hedge Transactions”) with certain parties, including the initial purchasers of the 2024 Notes (the “Option Counterparties”). The Note Hedge Transactions are expected generally to reduce the potential dilution upon any future conversion of the 2024 Notes. Payments for the Note Hedge Transactions totaled approximately $59.5 and were recorded as a reduction to additional paid-in capital in the December 31, 2017 consolidated balance sheet.

21

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

We also entered into separate, privately negotiated warrant transactions (the “Warrant Transactions”) with the Option Counterparties to acquire up to 4.41 shares of our common stock. Proceeds received from the issuance of the Warrant Transactions totaled approximately $46.0 and were recorded as an addition to additional paid-in capital in the December 31, 2017 consolidated balance sheet. The strike price of the Warrant Transactions will initially be $71.775 per share (subject to adjustment), which is approximately 65% above the last reported sale price of our common stock on October 31, 2017. The Warrant Transactions could have a dilutive effect to our stockholders to the extent that the market price per share of our common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants.

The Note Hedge Transactions and Warrant Transactions effectively increased the conversion price of the 2024 Notes. The net cost of the Note Hedge Transactions and Warrant Transactions was approximately $13.5.

Foreign Facilities

In various markets where we do business, we have local credit facilities to meet local working capital demands, fund letters of credit and bank guarantees, and support other short-term cash requirements. The facilities generally have variable interest rates and are denominated in local currency but may, in some cases, facilitate borrowings in multiple currencies. We are permitted to borrow up to USD equivalent $80.9 under certain of our foreign facilities. As of March 31, 2021 and December 31, 2020 there were none outstanding in USD equivalent in borrowings outstanding under these facilities. The weighted-average interest rate on foreign facilities was of 1.3% as of March 31, 2021.

Certain of our foreign facilities allow us to request bank guarantees and letters of credit. None of these facilities allow revolving credit borrowings. We have foreign letters of credit and bank guarantees that totaled USD equivalent $51.6 and $47.7 as of March 31, 2021 and December 31, 2020, respectively.

Letters of Credit

Chart Energy & Chemicals, Inc., a wholly-owned subsidiary of the Company, had $1.0 in deposits in a bank outside of the SSRCF to secure letters of credit. The deposits are treated as restricted cash and restricted cash equivalents in the unaudited condensed consolidated balance sheets $1.0 in other assets at both March 31, 2021 and December 31, 2020.

Fair Value Disclosures

The fair value of the 2024 Notes was approximately 242% and 210% of their par value as of March 31, 2021 and December 31, 2020, respectively. The 2024 Notes are actively quoted instruments and, accordingly, the fair value of the 2024 Notes was determined using Level 1 inputs.

NOTE 10 — Product Warranties

We provide product warranties with varying terms and durations for the majority of our products. We estimate our warranty reserve by considering historical and projected warranty claims, historical and projected cost-per-claim, and knowledge of specific product issues that are outside our typical experience. We record warranty expense in cost of sales in the unaudited condensed consolidated statements of income and comprehensive income. Product warranty claims not expected to occur within one year are included as part of other long-term liabilities in the unaudited condensed consolidated balance sheets.

The following table represents changes in our consolidated warranty reserve:

Balance at December 31, 2020	$	11.9
Issued – warranty expense	(0.9)
Warranty usage	0.3
Balance at March 31, 2021	$	11.3

NOTE 11 — Business Combinations

Cryo Technologies Acquisition

On February 16, 2021, we acquired 100% of the equity interests of Cryogenic Gas Technologies, Inc. (“Cryo Technologies”) for approximately $55.0 in cash (subject to certain customary adjustments), net of $0.6 cash acquired. Cryo Technologies is a global leader in custom engineered process systems to separate, purify, refrigerate, liquefy and distribute high value industrial gases such as hydrogen, helium, argon and hydrocarbons with design capabilities for cold boxes for hydrogen

22

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

and helium use. The distribution systems Cryo Technologies supplies are located within the helium and hydrogen liquefaction facilities and are inclusive of trailer loading systems, which facilitates the first step in product distribution. The preliminary estimated fair value of the net assets acquired and goodwill at the date of acquisition was $2.9 and $52.1, respectively. Net assets includes $1.8 in intangible assets, which consists of unpatented technology and customer relationships. The acquisition consideration allocation is preliminary and shall be further revised as we finalize third-party valuations and other analyses to include identifiable intangible assets during the remainder of the measurement period, which shall not exceed twelve months from the closing of the acquisition.

Sustainable Energy Solutions, Inc. Acquisition

On December 23, 2020, we completed the acquisition of Sustainable Energy Solutions, Inc. (“SES”). SES’s Cryogenic Carbon Capture™ (CCC) technology eliminates most emissions from fossil fuels while enabling better use of intermittent renewables through grid-scale energy storage. The stock purchase was completed for a closing purchase price of $20.0 in cash at closing, subject to a post-closing working capital adjustment, plus a potential earn-out not to exceed $25.0. The preliminary estimated fair value of the net assets acquired and goodwill at the date of acquisition was $13.4 and $24.0, respectively. Net assets includes $17.3 in intangible assets, which consists of unpatented technology, trade names and non-compete contracts.

BlueInGreen, LLC Acquisition

On November 3, 2020, we completed the acquisition of BlueInGreen, LLC (“BIG”), a leading dissolved-gas expert providing custom-engineered solutions for water treatment and industrial process applications that delivers tangible economic, social and environmental value. The stock purchase was completed for a purchase price of $20.0 in cash at closing (subject to customary adjustments), plus a potential earn-out not to exceed $6.0. The preliminary estimated fair value of the net assets acquired and goodwill at the date of acquisition was $8.8 and $14.8, respectively. The purchase price allocation reported at December 31, 2020 was preliminary and was based on provisional fair values. During the first three months of 2021, we received and analyzed new information about certain intangible assets and subsequently decreased their estimated fair value by $0.7. Net assets includes $6.2 in intangible assets, which consists of non-compete contracts, unpatented technology, trademarks and trade names, certifications and licenses and customer relationships.

Alabama Trailers Acquisition

On October 13, 2020, we completed the acquisition of the Theodore, Alabama cryogenic trailer and hydrogen trailer (transport) assets of Worthington Industries, Inc. (NYSE: WOR) for $10.0 in cash (“Alabama Trailers”). Worthington Industries, Inc. made the decision to exit the hydrogen trailer business and sold the business to Chart at a discount. As a result of the acquisition, we recorded a bargain purchase gain of $5.0. Alabama Trailers designs, manufactures and sells cryogenic trailers and hydrogen trailers used in industrial gas and energy applications.

The purchase price allocations of Cryo Technologies, SES, BIG and Alabama Trailers are preliminary and are based on provisional fair values and subject to revision as we finalize third-party valuations and other analyses. Final determination of the fair values may result in further adjustments to the value of net assets acquired.

Contingent Consideration

The fair value of contingent consideration was $16.9 for SES and $3.2 for BIG at the date of acquisitions and was valued according to a discounted cash flow approach, which included assumptions regarding the probability of achieving certain targets and a discount rate applied to the potential payments. Potential payments are measured between the period commencing April 1, 2021 and ending on December 31, 2028 based on the attainment of certain earnings targets. The potential payments related to both SES and BIG contingent consideration on a combined basis is between $0.0 and $31.0.

Valuations are performed using Level 3 inputs as defined in Note 2, “Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended December 31, 2020 and are evaluated on a quarterly basis based on forecasted sales and earnings targets. Contingent consideration liabilities are classified as other current liabilities and other long-term liabilities in the condensed consolidated balance sheets. Changes in fair value of contingent consideration, including accretion, are recorded as selling, general and administrative expenses in the condensed consolidated statements of income and comprehensive income.

The following table represents the changes to our contingent consideration liabilities:

23

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

	SES		BIG		Total
Balance at December 31, 2020	$	16.9	$	3.2	$	20.1
Increase in fair value of contingent consideration liabilities	0.7		0.1		0.8
Balance at March 31, 2021	$	17.6	$	3.3	$	20.9

NOTE 12 — Accumulated Other Comprehensive (Loss) Income

The components of accumulated other comprehensive (loss) income are as follows:

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive income (loss)
Balance at December 31, 2020	$	13.8	$	(11.4)	$	2.4
Other comprehensive loss	(19.6)		—		(19.6)
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes	—		0.4		0.4
Net current-period other comprehensive (loss) income, net of taxes	(19.6)		0.4		(19.2)
Balance at March 31, 2021	$	(5.8)	$	(11.0)	$	(16.8)

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive loss
Balance at December 31, 2019	$	(25.0)	$	(10.9)	$	(35.9)
Other comprehensive loss	(10.2)		—		(10.2)
Amounts reclassified from accumulated other comprehensive loss, net of income taxes	—		0.3		0.3
Net current-period other comprehensive (loss) income, net of taxes	(10.2)		0.3		(9.9)
Balance at March 31, 2020	$	(35.2)	$	(10.6)	$	(45.8)

24

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

NOTE 13 — Earnings Per Share

The following table represents calculations of net earnings per share of common stock:

	Three Months Ended March 31,
	2021		2020
Net income attributable to Chart Industries, Inc.
Income from continuing operations	$	25.6	$	2.1
Income from discontinued operations, net of tax	—		6.4
Net income attributable to Chart Industries, Inc.	$	25.6	$	8.5
Earnings per common share – basic:
Income from continuing operations	$	0.72	$	0.06
Income from discontinued operations	—		0.18
Net income attributable to Chart Industries, Inc.	$	0.72	$	0.24
Earnings per common share – diluted:
Income from continuing operations	$	0.63	$	0.06
Income from discontinued operations	—		0.18
Net income attributable to Chart Industries, Inc.	$	0.63	$	0.24
Weighted average number of common shares outstanding – basic	35.55		35.77
Incremental shares issuable upon assumed conversion and exercise of share-based awards	0.33		0.24
Incremental shares issuable due to dilutive effect of convertible notes	2.57		—
Incremental shares issuable due to dilutive effect of warrants	2.17		—
Weighted average number of common shares outstanding – diluted	40.62		36.01

Diluted earnings per share does not reflect the following potential common shares as the effect would be anti-dilutive:

	Three Months Ended March 31,
	2021	2020
Share-based awards	0.06	0.50
Convertible note hedge and capped call transactions (1)	2.57	—
Warrants	—	4.41
Total anti-dilutive securities	2.63	4.91

 _______________

(1)The convertible note hedge offsets any dilution upon actual conversion of the 2024 Notes up to a common stock price of $71.775 per share. For further information, refer to Note 9, “Debt and Credit Arrangements.”

NOTE 14 — Income Taxes

Income tax expense of $3.1 and $0.4 for the three months ended March 31, 2021 and 2020, respectively, represents taxes on both U.S. and foreign earnings at a combined effective income tax rate of 10.6% and 16.0%, respectively.

The effective income tax rate of 10.6% for the three months ended March 31, 2021 differed from the U.S. federal statutory rate of 21% primarily due to losses incurred by some of our foreign operations for which no benefit was recorded, partially offset by the effect of income earned by our certain foreign entities being taxed at higher rates than the U.S. federal statutory rate and excess tax benefits associated with share-based compensation.

25

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

The effective income tax rate of 16.0% for the three months ended March 31, 2020 differed from the U.S. federal statutory rate of 21% primarily due to losses incurred by certain of our foreign operations for which no benefit was recorded, partially offset by the effect of income earned by certain of our foreign entities being taxed at higher rates than the U.S. federal statutory rate and excess tax benefits associated with share-based compensation.

As of both March 31, 2021 and December 31, 2020, we had a liability for gross unrecognized tax benefits of $1.9. This amount includes $1.3 of unrecognized tax benefits as of both March 31, 2021 and December 31, 2020, which, if ultimately recognized, would reduce our annual effective income tax rate. We recognized interest and penalties of $0.3 related to uncertain tax positions in income tax expense as of March 31, 2021.

NOTE 15 — Share-based Compensation

During the three months ended March 31, 2021, we granted 0.06 stock options, 0.05 restricted stock units and 0.03 performance units. The total fair value of awards granted to employees during the three months ended March 31, 2021 was $12.5. In addition, our non-employee directors received stock awards with a total fair value of $0.1. During the three months ended March 31, 2021, participants in our stock option plans exercised options to purchase 0.10 shares of our common stock.

Stock options generally have a four-year graded vesting period. Restricted stock and restricted stock units generally vest ratably over a three-year period. Performance units generally vest at the end of a three-year performance period based on the attainment of certain pre-determined performance condition targets. During the three months ended March 31, 2021, 0.07 restricted stock and restricted stock units vested and 0.01 performance units vested.

Share-based compensation expense was $3.4 and $2.9 for the three months ended March 31, 2021 and 2020, respectively. Share-based compensation expense is included in selling, general, and administrative expenses in the unaudited condensed consolidated statements of income and comprehensive income. As of March 31, 2021, total share-based compensation of $18.0 is expected to be recognized over the weighted-average period of approximately 2.4 years.

NOTE 16 — Commitments and Contingencies

Environmental

We are subject to federal, state, local, and foreign environmental laws and regulations concerning, among other matters, waste water effluents, air emissions, and handling and disposal of hazardous materials, such as cleaning fluids. We are involved with environmental compliance, investigation, monitoring, and remediation activities at certain of our owned and formerly owned manufacturing facilities and at one owned facility that is leased to a third party, and, except for these continuing remediation efforts, believe we are currently in substantial compliance with all known environmental regulations. At both March 31, 2021 and December 31, 2020, we had undiscounted accrued environmental reserves of $0.3.

Legal Proceedings

Stainless Steel Cryobiological Tank Legal Proceedings

During the second quarter of 2018, Chart was named in lawsuits (including lawsuits filed in the U.S. District Court for the Northern District of California) filed against Chart and other defendants with respect to the alleged failure of a stainless steel cryobiological storage tank (model MVE 808AF-GB) at the Pacific Fertility Center in San Francisco, California.  We continue to evaluate the merits of such claims in light of the information available to date regarding use, maintenance and operation of the tank that was sold to the Pacific Fertility Center through an independent distributor and which has been out of our control for six years prior to the alleged failure.  Accordingly, an accrual related to any damages that may result from the lawsuits has not been recorded because a potential loss is not currently probable or estimable. In connection with the Cryobiological Divestiture, Chart retained certain potential liabilities and claims, including the claims asserted in connection with this litigation.

We have asserted various defenses against the claims in the lawsuits, including a defense that since manufacture, we were not in any way involved with the installation, ongoing maintenance or monitoring of the tank or related fertility center cryogenic systems at any time since the initial delivery of the tank.

We are occasionally subject to various legal claims related to performance under contracts, product liability, taxes, employment matters, environmental matters, intellectual property, and other matters incidental to the normal course of our business. Based on our historical experience in litigating these claims, as well as our current assessment of the underlying

26

CHART INDUSTRIES, INC. AND SUBSIDIARIES

Notes to the Unaudited Condensed Consolidated Financial Statements – March 31, 2021

(Dollars and shares in millions, except per share amounts) – Continued

merits of the claims and applicable insurance, if any, management believes that the final resolution of these matters will not have a material adverse effect on our financial position, liquidity, cash flows, or results of operations. Future developments may, however, result in resolution of these legal claims in a way that could have a material adverse effect.

NOTE 17 — Restructuring Activities

Restructuring costs of $0.7 for the first three months of 2021 were primarily related to headcount reductions and facility relocation and moving expenses. As previously reported, on July 17, 2020, we announced internally our intention to transfer operations of our heat exchanger leased facility in Tulsa, Oklahoma to our Beasley, Texas location at which we own 260 acres of land. This closure is a cost reduction measure within our Heat Transfer Systems segment to continue to structure the business for profitable growth and capacity efficiency. Total costs related to this closure are expected to be approximately $9.0, of which $2.7 was spent in 2020 and $0.4 has been spent year to date, associated with severance, relocation and moving expenses. We expect this project to be completed by June 30, 2021. We are closely monitoring our end markets and order rates and will continue to take appropriate and timely actions as necessary.

Restructuring costs of $5.2 for the three months ended March 31, 2020 were related to certain cost reduction actions across all segments and corporate to appropriately size our workforce with demand as well as eliminate redundant work. Costs were primarily related to headcount reductions.

The following table summarizes severance and other restructuring costs, which includes employee-related costs, facility rent and exit costs, relocation, recruiting, travel and other:

	Three Months Ended March 31,
	2021		2020
Severance:
Cost of sales	$	—	$	2.3
Selling, general, and administrative expenses	0.3		2.9
Total severance costs	0.3		5.2
Other restructuring:
Cost of sales	0.4		—
Total other restructuring costs	0.4		—
Total restructuring costs	$	0.7	$	5.2

The following tables summarize our restructuring activities:

	Three Months Ended March 31, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at December 31, 2020	$	0.5	$	0.2	$	—	$	—	$	0.1	$	0.8
Restructuring charges	0.3		0.4		—		—		—		0.7
Cash payments and other	(0.3)		(0.6)		—		—		(0.1)		(1.0)
Balance at March 31, 2021	$	0.5	$	—	$	—	$	—	$	—	$	0.5

	Three Months Ended March 31, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at December 30, 2019	$	0.5	$	0.2	$	—	$	—	$	0.2	$	0.9
Restructuring charges	1.8		2.8		—		—		0.6		5.2
Cash payments and other	(0.8)		(2.5)		—		—		—		(3.3)
Balance at March 31, 2020	$	1.5	$	0.5	$	—	$	—	$	0.8	$	2.8

27

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our results of operations and financial condition should be read in conjunction with our condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements. Actual results may differ materially from those discussed below. See “Forward-Looking Statements” at the end of this discussion and Item 1A. “Risk Factors” for a discussion of the uncertainties, risks and assumptions associated with this discussion.

Overview

We are a leading independent global manufacturer of highly engineered equipment servicing multiple applications in the Clean Energy and Industrial Gas markets. Our unique product portfolio is used in every phase of the liquid gas supply chain, including upfront engineering, service and repair. Being at the forefront of the clean energy transition, Chart is a leading provider of technology, equipment and services related to liquefied natural gas, hydrogen, biogas and CO2 Capture amongst other applications. We are committed to excellence in environmental, social and corporate governance (ESG) issues both for our company as well as our customers. With over 25 global locations from the United States to Asia, Australia, India, Europe and South America, we maintain accountability and transparency to our team members, suppliers, customers and communities.

Covid-19 Update

The outbreak and continued uncertainty associated with the coronavirus (Covid-19) did not have a material adverse effect on our reported results for the first three months of 2021, however, we continue to actively monitor the impact of the Covid-19 outbreak on our results of operations for the remainder of 2021 and beyond. The extent to which our operations will be impacted by the outbreak will largely depend on future developments, which are highly uncertain and cannot be accurately predicted, including new information which may emerge concerning the severity, or reemergence, of the outbreak and actions by government authorities to contain the outbreak or treat its impact, among other things.

First Quarter 2021 Highlights

Orders of $417.2 million were the highest in our history (excluding big LNG), driven by broad based demand including a recovery in certain end markets, continued demand for our clean products supporting the strongest current macroeconomic trend of sustainability, and the combination of larger liquefaction orders for LNG and hydrogen. Total orders increased across three out of four of our segments during the first quarter 2021 as compared to the first quarter 2020. This continued record level order activity contributed to record ending total backlog as of March 31, 2021 of $934.1 million compared to $723.3 million as of March 31, 2020 and $810.0 million as of December 31, 2020, representing an increase of $210.8 million or 29.1% and $124.1 million or 15.3%, respectively. These increases were largely driven by record orders in our Specialty Products segment mainly driven by orders in hydrogen equipment, HLNG vehicle tanks, lasers and LNG regasification applications. Specialty Products segment backlog was $270.5 million as of March 31, 2021 as compared to $130.3 million and $199.7 million as of March 31, 2020 and December 31, 2020, respectively.

Although consolidated sales decreased to $288.5 million in the first quarter 2021 from $301.9 million in the first quarter 2020, which was mainly driven by volume softness in our Heat Transfer Systems segment and the timing of the recognition of certain orders into the second quarter, sales increased in the remaining three segments led by a $24.4 million or 46.1% increase in Specialty Products segment sales. Furthermore, first quarter 2021 gross margin as a percent of sales of 29.1% increased from 27.3% in the first quarter of 2020 and from 28.1% in the prior quarter. The increase in margin as a percent of sales in the current quarter over first quarter of 2020 was primarily driven by our Repair, Service & Leasing segment mainly on lower costs in our repair facilities. The improvement in gross margin as a percentage of sales compared to the prior quarter was primarily driven by favorable product mix in cannabis and space-related products within our Specialty products segment as well as favorable execution, especially in China.

Consolidated selling, general and administrative (“SG&A”) expenses as a percentage of consolidated sales in the first quarter of 2021 increased by 2.9% as compared to the prior quarter primarily driven by ramp up in our Specialty Products business and decreased by 1.4% compared to the first quarter of 2020 based on the effect of cost reduction actions we took in 2020.

Outlook

Our 2021 full year outlook reflects execution on the clean energy transition including recovery in air cooled heat exchangers related to growth in CO2 Capture applications, small scale LNG opportunities and growth in our Specialty Products business, especially in water treatment, over the road trucking and hydrogen applications driven by strength in first quarter orders, including specific liquefaction projects and commercial opportunities increasing from our inorganic investments and acquisition completed in the past six months.

28

Our 2021 sales outlook is inclusive of $6.4 million of Venture Global’s Calcasieu Pass revenue for the remainder of 2021 as well as $30 million of 2021 revenue from the acquisition of Cryo Technologies. There is no additional Big LNG revenue included in our outlook although we currently anticipate that at least one order will be received during the year. We continue to invest in our automation, process improvement, and productivity activities across Chart, with total anticipated 2021 capital expenditures spend of $40.0 million to $50.0 million.

29

Consolidated Results for the Three Months Ended March 31, 2021 and 2020, and December 31, 2020

The following table includes key metrics used to evaluate our business and measure our performance and represents selected financial data for our operating segments for the three months ended March 31, 2021 and 2020 and December 31, 2020 (dollars in millions). Financial data for the three months ended December 31, 2020 has been included to provide additional information regarding our business trends on a sequential quarter basis.

Selected Financial Information

	Three Months Ended									Current Quarter vs. Prior Year Same Quarter				Current Quarter vs. Prior Sequential Quarter
	March 31, 2021			March 31, 2020			December 31, 2020			Variance  ($)		Variance (%)		Variance  ($)		Variance (%)
Sales
Cryo Tank Solutions	$	103.9		$	98.0		$	110.5		$	5.9	6.0	%	$	(6.6)	(6.0)	%
Heat Transfer Systems	69.2			112.9			78.9			(43.7)		(38.7)	%	(9.7)		(12.3)	%
Specialty Products	77.3			52.9			85.1			24.4		46.1	%	(7.8)		(9.2)	%
Repair, Service & Leasing	41.4			40.7			41.0			0.7		1.7	%	0.4		1.0	%
Intersegment eliminations	(3.3)			(2.6)			(3.1)			(0.7)		26.9	%	(0.2)		6.5	%
Consolidated	$	288.5		$	301.9		$	312.4		$	(13.4)	(4.4)	%	$	(23.9)	(7.7)	%
Gross Profit
Cryo Tank Solutions	$	25.2		$	24.1		$	24.0		$	1.1	4.6	%	$	1.2	5.0	%
Heat Transfer Systems	15.8			26.1			19.5			(10.3)		(39.5)	%	(3.7)		(19.0)	%
Specialty Products	28.2			20.3			26.5			7.9		38.9	%	1.7		6.4	%
Repair, Service & Leasing	14.7			11.8			17.9			2.9		24.6	%	(3.2)		(17.9)	%
Consolidated	$	83.9		$	82.3		$	87.9		$	1.6	1.9	%	$	(4.0)	(4.6)	%
Gross Profit Margin
Cryo Tank Solutions	24.3		%	24.6		%	21.7		%
Heat Transfer Systems	22.8		%	23.1		%	24.7		%
Specialty Products	36.5		%	38.4		%	31.1		%
Repair, Service & Leasing	35.5		%	29.0		%	43.7		%
Consolidated	29.1		%	27.3		%	28.1		%
SG&A Expenses
Cryo Tank Solutions	$	8.9		$	11.1		$	11.6		$	(2.2)	(19.8)	%	$	(2.7)	(23.3)	%
Heat Transfer Systems	7.0			11.2			8.2			(4.2)		(37.5)	%	(1.2)		(14.6)	%
Specialty Products	9.1			6.1			6.4			3.0		49.2	%	2.7		42.2	%
Repair, Service & Leasing	4.4			4.4			4.1			—		—	%	0.3		7.3	%
Corporate	16.8			19.7			10.7			(2.9)		(14.7)	%	6.1		57.0	%
Consolidated	$	46.2		$	52.5		$	41.0		$	(6.3)	(12.0)	%	$	5.2	12.7	%
SG&A Expenses (% of Sales)
Cryo Tank Solutions	8.6		%	11.3		%	10.5		%
Heat Transfer Systems	10.1		%	9.9		%	10.4		%
Specialty Products	11.8		%	11.5		%	7.5		%
Repair, Service & Leasing	10.6		%	10.8		%	10.0		%
Consolidated	16.0		%	17.4		%	13.1		%

30

	Three Months Ended									Current Quarter vs. Prior Year Same Quarter				Current Quarter vs. Prior Sequential Quarter
	March 31, 2021			March 31, 2020			December 31, 2020			Variance  ($)		Variance (%)		Variance  ($)		Variance (%)
Operating Income (Loss) (1)
Cryo Tank Solutions	$	15.6		$	11.6		$	11.2		$	4.0	34.5	%	$	4.4	39.3	%
Heat Transfer Systems (2)	3.9			5.5			(9.9)			(1.6)		(29.1)	%	13.8		(139.4)	%
Specialty Products (3)	17.9			13.8			19.9			4.1		29.7	%	(2.0)		(10.1)	%
Repair, Service & Leasing	8.3			4.6			12.1			3.7		80.4	%	(3.8)		(31.4)	%
Corporate (4) (5)	(16.8)			(19.7)			(10.8)			2.9		(14.7)	%	(6.0)		55.6	%
Consolidated	$	28.9		$	15.8		$	22.5		$	13.1	82.9	%	$	6.4	28.4	%
Operating Margin
Cryo Tank Solutions	15.0		%	11.8		%	10.1		%
Heat Transfer Systems	5.6		%	4.9		%	(12.5)		%
Specialty Products	23.2		%	26.1		%	23.4		%
Repair, Service & Leasing	20.0		%	11.3		%	29.5		%
Consolidated	10.0		%	5.2		%	7.2		%

_______________

(1)Restructuring costs (credits) for the three months ended:

•March 31, 2021 were $0.7 ($0.3 - Cryo Tank Solutions, $0.4 - Heat Transfer Systems).

•March 31, 2020 were $5.2 ($1.8 - Cryo Tank Solutions, $2.8 - Heat Transfer Systems, and $0.6 Corporate).

•December 31, 2020 were $0.9 ($0.1 - Cryo Tank Solutions, $0.6 - Heat Transfer Systems, $0.3 - Specialty Products, and $(0.1) - Corporate).

(2)Includes $16.0 impairment of our trademarks and trade names indefinite-lived intangible assets related to the AXC business in our Heat Transfer Systems segment for the three months ended December 31, 2020.

(3)Includes acquisition-related contingent consideration adjustments of $0.8 in our Specialty Products segment for the three months ended March 31, 2021.

(4)Includes transaction-related costs of $4.3 for the three months ended March 31, 2020.

(5)Includes transaction-related costs of $2.6 for the three months ended December 31, 2020, which were mainly related to the Sustainable Energy Solutions, Inc., BlueInGreen, LLC and Alabama Trailers acquisitions.

Results of Operations for the Three Months Ended March 31, 2021 and 2020, and December 31, 2020

Sales for the first quarter of 2021 compared to the same quarter in 2020 decreased $13.4 million, from $301.9 million to $288.5 million, or 4.4%. The decrease in sales was primarily driven by the continued softness in demand for midstream and upstream compression equipment within our Heat Transfer Systems segment, partially offset by an increase in Specialty Products segment sales. Furthermore, Cryo Tank Solutions sales increased in the first quarter of 2021 as compared to the first quarter of 2020. First quarter 2020 Cryo Tank Solutions sales were negatively impacted by the Covid-19 outbreak, particularly in Europe and Asia due to temporary facility shutdowns.

Gross profit increased during the first quarter of 2021 compared to the first quarter of 2020 by $1.6 million or 1.9%, and first quarter 2021 gross margin as a percent of sales of 29.1% increased from 27.3% in the first quarter of 2020. The increase in margin as a percent of sales in the current quarter over first quarter of 2020 was primarily driven by higher margins associated with our Repair, Service & Leasing segment mainly on lower costs in our repair facilities and increasing mix of our higher margined Specialty Products and Repair, Service & Leasing businesses. Restructuring costs recorded to cost of sales were $0.4 million and $2.3 million for the three months ended March 31, 2021 and 2020, respectively.

Consolidated SG&A expenses decreased by $6.3 million or 12.0% during the first quarter of 2021 compared to the same quarter in 2020. Consolidated selling, general and administrative (“SG&A”) expenses as a percentage of consolidated sales in the first quarter of 2021 increased by 2.9% as compared to the prior quarter primarily driven by ramp up in our Specialty Products business and decreased by 1.4% compared to the first quarter of 2020 based on the effect of cost reduction actions we took in 2020. Restructuring costs recorded to consolidated SG&A expenses were $0.3 million and $2.9 million for the three months ended March 31, 2021 and 2020, respectively.

31

Interest Expense, Net and Financing Costs Amortization

Interest expense, net for the three months ended March 31, 2021 and 2020 was $2.0 million and $7.2 million, respectively, representing a decrease of $5.2 million. The decrease in interest expense, net, is primarily due to lower borrowings outstanding on our term loan due June 2024 during the first quarter of 2021 as compared to the first quarter of 2020. Furthermore, we no longer recognize interest accretion of convertible notes discount due to a change in accounting principle adopted at the beginning of fiscal year 2021 whereas we recognized $1.9 million in interest accretion expense in the first quarter of 2020. For further information regarding the change in accounting principle, refer to Note 1, “Basis of Preparation” to our unaudited condensed consolidated financial statements included under Item 1, “Financial Statements” in this report. Interest expense for both the three months ended March 31, 2021 and 2020 included $0.6 million of 1.0% cash interest expense related to our convertible notes due November 2024 and $1.3 million and $4.8 million, respectively, in interest related to borrowings on our senior secured revolving credit facility and term loan due 2024. Financing costs amortization was $1.2 million for the three months ended March 31, 2021 as compared to $1.0 million for the three months ended March 31, 2020.

Unrealized (Gain) Loss On Investments In Equity Securities

During the first quarter of 2021, we recognized an unrealized gain on investments in equity securities of $3.3 million, which was driven by a $5.9 million unrealized gain on the mark-to-market adjustment of our investment in Stabilis, partially offset by a $2.6 million unrealized loss on the mark-to-market adjustment of our investment in McPhy. We recognized an unrealized loss on investments in equity securities of $4.8 million in the first quarter of 2020 which was driven by a $4.8 million unrealized loss on the mark-to-market adjustment of our investment in Stabilis.

Foreign Currency (Gain) Loss and Other

For the three months ended March 31, 2021 foreign currency gain was zero as compared to foreign currency gain of $0.3 million for the three months ended March 31, 2020. The variance between periods was primarily driven by fluctuations in the U.S dollar as compared to the euro and Chinese yuan.

Income Tax Expense

Income tax expense of $3.1 million and $0.4 million for the three months ended March 31, 2021 and 2020, respectively, represents taxes on both U.S. and foreign earnings at a combined effective income tax rate of 10.6% and 16.0%, respectively. The effective income tax rate of 10.6% for the three months ended March 31, 2021 differed from the U.S. federal statutory rate of 21% primarily due to losses incurred by some of our foreign operations for which no benefit was recorded, partially offset by the effect of income earned by our certain foreign entities being taxed at higher rates than the U.S. federal statutory rate and excess tax benefits associated with share-based compensation.

The effective income tax rate of 16.0% for the three months ended March 31, 2020 differed from the U.S. federal statutory rate of 21% primarily due to losses incurred by certain of our foreign operations for which no benefit was recorded, partially offset by the effect of income earned by certain of our foreign entities being taxed at higher rates than the U.S. federal statutory rate and excess tax benefits associated with share-based compensation.

Net Income from Continuing Operations

As a result of the foregoing, net income attributable to Chart for the three months ended March 31, 2021 and 2020 was $25.6 million and $2.1 million, respectively.

Discontinued Operations

The results from our cryobiological related products business formerly reported in our Distribution & Storage Western Hemisphere segment are reflected in our condensed consolidated financial statements as discontinued operations for the three months ended March 31, 2020. For further information, refer to Note 2, “Discontinued Operations” of our unaudited condensed consolidated financial statements included under Item 1, “Financial Statements” in this report.

Segment Results for the Three Months Ended March 31, 2021 and 2020

Our reportable and operational segments include: Cryo Tank Solutions, Heat Transfer Systems, Specialty Products, and Repair, Service & Leasing. Corporate includes operating expenses for executive management, accounting, tax, treasury, corporate development, human resources, information technology, investor relations, legal, internal audit, and risk management. Corporate support functions are not currently allocated to the segments. For further information, refer to Note 3, “Reportable Segments” note of our unaudited condensed consolidated financial statements included under Item 1, “Financial Statements” in this report. The following tables include key metrics used to evaluate our business and measure our performance and represents

32

selected financial data for our operating segments for the three months ended March 31, 2021 and 2020 (dollars in millions):

Cryo Tank Solutions

	Three Months Ended						Current Quarter vs. Prior Year Same Quarter
	March 31, 2021			March 31, 2020			Variance ($)		Variance (%)
Sales	$	103.9		$	98.0		$	5.9	6.0	%
Gross Profit	25.2			24.1			1.1		4.6	%
Gross Profit Margin	24.3		%	24.6		%
SG&A Expenses	$	8.9		$	11.1		$	(2.2)	(19.8)	%
SG&A Expenses (% of Sales)	8.6		%	11.3		%
Operating Income	$	15.6		$	11.6		$	4.0	34.5	%
Operating Margin	15.0		%	11.8		%

For the first quarter of 2021, Cryo Tank Solutions sales increased by $5.9 million as compared to the same quarter in 2020 primarily due to higher volume in engineered systems globally and higher sales in storage equipment. Cryo Tank Solutions sales in the first quarter of 2020 were negatively impacted by the Covid-19 outbreak, particularly in Europe and Asia due to temporary facility shutdowns.

During the first quarter of 2021, Cryo Tank Solutions segment gross profit increased by $1.1 million as compared to the same quarter in 2020. The increase in gross profit was mainly driven by volume.

Cryo Tank Solutions segment SG&A expenses decreased by $2.2 million during the first quarter of 2021 as compared to the same quarter in 2020. Furthermore, Cryo Tank Solutions segment SG&A expenses as a percentage of Cryo Tank Solutions segment sales improved by 270 basis points in the first quarter of 2021 as compared to the same quarter in 2020 primarily driven by the effect of cost reduction efforts completed in 2020, lower severance costs and lower employee-related costs.

Heat Transfer Systems

	Three Months Ended						Current Quarter vs. Prior Year Same Quarter
	March 31, 2021			March 31, 2020			Variance ($)		Variance (%)
Sales	$	69.2		$	112.9		$	(43.7)	(38.7)	%
Gross Profit	15.8			26.1			(10.3)		(39.5)	%
Gross Profit Margin	22.8		%	23.1		%
SG&A Expenses	$	7.0		$	11.2		$	(4.2)	(37.5)	%
SG&A Expenses (% of Sales)	10.1		%	9.9		%
Operating Income	$	3.9		$	5.5		$	(1.6)	(29.1)	%
Operating Margin	5.6		%	4.9		%

For the first quarter of 2021, Heat Transfer Systems segment sales decreased by $43.7 million as compared to the same quarter in 2020 primarily due to continued industry-wide softness in demand for midstream and upstream compression equipment that mainly impacted air cooled heat exchanger sales. Furthermore, during the first quarter of 2021 we recognized $14.7 million in sales relative to Venture Global’s Calcasieu Pass LNG export terminal project (“Calcasieu Pass”) as compared to $22.9 million recognized during the first quarter of 2020.

During the first quarter of 2021, Heat Transfer Systems segment gross profit decreased by $10.3 million as compared to the same quarter in 2020 mainly driven by lower volume partially offset by lower restructuring costs. Heat Transfer Systems segment gross profit as a percentage of Heat Transfer Systems segment sales was 22.8% in the first quarter of 2021 as compared to 23.1% in the first quarter of 2020, which is a decline of 30 basis points on a quarter over prior year quarter basis primarily due to the Calcasieu Pass volume mix which drove higher margins in the first quarter of 2020.

Heat Transfer Systems segment SG&A expenses decreased during the first quarter of 2021 as compared to the same quarter in 2020 primarily driven by cost reduction efforts relative to the transfer of operations of our heat exchanger leased facility in Tulsa, Oklahoma to our Beasley, Texas location, lower restructuring costs and lower employee-related costs.

33

Specialty Products

	Three Months Ended						Current Quarter vs. Prior Year Same Quarter
	March 31, 2021			March 31, 2020			Variance ($)		Variance (%)
Sales	$	77.3		$	52.9		$	24.4	46.1	%
Gross Profit	28.2			20.3			7.9		38.9	%
Gross Profit Margin	36.5		%	38.4		%
SG&A Expenses	$	9.1		$	6.1		$	3.0	49.2	%
SG&A Expenses (% of Sales)	11.8		%	11.5		%
Operating Income	$	17.9		$	13.8		$	4.1	29.7	%
Operating Margin	23.2		%	26.1		%

Specialty Products segment sales increased by $24.4 million during the first quarter of 2021 as compared to the same quarter in 2020. This increase was primarily driven by favorable sales in HLNG vehicle tanks, laser, cannabis and hydrogen applications.

Specialty Products segment gross profit increased by $7.9 million during the first quarter of 2021 as compared to the same quarter in 2020 primarily due to higher volume. The related margin decreased driven by product mix.

Specialty Products segment SG&A expenses increased by $3.0 million during the first quarter of 2021 as compared to the same quarter in 2020 primarily driven by ramp up in the business. Furthermore, Specialty Products segment SG&A expenses increased by $0.8 million relative to acquisition-related contingent consideration adjustments recognized during the first quarter of 2021.

Repair, Service & Leasing

	Three Months Ended						Current Quarter vs. Prior Year Same Quarter
	March 31, 2021			March 31, 2020			Variance ($)		Variance (%)
Sales	$	41.4		$	40.7		$	0.7	1.7	%
Gross Profit	14.7			11.8			2.9		24.6	%
Gross Profit Margin	35.5		%	29.0		%
SG&A Expenses	$	4.4		$	4.4		$	—	—	%
SG&A Expenses (% of Sales)	10.6		%	10.8		%
Operating Income	$	8.3		$	4.6		$	3.7	80.4	%
Operating Margin	20.0		%	11.3		%

For the first quarter of 2021, Repair, Service & Leasing segment sales increased by $0.7 million as compared to the same quarter in 2020. This increase was mainly driven by favorable sales in our Cryo-Lease and Lifecycle businesses partially offset by lower sales in aftermarket air cooled heat exchangers and fans.

During the first quarter of 2021, Repair, Service & Leasing segment gross profit increased by $2.9 million as compared to the same quarter in 2020, and the related margin percentage increased by 650 basis points mainly driven by lower costs in our repair facilities.

Repair, Service & Leasing segment SG&A expenses were flat to the same quarter in 2020.

Corporate

Corporate SG&A expenses decreased in the first quarter of 2021 as compared to the same quarter in 2020 by $2.9 million primarily due to lower employee-related costs and restructuring costs.

34

Liquidity and Capital Resources

Debt Instruments and Related Covenants

Our debt instruments and related covenants are described in Note 9, “Debt and Credit Arrangements” to our unaudited condensed consolidated financial statements included under Item 1, “Financial Statements” in this report.

Sources and Uses of Cash

Our cash and cash equivalents totaled $114.9 million at March 31, 2021, a decrease of $10.2 million from the balance at December 31, 2020. Our foreign subsidiaries held cash of approximately $102.0 million and $102.7 million, at March 31, 2021, and December 31, 2020, respectively, to meet their liquidity needs. No material restrictions exist to accessing cash held by our foreign subsidiaries. We expect to meet our U.S. funding needs without repatriating non-U.S. cash and incurring incremental U.S. taxes. Cash equivalents are primarily invested in money market funds that invest in high quality, short-term instruments, such as U.S. government obligations, certificates of deposit, repurchase obligations, and commercial paper issued by corporations that have been highly rated by at least one nationally recognized rating organization, and in the case of cash equivalents in China, obligations of local banks. We believe that our existing cash and cash equivalents, funds available under our senior secured revolving credit facility due June 2024 (“SSRCF”) or other financing alternatives, and cash provided by operations will be sufficient to meet our normal working capital needs, capital expenditures, investments and prioritize the pay down of debt for the foreseeable future.

Cash provided by operating activities was $8.3 million for the three months ended March 31, 2021, a decrease of $17.2 million compared to cash provided by operating activities of $25.5 million for the three months ended March 31, 2020 primarily due to a decrease in operating cash provided by working capital in the first three months of 2021.

Cash used in investing activities was $106.3 million and $10.2 million for the three months ended March 31, 2021 and 2020, respectively. During the three months ended March 31, 2021, we used approximately $55.0 million for the acquisition of Cryo Technologies and $40.0 million for investments in Svante and Transform Materials. During the three months ended March 31, 2021, we paid approximately $11.5 million for capital expenditures as compared to $10.3 million for the three months ended March 31, 2020.

Cash provided by financing activities was $87.8 million for the three months ended March 31, 2021 compared to cash used in financing activities of $42.0 million for the three months ended March 31, 2020. During the three months ended March 31, 2021, we borrowed $187.7 million on credit facilities and repaid $102.5 million in borrowings on credit facilities primarily to fund the acquisition of Cryo Technologies and investments in Svante and Transform Materials. During the first quarter of 2020, we used $19.3 million to repurchase shares of Chart common stock related to our share purchase program during the three months ended March 31, 2020. We suspended the program on March 20, 2020 (the “Suspension Date”) in light of uncertainty resulting from the Covid-19 pandemic and the desire to conserve cash resources. On March 11, 2021, the share repurchase program expired with no further repurchases since the Suspension Date.

Cash Requirements

We do not currently anticipate any unusual cash requirements for working capital needs for the year ending December 31, 2021. Management anticipates we will be able to satisfy cash requirements for our ongoing business for the foreseeable future with cash generated by operations, existing cash balances and available borrowings under our credit facilities. Capital expenditures for the remaining nine months of 2021 is expected to be in the range of $28.5 million to $38.5 million.

Orders and Backlog

We consider orders to be those for which we have received a firm signed purchase order or other written contractual commitments from the customer. Backlog is comprised of the portion of firm signed purchase orders or other written contractual commitments from customers for which work has not been performed, or is partially completed, that we have not recognized as revenue and excludes unexercised contract options and potential orders. Our backlog as of March 31, 2021 was $934.1 million, inclusive of $6.4 million of backlog remaining on Calcasieu Pass, compared to $723.3 million, inclusive of $93.0 million of Calcasieu Pass backlog as of March 31, 2020 and $810.0 million, inclusive of $21.0 million of Calcasieu Pass backlog as of December 31, 2020. Excluding Calcasieu Pass, backlog increased by $297.4 million or 47.2% in the current quarter compared to the prior year same quarter and $138.7 million or 17.6% compared to the prior quarter.

35

The tables below represent orders received and backlog by segment for the periods indicated (dollars in millions):

	Three Months Ended
	March 31, 2021		March 31, 2020		December 31, 2020
Orders
Cryo Tank Solutions	$	129.5	$	100.9	$	132.0
Heat Transfer Systems	104.9		91.6		139.9
Specialty Products	144.5		57.1		94.4
Repair, Service & Leasing	40.5		42.9		54.5
Intersegment eliminations	(2.2)		(6.7)		(3.8)
Consolidated	$	417.2	$	285.8	$	417.0

	As of
	March 31, 2021		March 31, 2020		December 31, 2020
Backlog
Cryo Tank Solutions	$	245.8	$	222.3	$	222.6
Heat Transfer Systems	361.4		334.4		329.2
Specialty Products	270.5		130.3		199.7
Repair, Service & Leasing	57.4		39.9		63.1
Intersegment eliminations	(1.0)		(3.6)		(4.6)
Consolidated	$	934.1	$	723.3	$	810.0

Cryo Tank Solutions segment orders for the three months ended March 31, 2021 were $129.5 million compared to $100.9 million for the three months ended March 31, 2020 and $132.0 million for the three months ended December 31, 2020. The increase in Cryo Tank Solutions segment orders during the three months ended March 31, 2021 when compared to the same quarter last year was primarily driven by strong order intake for mobile equipment, particularly in China. Cryo Tank Solutions orders were negatively impacted in the first quarter of 2020 due to Covid-19-related shut downs. Cryo Tank Solutions segment backlog at March 31, 2021 totaled $245.8 million and is a record high compared to $222.3 million as of March 31, 2020 and $222.6 million as of December 31, 2020.

Heat Transfer Systems segment orders for the three months ended March 31, 2021 were $104.9 million compared to $91.6 million for the three months ended March 31, 2020, and $139.9 million for the three months ended December 31, 2020. The increase in Heat Transfer Systems segment orders during the three months ended March 31, 2021 when compared to the same quarter last year was primarily driven by large project orders for ethylene and natural gas liquefaction. Heat Transfer Systems segment backlog at March 31, 2021 totaled $361.4 million, up 8.1% over the first quarter of 2020 and 9.8% over the fourth quarter of 2020, which was then a record. Excluding Calcasieu Pass, Heat Transfer Systems backlog increased by $113.6 million or 47.1% in the current quarter compared to the prior year same quarter and $46.8 million or 15.2% compared to the prior quarter. Included in Heat Transfer Systems segment backlog for all periods presented is approximately $40.0 million related to the previously announced Magnolia LNG order where production release is delayed. As we previously reported, in general, similar projects previously put on hold in the market are beginning to move ahead as the clean energy infrastructure build out ramps up.

Specialty Products segment orders for the three months ended March 31, 2021 were $144.5 million compared to $57.1 million for the three months ended March 31, 2020 and $94.4 million for the three months ended December 31, 2020. The increases over prior quarter and prior year same quarter were mainly driven by strong orders in hydrogen equipment, HLNG vehicle tanks, lasers and LNG regasification applications. Specialty Products segment backlog totaled $270.5 million as of March 31, 2021, compared to $130.3 million as of March 31, 2020 and $199.7 million as of December 31, 2020.

Repair, Service & Leasing segment orders for the three months ended March 31, 2021 were $40.5 million compared to $42.9 million for the three months ended March 31, 2020 and $54.5 million for the three months ended December 31, 2020. The decrease in Repair, Service & Leasing segment orders during the three months ended March 31, 2021 when compared to the prior year same quarter was primarily due to ramp up in our Cryo-Lease business. Repair, Service & Leasing segment backlog totaled $57.4 million as of March 31, 2021, compared to $39.9 million as of March 31, 2020 and $63.1 million as of December 31, 2020.

36

Off-Balance Sheet Arrangements

We do not have any material off-balance sheet arrangements.

Application of Critical Accounting Policies

Our unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles. As such, some accounting policies have a significant impact on amounts reported in these unaudited condensed consolidated financial statements. A summary of those significant accounting policies can be found in our Annual Report on Form 10-K for the year ended December 31, 2020. In particular, judgment is used in areas such as revenue from contracts with customers, goodwill, indefinite-lived intangibles, long-lived assets (including finite-lived intangible assets), product warranty costs, and pensions. There have been no significant changes to our critical accounting policies since December 31, 2020.

Forward-Looking Statements

We are making this statement in order to satisfy the “safe harbor” provisions contained in the Private Securities Litigation Reform Act of 1995. This Quarterly Report on Form 10-Q includes “forward-looking statements.” These forward-looking statements include statements concerning the Company’s business plans, including statements regarding completed acquisitions, investments, cost synergies and efficiency savings, objectives, future orders, revenues, margins, earnings or performance, liquidity and cash flow, capital expenditures, business trends, clean energy market opportunities, governmental initiatives, including executive orders and other information that is not historical in nature.  Forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “anticipates,” “believes,” “projects,” “forecasts,” “outlook,” “guidance,” “continue,” “target,” or the negative of such terms or comparable terminology.

Forward-looking statements contained herein (including future cash contractual obligations, liquidity, cash flow, orders, results of operations, projected revenues, margins, capital expenditures, industry and business trends, cost synergies and savings objectives, clean energy market opportunities and government initiatives, among other matters) or in other statements made by us are made based on management’s expectations and beliefs concerning future events impacting us and are subject to uncertainties and factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control, that could cause the Company’s actual results to differ materially from those expressed or implied by forward-looking statements made by us or on our behalf. These include: the other factors discussed in Item 1A. “Risk Factors” and the factors discussed in Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2020, which should be reviewed carefully; risks relating to the recent outbreak and continued uncertainty associated with the coronavirus (Covid-19); Chart’s ability to successfully integrate recent acquisitions, and achieve the anticipated revenue, earnings, accretion and other benefits from these acquisitions; slower than anticipated growth and market acceptance of new clean energy product offerings; estimated segment revenues, future revenue, earnings, cash flows and margin targets and run rates; our ability to remediate the material weaknesses identified during the preparation of the consolidated financial statements which are included in our Annual Report on Form 10-K for the year ended December 31, 2020. These factors should not be construed as exhaustive and there may also be other risks that we are unable to predict at this time.

All forward-looking statements attributable to us or persons acting on our behalf apply only as of the date of this Quarterly Report and are expressly qualified in their entirety by the cautionary statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as the same may be updated from time to time. We undertake no obligation to update or revise forward-looking statements which may be made to reflect events or circumstances that arise after the filing date of this document or to reflect the occurrence of unanticipated events, except as otherwise required by law.

Item 3.Quantitative and Qualitative Disclosures About Market Risk

In the normal course of business, our operations are exposed to fluctuations in interest rates and foreign currency values that can affect the cost of operating and financing. Accordingly, we address a portion of these risks through a program of risk management.

Interest Rate Risk: Our primary interest rate risk exposure results from the SSRCF’s various floating rate pricing mechanisms. If interest rates were to increase 100 basis points (1 percent) from the weighted-average interest rate of 1.8% at March 31, 2021, and assuming no changes in the $204.7 million of borrowings outstanding under the SSRCF at March 31, 2021, our additional annual expense would be approximately $2.0 million on a pre-tax basis.

Foreign Currency Exchange Rate Risk: We operate in the United States and other foreign countries, which creates exposure to foreign currency exchange fluctuations in the normal course of business, which can impact our financial position,

37

results of operations, cash flows, and competitive position. The financial statements of foreign subsidiaries are translated into their U.S. dollar equivalents at end-of-period exchange rates for assets and liabilities, while income and expenses are translated at average monthly exchange rates. Translation gains and losses are components of other comprehensive income as reported in the unaudited condensed consolidated statements of income and comprehensive income. Translation exposure is primarily with the euro, the Czech koruna, the Chinese yuan, and the Indian rupee. During the first quarter of 2021, the U.S. dollar strengthened in relation to the Chinese yuan by 1%, the euro by 5%, the Czech koruna by 4% and the Japanese Yen by 7%. Additionally, the euro remained relatively flat in relation to the Czech koruna, weakening by less than 1%. At March 31, 2021, a hypothetical 10% weakening of the U.S. dollar would not materially affect our financial statements.

Chart’s primary transaction exchange rate exposures are with the euro, the Chinese yuan, the Czech koruna, the Indian rupee, the Australian dollar, the British pound, the Canadian dollar and the Japanese yen. Transaction gains and losses arising from fluctuations in currency exchange rates on transactions denominated in currencies other than the functional currency are recognized in the unaudited condensed consolidated statements of income and comprehensive income as a component of foreign currency (gain) loss and other. We enter into foreign exchange forward contracts to hedge anticipated and firmly committed foreign currency transactions. We do not use derivative financial instruments for speculative or trading purposes. The terms of the contracts are generally one year or less. At March 31, 2021, a hypothetical 10% weakening of the U.S. dollar would not materially affect our outstanding foreign exchange forward contracts. Additionally, assuming no changes in the EUR 71.5 million in EUR Revolver Borrowings outstanding under the SSRCF and an additional 100 basis points (1 percent) strengthening in the U.S dollar in relation to the euro as of the beginning of 2021, during the three months ended March 31, 2021, our additional unrealized foreign currency gain would be approximately $0.9 million on a pre-tax basis.

Market Price Sensitive Instruments

In connection with the pricing of the 2024 Notes, we entered into privately-negotiated convertible note hedge transactions (the “Note Hedge Transactions”) with certain parties, including affiliates of the initial purchasers of the 2024 Notes (the “Option Counterparties”). These Note Hedge Transactions are expected to reduce the potential dilution upon any future conversion of the 2024 Notes.

We also entered into separate, privately-negotiated warrant transactions with the Option Counterparties to acquire up to 4.41 million shares of our common stock. The warrant transactions will have a dilutive effect with respect to our common stock to the extent that the price per share of our common stock exceeds the strike price of the warrants unless we elect, subject to certain conditions, to settle the warrants in cash. The strike price of the warrant transactions related to the 2024 Notes was initially $71.775 per share. Further information is located in Note 9, “Debt and Credit Arrangements” to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

Item 4.Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We performed an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer and Treasurer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”) as of March 31, 2021. As a result of the material weaknesses described below, our Chief Executive Officer and Chief Financial Officer have concluded that as of March 31, 2021, our disclosure controls and procedures were not effective to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act (1) is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (2) is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow for timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management has assessed the effectiveness of its internal control over financial reporting as of December 31, 2020 based on the framework established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework) (the “COSO criteria”).

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the registrant’s annual or interim financial statements will not be prevented or detected on a timely basis.

38

As a result of its review during the preparation of the consolidated financial statements which are included in our Annual Report on Form 10-K for the year ended December 31, 2020, management concluded that we had material weaknesses in our internal control over financial reporting that were identified in connection with our annual goodwill and trademark impairment testing, consisting of the following:

•Control Activities – The Company did not maintain effective control activities based on criteria established by the COSO framework as the control activities that involve more complex judgments did not adequately consider the competency of personnel assigned to perform the review.

•Goodwill and Identifiable Intangible Assets, Net – As a result of the material weakness identified above, the Company failed to adequately design and implement internal controls over the review of its goodwill and indefinite-lived intangible assets for impairment.

Based on the evaluation of our disclosure controls and procedures as of December 31, 2020, our Chief Executive Officer and Chief Financial Officer concluded that, as a result of the material weaknesses in the Company’s internal control over financial reporting described above, as of such date, our disclosure controls and procedures were not effective.

In response to the material weaknesses described above, during the three months ended March 31, 2021, we began implementing, evaluating, and designing new controls and procedures. The following measures have been implemented effective March 31, 2021:

•Evaluated and re-assessed the design of our goodwill and intangible asset impairment process, including control activities associated with the review of data provided to third-party valuation specialists and evaluated the appropriateness of the assumptions and methodology used to measure fair value of reporting units and the reasonableness of the conclusions in the third-party valuation specialists’ reports;

•Evaluated the assignment of responsibilities associated with the accounting for goodwill and intangible asset impairment, including hiring additional resources and providing additional training to existing resources; and

•In order to ensure the quality and consistency of accounting treatments and interpretation across the impairment analysis process and maintain effective control activities, designated one of our senior accounting personnel to provide enhanced oversight to monitor the process, provided guidance on accounting treatment and assumptions and ensured quality-control for the process.

With respect to our annual impairment analysis, we plan to complete the formal review of the annual forecast by no later than September 30, 2021.

Our remediation of the identified material weaknesses and strengthening our internal control environment is ongoing. We will test the ongoing design and implementation and operating effectiveness of the new and existing controls in future periods. The material weaknesses cannot be considered remediated until the applicable controls have operated for a sufficient period of time and management has concluded, through testing, that these controls are designed and operating effectively. Accordingly, we will continue to monitor and evaluate the effectiveness of our internal control over financial reporting in the areas affected by the material weaknesses described above.

39

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

As disclosed in Note 16, “Commitments and Contingencies”, Chart was named in lawsuits (including lawsuits filed in the U.S. District Court for the Northern District of California) filed against Chart and other defendants with respect to the alleged failure of a stainless steel cryobiological storage tank (model MVE 808AF-GB) at the Pacific Fertility Center in San Francisco, California. We hereby incorporate by reference into this Item 1 the disclosure under the headings “Note 16, Commitments and Contingencies – Stainless Steel Cryobiological Tank Legal Proceedings.”

Although we have not completed our factual investigations into these proceedings, which remain in their early stages, we believe that we have strong factual and legal defenses to the claims and intend to vigorously assert such defenses.

We are occasionally subject to various legal claims related to performance under contracts, product liability, taxes, employment matters, environmental matters, intellectual property, and other matters incidental to the normal course of our business. Based on our historical experience in litigating these claims, as well as our current assessment of the underlying merits of the claims and applicable insurance, if any, management believes that the final resolution of these matters will not have a material adverse effect on our financial position, liquidity, cash flows, or results of operations. Future developments may, however, result in resolution of these legal claims in a way that could have a material adverse effect.

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the risk factors disclosed in Item 1A. “Risk Factors,” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

	Issuer Purchases of Equity Securities
Period	Total Number of Shares Purchased (1)	Average Price Paid Per Share (1)		Total Number of Shares Purchased As Part of Publicly Announced Plans or Programs (2)	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (2)
January 1 - 31, 2021	21,151	$	119.32	—	$	—
February 1 – 28, 2021	2,643	154.54		—	—
March 1 – 31, 2021	382	150.88		—	—
Total	24,176	123.67		—	$	—

_______________

(1)Includes shares of common stock surrendered to us during the first quarter of 2021 by participants under our share-based compensation plans to satisfy tax withholding obligations relating to the vesting or payment of equity awards for an aggregate purchase price of approximately $2,989,846. The total number of shares repurchased represents the net shares issued to satisfy tax withholdings. All such repurchased shares were subsequently retired during the three months ended March 31, 2021.

(2)On March 11, 2020, our Board of Directors authorized a share repurchase program for up to $75 million of the Company’s common stock over the next twelve months through various means, including open market transactions, block purchases, privately negotiated transactions or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. We suspended the program on March 20, 2020 (the “Suspension Date”) in light of uncertainty resulting from the Covid-19 pandemic and the desire to conserve cash resources. On March 11, 2021, the share repurchase program expired with no further repurchases since the Suspension Date.

Item 4. Mine Safety Disclosures

Not applicable.

40

Item 6.Exhibits

The following exhibits are included with this report:    

31.1    Rule 13a-14(a) Certification of the Company’s Chief Executive Officer and President (Principal Executive Officer). (x)

31.2    Rule 13a-14(a) Certification of the Company's Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer). (x)

32.1    Section 1350 Certification of the Company’s Chief Executive Officer and President (Principal Executive Officer). (xx)

32.2    Section 1350 Certification of the Company's Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer). (xx)

101.INS    XBRL Instance Document *

101.SCH    XBRL Taxonomy Extension Schema Document

101.CAL    XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF    XBRL Taxonomy Extension Definition Linkbase Document

101.LAB    XBRL Taxonomy Extension Label Linkbase Document

101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document

_______________

(x)    Filed herewith.

(xx)     Furnished herewith.

*    The Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

41

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Chart Industries, Inc.

(Registrant)

Date:	April 22, 2021	By:	/s/ Jillian C. Evanko
			Jillian C. Evanko
			Chief Executive Officer and President
			(Principal Executive Officer)
Date:	April 22, 2021	By:	/s/ Scott W. Merkle
			Scott W. Merkle
			Vice President, Chief Financial Officer and Treasurer
			(Principal Financial Officer)

42

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Jillian C. Evanko, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Chart Industries, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 22, 2021

    /s/ Jillian C. Evanko

Jillian C. Evanko

Chief Executive Officer and President

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Scott W. Merkle, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Chart Industries, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 22, 2021

    /s/ Scott W. Merkle

Scott W. Merkle

Vice President, Chief Financial Officer and Treasurer

EX-32.1

Exhibit 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Chart Industries, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer's knowledge, that:

(a)The Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(b)The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Form 10-Q.

Dated: April 22, 2021

  /s/ Jillian C. Evanko

Jillian C. Evanko

Chief Executive Officer and President

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Form 10-Q or as a separate disclosure document.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Chart Industries, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer's knowledge, that:

(a)The Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(b)The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Form 10-Q.

Dated: April 22, 2021

  /s/ Scott W. Merkle

Scott W. Merkle

Vice President, Chief Financial Officer and Treasurer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Form 10-Q or as a separate disclosure document.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover - shares	3 Months Ended
	Mar. 31, 2021	Apr. 19, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2021
Document Transition Report	false
Entity File Number	1-11442
Entity Registrant Name	CHART INDUSTRIES, INC.
Entity Incorporation, State	DE
Entity Tax Identification Number	34-1712937
Street Address	3055 Torrington Drive
Entity City or Town	Ball Ground
Entity State or Province	GA
Entity Postal Zip Code	30107
City Area Code	770
Local Phone Number	721-8800
Title of each class	Common Stock, par value $0.01
Trading Symbol(s)	GTLS
Name of each exchange on which registered	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		36,348,534
Amendment Flag	false
Document Fiscal Period Focus	Q1
Entity Central Index Key	0000892553
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--12-31

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Current Assets
Cash and cash equivalents	$ 114.9	$ 125.1
Accounts receivable, less allowances of $7.9 and $8.4, respectively	186.4	200.8
Inventories, net	279.9	248.4
Unbilled contract revenue	74.6	79.4
Prepaid expenses	26.4	20.0
Other current assets	31.6	29.3
Total Current Assets	713.8	703.0
Property, plant, and equipment, net	409.3	414.5
Goodwill	911.3	865.9
Identifiable intangible assets, net	481.4	493.1
Investments	119.9	78.9
Other assets	16.6	15.1
TOTAL ASSETS	2,652.3	2,570.5
Current Liabilities
Accounts payable	151.8	140.1
Customer advances and billings in excess of contract revenue	106.3	118.9
Accrued salaries, wages, and benefits	27.3	39.7
Accrued income taxes	46.0	46.5
Current portion of warranty reserve	10.3	11.0
Current convertible notes	255.2	220.9
Operating lease liabilities, current	5.1	5.1
Other current liabilities	58.3	52.6
Total Current Liabilities	660.3	634.8
Long-term debt	303.1	221.6
Long-term deferred tax liabilities	49.9	60.2
Accrued pension liabilities	9.1	9.6
Operating lease liabilities, non-current	22.7	23.6
Other long-term liabilities	41.2	41.4
Total Liabilities	1,086.3	991.2
Equity
Common stock, par value $0.01 per share – 150,000,000 shares authorized, 36,347,850 and 36,185,829 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively	0.4	0.4
Additional paid-in capital	750.0	780.8
Treasury stock; 760,782 shares at March 31, 2021	(19.3)	(19.3)
Retained earnings	844.7	808.4
Accumulated other comprehensive (loss) income	(16.8)	2.4
Total Chart Industries, Inc. Shareholders’ Equity	1,559.0	1,572.7
Noncontrolling interests	7.0	6.6
Total Equity	1,566.0	1,579.3
TOTAL LIABILITIES AND EQUITY	$ 2,652.3	$ 2,570.5

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 7.9	$ 8.4
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized (shares)	150,000,000	150,000,000
Common stock, shares issued (shares)	36,347,850	36,185,829
Common stock, shares outstanding (shares)	36,347,850	36,185,829
Treasury stock (shares)	760,782

XML

Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Sales	$ 288.5	$ 301.9
Cost of sales	204.6	219.6
Gross profit	83.9	82.3
Selling, general, and administrative expenses	46.2	52.5
Amortization expense	8.8	14.0
Operating expenses	55.0	66.5
Operating income	28.9	15.8
Interest expense, net	2.0	7.2
Unrealized (gain) loss on investments in equity securities	(3.3)	4.8
Financing costs amortization	1.2	1.0
Foreign currency (gain) loss and other	(0.2)	0.3
Income from continuing operations before income taxes	29.2	2.5
Income tax expense	3.1	0.4
Net income from continuing operations	26.1	2.1
Income from discontinued operations, net of tax	0.0	6.4
Net income	26.1	8.5
Less: Income attributable to noncontrolling interests of continuing operations, net of taxes	0.5	0.0
Net income attributable to Chart Industries, Inc.	25.6	8.5
Net income attributable to Chart Industries, Inc.
Income from continuing operations	25.6	2.1
Income from discontinued operations, net of tax	0.0	6.4
Net income attributable to Chart Industries, Inc.	$ 25.6	$ 8.5
Basic earnings per common share attributable to Chart Industries, Inc.:
Income from continuing operations (usd per share)	$ 0.72	$ 0.06
Income from discontinued operations (usd per share)	0	0.18
Net income attributable to Chart Industries, Inc. (usd per share)	0.72	0.24
Diluted earnings per common share attributable to Chart Industries, Inc.
Income from continuing operations (usd per share)	0.63	0.06
Income from discontinued operations (usd per share)	0	0.18
Net income attributable to Chart Industries, Inc.	$ 0.63	$ 0.24
Weighted-average number of common shares outstanding:
Basic (shares)	35,550	35,770
Diluted (shares)	40,620	36,010
Comprehensive income (loss), net of taxes	$ 6.9	$ (1.4)
Less: Comprehensive income attributable to noncontrolling interests, net of taxes	0.5	0.0
Comprehensive income (loss) attributable to Chart Industries, Inc., net of taxes	$ 6.4	$ (1.4)

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2021	Mar. 31, 2020
OPERATING ACTIVITIES
Net income		$ 26.1	$ 8.5
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		19.5	23.9
Interest accretion of convertible notes discount		0.0	1.9
Employee share-based compensation expense		3.4	2.9
Financing costs amortization		1.2	1.0
Unrealized foreign currency transaction gain		(4.6)	0.0
Unrealized (gain) loss on investments in equity securities		(3.3)	4.8
Other non-cash operating activities		1.9	3.2
Changes in assets and liabilities, net of acquisitions:
Accounts receivable		13.6	7.5
Inventories		(36.3)	(16.1)
Unbilled contract revenues and other assets		(6.8)	8.4
Accounts payable and other liabilities		4.1	(17.0)
Customer advances and billings in excess of contract revenue		(10.5)	(3.5)
Net Cash Provided By Operating Activities		8.3	25.5
INVESTING ACTIVITIES
Acquisition of businesses, net of cash acquired		(55.0)	0.0
Investments		(40.0)	0.0
Capital expenditures		(11.5)	(10.3)
Government grants		0.2	0.1
Net Cash Used In Investing Activities		(106.3)	(10.2)
FINANCING ACTIVITIES
Borrowings on revolving credit facilities		187.7	64.5
Repayments on revolving credit facilities		(102.5)	(84.7)
Repayments on term loan		0.0	(2.8)
Proceeds from exercise of stock options		5.6	2.0
Common stock repurchases from share-based compensation plans		(3.0)	(1.7)
Common stock repurchases		0.0	(19.3)
Net Cash Provided By (Used In) Financing Activities		87.8	(42.0)
Effect of exchange rate changes on cash and cash equivalents		0.0	(3.0)
Net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents	[1]	(10.2)	(29.7)
Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period		126.1	120.0
CASH, CASH EQUIVALENTS, RESTRICTED CASH, AND RESTRICTED CASH EQUIVALENTS AT END OF PERIOD	[2]	$ 115.9	$ 90.3

[1] Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents represents cash flows of consolidated operations for all periods presented. For cash flows of discontinued operations, refer to Note 2, “Discontinued Operations.”

[2] Includes restricted cash and restricted cash equivalents of $1.0 in other assets for each of the periods presented. For further information regarding restricted cash and restricted cash equivalents balances, refer to Note 9, “Debt and Credit Arrangements.”

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parentheticals) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Statement of Cash Flows [Abstract]
Restricted cash and cash equivalents, noncurrent	$ 1.0	$ 1.0

XML

Condensed Consolidated Statements of Equity (Unaudited) - USD ($) $ in Millions		Total	Cumulative Effect, Period of Adoption, Adjustment	[2]	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	[2]	Treasury Stock	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	[2]	Accumulated Other Comprehensive Income (Loss)	Non-controlling Interests
Beginning balance at Dec. 31, 2019		$ 1,232.4			$ 0.4	$ 762.8			$ 0.0	$ 500.3			$ (35.9)	$ 4.8
Beginning balance (shares) at Dec. 31, 2019					35,800,000
Increase (Decrease) in Stockholders' Equity
Net income		8.5								8.5
Other comprehensive loss		(9.9)											(9.9)
Share-based compensation expense		2.9				2.9
Common stock issued from share-based compensation plans		2.0				2.0
Common stock issued from share-based compensation plans (shares)					160,000
Common stock repurchases	[1]	(19.3)							(19.3)
Common stock repurchases from share-based compensation plans		(1.7)				(1.7)
Common stock repurchases from share-based compensation plans (in shares)					(10,000.00)
Ending balance at Mar. 31, 2020		1,214.9			$ 0.4	766.0			(19.3)	508.8			(45.8)	4.8
Ending balance (shares) at Mar. 31, 2020					35,950,000
Beginning balance at Dec. 31, 2020		$ 1,579.3	$ (26.2)		$ 0.4	780.8	$ (36.9)		(19.3)	808.4	$ 10.7		2.4	6.6
Beginning balance (shares) at Dec. 31, 2020		36,185,829			36,190,000
Increase (Decrease) in Stockholders' Equity
Net income		$ 26.1								25.6				0.5
Other comprehensive loss		(19.2)											(19.2)
Share-based compensation expense		3.4				3.4
Common stock issued from share-based compensation plans		5.6				5.6
Common stock issued from share-based compensation plans (shares)					180,000
Common stock repurchases from share-based compensation plans		(3.0)				(3.0)
Common stock repurchases from share-based compensation plans (in shares)					(20,000.00)
Dividend distribution to noncontrolling interest		0.0
Other		0.0												(0.1)
Ending balance at Mar. 31, 2021		$ 1,566.0			$ 0.4	$ 750.0			$ (19.3)	$ 844.7			$ (16.8)	$ 7.0
Ending balance (shares) at Mar. 31, 2021		36,347,850			36,350,000

[1] Includes $19.3 in shares repurchased through our share repurchase program. On March 11, 2021, the share repurchase program expired with no further repurchases. Refer to Note 1, “Basis of Preparation” for further information.

[2] Refer to Note 1, “ Basis of Preparation” for discussion regarding the cumulative effect of change in accounting principle.

XML

Condensed Consolidated Statements of Equity (Unaudited) (Parentheticals) $ in Millions	3 Months Ended
	Mar. 31, 2020 USD ($)
Statement of Stockholders' Equity [Abstract]
Common stock repurchases	$ 19.3	[1]

[1] Includes $19.3 in shares repurchased through our share repurchase program. On March 11, 2021, the share repurchase program expired with no further repurchases. Refer to Note 1, “Basis of Preparation” for further information.

XML

Basis of Preparation

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Basis of Preparation

Basis of Preparation

The accompanying unaudited condensed consolidated financial statements of Chart Industries, Inc. and its consolidated subsidiaries (herein referred to as the “Company,” “Chart,” “we,” “us,” or “our”) have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for annual financial statements. These financial statements should be read in conjunction with the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2020. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021.

Nature of Operations: We are a leading independent global manufacturer of highly engineered equipment servicing multiple applications in the Clean Energy and Industrial Gas markets. Our unique product portfolio is used in every phase of the liquid gas supply chain, including upfront engineering, service and repair. Being at the forefront of the clean energy transition, Chart is a leading provider of technology, equipment and services related to liquefied natural gas, hydrogen, biogas and CO2 Capture amongst other applications. We are committed to excellence in environmental, social and corporate governance (ESG) issues both for our company as well as our customers. With over 25 global locations from the United States to Asia, Australia, India, Europe and South America, we maintain accountability and transparency to our team members, suppliers, customers and communities.

Principles of Consolidation: The unaudited condensed consolidated financial statements include the accounts of Chart Industries, Inc. and its subsidiaries. Intercompany accounts and transactions are eliminated in consolidation.

Reclassifications: As discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, on October 1, 2020, we closed on the sale of our cryobiological products business to Cryoport, Inc. (CYRX) (refer to Note 2, “Discontinued Operations” for further information). Furthermore, we reorganized our reporting structure such that the composition of our reportable segments changed effective October 1, 2020 (refer to Note 3, “Reportable Segments” for further information). As such, certain reclassifications have been made to the statement of income and comprehensive income for the three months ended March 31, 2020 and certain notes to the unaudited condensed consolidated financial statements in order to conform to the 2021 presentation.

Use of Estimates: The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. These estimates may also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions. While our production has been considered “essential” in all locations we operate in, we have experienced, and may again experience in the future, temporary facility closures while awaiting appropriate government approvals in certain jurisdictions. The Covid-19 outbreak could also disrupt our supply chain and materially adversely impact our ability to secure supplies for our facilities, which could materially adversely affect our operations. There may also be long-term effects on our customers in and the economies of affected countries. As a result of these uncertainties, actual results could differ from those estimates and assumptions. If the economy or markets in which we operate remain weak or deteriorate further, our business, financial condition and results of operations may be materially and adversely impacted.

Share Repurchase Program: As discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, on March 11, 2020, our Board of Directors authorized a share repurchase program for up to $75 million of the Company’s common stock over the next twelve months through various means, including open market transactions, block purchases, privately negotiated transactions or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. During the first quarter of 2020, we repurchased 0.76 shares of our common stock at an average price of $25.40 per share for a total purchase price of $19.3. We suspended the program on March 20, 2020 (the “Suspension Date”) in light of uncertainty resulting from the Covid-19 pandemic and the desire to conserve cash resources. On March 11, 2021, the share repurchase program expired with no further repurchases since the Suspension Date.

Recently Issued Accounting Standards (Not Yet Adopted): In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” and in January 2021, the FASB subsequently issued ASU 2021-01,

“Reference Rate Reform (Topic 848): Scope.” ASU 2020-04 and the subsequent modifications are identified as Accounting Standards Codification (“ASC”) 848 (“ASC 848”). ASC 848 simplifies the accounting for modifying contracts (including those in hedging relationships) that refer to LIBOR and other interbank offered rates that are expected to be discontinued due to reference rate reform. The amendments in ASC 848 are effective for all entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments for contract modifications by Topic or Industry Subtopic as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020, up to the date that the financial statements are available to be issued. Once elected for a Topic or an Industry Subtopic, the amendments in ASC 848 must be applied prospectively for all eligible contract modifications for that Topic or Industry Subtopic. We expect application of the amendments to impact accounting for our senior secured revolving credit facility due June 2024. We are currently assessing the effect ASC 848 will have on our financial position, results of operations, and disclosures.

Recently Adopted Accounting Standards: In August 2020, the FASB issued ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entities Own Equity (Subtopic 815-40).” This ASU simplifies accounting for convertible instruments by eliminating two of the three models in ASC 470-20 that require separating embedded conversion features from convertible instruments. The guidance is effective for fiscal years beginning after December 15, 2021. We adopted this guidance effective January 1, 2021 under the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods.

As a result of the adoption of ASU 2020-06, our convertible notes due November 2024 are no longer bifurcated into separate liability and equity components in our March 31, 2021 condensed consolidated balance sheet. Rather, the $258.8 principal amount of our convertible notes due November 2024 was classified as a liability only in our March 31, 2021 condensed consolidated balance sheet. Upon adoption of ASU 2020-06, we recorded an adjustment to the convertible notes liability component, equity component (additional paid-in-capital) and retained earnings. This adjustment was calculated based on the carrying amount of the convertible notes as if it had always been treated as a liability only. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, i.e. as if debt issuance costs had always been treated as a contra liability only. Lastly, we derecognized deferred income taxes associated with the convertible notes debt discount and adjusted deferred incomes taxes relative to unamortized debt issuance costs associated with our convertible notes due November 2024.

Interest expense related to the accretion of our convertible notes due November 2024 is no longer recognized. Interest accretion of convertible notes discount and net income from continuing operations attributable to Chart Industries, Inc. for the three months ended March 31, 2021 would have been $2.0 and $24.0, respectively, without the adoption of ASU 2020-06. As such, net income from continuing operations attributable to Chart Industries, Inc. per common share (both basic and diluted) for the three months ended March 31, 2021 is $0.04 higher due to the effect of adoption of ASU 2020-06. As further described in Note 9, “Debt and Credit Arrangements,” on December 31, 2020, we amended the Indenture governing our convertible notes due November 2024 to eliminate share settlement thus leaving us with two settlement options: (1) cash settlement or (2) cash for par and any combination of cash and shares for the excess settlement amount above the $258.8 principal amount of our convertible notes due November 2024. ASU 2020-06 requires usage of the if-converted method to compute diluted earnings per share for our convertible notes due November 2024, however, based on the terms of the amended Indenture and the cessation of interest accretion expense recognition from the transition at adoption, the if-converted method was modified such that interest expense is no longer added to the numerator, and the denominator only includes incremental shares that would be issued upon conversion.

Impacts on Financial Statements

The following table summarizes the cumulative effect of the changes to our condensed consolidated balance sheet as of December 31, 2020 from the adoption of ASU 2020-06:

	Balance at December 31, 2020		Adjustments due to ASU 2020-06 adoption		Balance at January 1, 2021
Liabilities
Accrued income taxes	$	46.5	$	(0.2)	$	46.3
Current convertible notes (1)	220.9		34.0		254.9
Long-term deferred tax liabilities	60.2		(7.6)		52.6
Equity
Additional paid-in-capital	$	780.8	$	(36.9)	$	743.9
Retained earnings	808.4		10.7		819.1

_______________

(1)Current convertible notes is presented net of unamortized discount and debt issuance costs of $34.8 and $3.1, respectively at December 31, 2020. Current convertible notes is presented net of unamortized debt issuance costs of $3.9 at January 1, 2021.

In January 2020, the FASB issued ASU 2020-01, “Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815).” This ASU clarifies the interactions between the measurement alternative in Topic 321, the equity method of accounting in Topic 323 and the application of guidance for certain forward contracts and purchased options that upon settlement or exercise would be accounted for under the equity method of accounting in Topic 815. This guidance is effective for fiscal years ending after December 15, 2020. We adopted this guidance effective January 1, 2021. The adoption of this guidance did not have a material impact on our financial position, results of operations or disclosures.

XML

Discontinued Operations

3 Months Ended

Mar. 31, 2021

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

Discontinued Operations

As discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, on October 1, 2020, we closed on the sale of our cryobiological products business to Cryoport, Inc. (NASDAQ: CYRX) (the “Cryobiological Divestiture”). Our cryobiological products business asset group met the criteria to be held for sale. Furthermore, we determined that the assets held for sale qualified for discontinued operations. As such, the financial results of the cryobiological products business are reflected in our unaudited condensed consolidated statements of income and comprehensive income as discontinued operations for all prior periods presented.

Summarized Financial Information of Discontinued Operations

The following table represents income from discontinued operations, net of tax:

	Three Months Ended March 31, 2020
Sales	$	19.2
Cost of sales	10.1
Selling, general and administrative expenses	1.4
Operating income (1)	7.7
Income before income taxes from discontinued operations	7.7
Income tax expense	1.3
Income from discontinued operations, net of tax	$	6.4

________________

(1)Includes depreciation expense of $0.3 for the three months ended March 31, 2020.

The following table represents a summary of cash flows related to discontinued operations:

	Three Months Ended March 31, 2020
Net cash provided by (used in):
Operating activities	$	7.2
Investing activities	(0.1)
Net cash provided by discontinued operations	$	7.1

XML

Reportable Segments

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Reportable Segments

Reportable Segments

As reported in our Annual Report on Form 10-K for the year ended December 31, 2020, the structure of our internal organization is divided into the following four reportable segments, which are also our operating segments: Cryo Tank Solutions, Heat Transfer Systems, Specialty Products and Repair, Service & Leasing.

Our Cryo Tank Solutions segment, which has principal operations in the United States, Europe and Asia, supplies bulk, microbulk and mobile equipment used in the storage, distribution, vaporization, and application of industrial gases. Our Heat Transfer Systems segment, which has principal operations in the United States, Europe and India, supplies mission critical engineered equipment and systems used in the separation, liquefaction, and purification of hydrocarbon and industrial gases that span gas-to-liquid applications. Our Specialty Products segment with locations globally supplies products used in our specialty market applications including hydrogen, HLNG vehicle tanks, food and beverage, space exploration, lasers, cannabis and water treatment, amongst others. Our Repair, Service & Leasing segment, which includes repair and service centers globally, provides installation, service, repair, maintenance, and refurbishment of cryogenic products as well as global equipment leasing solutions.

Corporate includes operating expenses for executive management, accounting, tax, treasury, corporate development, human resources, information technology, investor relations, legal, internal audit and risk management. Corporate support functions are not currently allocated to the segments. All prior period amounts presented in the tables below have been reclassified based on our current reportable segments.

We evaluate performance and allocate resources based on operating income as determined in our condensed consolidated statements of income and comprehensive income.

Segment Financial Information

	Three Months Ended March 31, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	103.9	$	69.2	$	77.3	$	41.4	$	(3.3)	$	—	$	288.5
Depreciation and amortization expense	3.9		9.5		3.1		2.6		—		0.4		19.5
Operating income (loss) (1) (2)	15.6		3.9		17.9		8.3		—		(16.8)		28.9

	Three Months Ended March 31, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	98.0	$	112.9	$	52.9	$	40.7	$	(2.6)	$	—	$	301.9
Depreciation and amortization expense	4.4		14.1		1.4		3.3		—		0.4		23.6
Operating income (loss) (1)	11.6		5.5		13.8		4.6		—		(19.7)		15.8

_______________

(1)Restructuring costs for the:

•three months ended March 31, 2021 were $0.7 ($0.3 - Cryo Tank Solutions, $0.4 - Heat Transfer Systems).

•three months ended March 31, 2020 were $5.2 ($1.8 - Cryo Tank Solutions, $2.8 - Heat Transfer Systems, $0.6 - Corporate ).

(2)Includes acquisition-related contingent consideration adjustments of $0.8 in our Specialty Products segment for the three months ended March 31, 2021.

Sales by Geography

	Three Months Ended March 31, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	41.1	$	46.3	$	26.1	$	29.0	$	(1.7)	$	140.8
Europe, Middle East, Africa and India	37.7		7.8		45.6		10.5		(1.0)		100.6
Asia-Pacific	24.2		14.8		5.6		1.8		(0.6)		45.8
Rest of the World	0.9		0.3		—		0.1		—		1.3
Total	$	103.9	$	69.2	$	77.3	$	41.4	$	(3.3)	$	288.5

	Three Months Ended March 31, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	40.6	$	82.2	$	24.9	$	32.1	$	(1.3)	$	178.5
Europe, Middle East, Africa and India	34.3		9.5		25.6		6.7		(0.7)		75.4
Asia-Pacific	20.1		20.9		2.2		1.7		(0.5)		44.4
Rest of the World	3.0		0.3		0.2		0.2		(0.1)		3.6
Total	$	98.0	$	112.9	$	52.9	$	40.7	$	(2.6)	$	301.9

Total Assets

Corporate assets mainly include cash and cash equivalents and long-term deferred income taxes as well as certain corporate-specific property, plant and equipment, net and certain investments. Our allocation methodology for property, plant and equipment, net of the reportable segments differs from our allocation method of depreciation expense of a reportable segment and therefore, depreciation expense does not entirely align with the related depreciable assets of the reportable segments. Furthermore, since finite-lived intangible assets are excluded from total assets of reportable segments while amortization expense is allocated to each of our reportable segments, amortization expense by segment inherently does not align with the related amortizable intangible assets of the reportable segments.

	March 31, 2021		December 31, 2020
Cryo Tank Solutions	$	392.0	$	399.2
Heat Transfer Systems	230.1		247.2
Specialty Products	216.3		178.3
Repair, Service & Leasing	145.7		142.6
Total assets of reportable segments	984.1		967.3
Goodwill (1)	911.3		865.9
Identifiable intangible assets, net (1)	481.4		493.1
Corporate	275.5		244.2
Total	$	2,652.3	$	2,570.5

_______________

(1)See Note 8, “Goodwill and Intangible Assets,” for further information related to goodwill and identifiable intangible assets, net.

XML

Revenue

3 Months Ended

Mar. 31, 2021

Revenue from Contract with Customer [Abstract]

Revenue

Revenue

Disaggregation of Revenue

The following tables represent a disaggregation of revenue by timing of revenue along with the reportable segment for each category:

	Three Months Ended March 31, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	98.7	$	5.6	$	61.9	$	26.7	$	(2.9)	$	190.0
Over time	5.2		63.6		15.4		14.7		(0.4)		98.5
Total	$	103.9	$	69.2	$	77.3	$	41.4	$	(3.3)	$	288.5

	Three Months Ended March 31, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	89.8	$	7.1	$	38.8	$	28.0	$	(1.5)	$	162.2
Over time	8.2		105.8		14.1		12.7		(1.1)		139.7
Total	$	98.0	$	112.9	$	52.9	$	40.7	$	(2.6)	$	301.9

Refer to Note 3, “Reportable Segments,” for a table of revenue by reportable segment disaggregated by geography.

Contract Balances

The following table represents changes in our contract assets and contract liabilities balances:

	March 31, 2021		December 31, 2020		Year-to-date Change ($)		Year-to-date Change (%)
Contract assets
Accounts receivable, net of allowances	$	186.4	$	200.8	$	(14.4)	(7.2)	%
Unbilled contract revenue	74.6		79.4		(4.8)		(6.0)	%
Contract liabilities
Customer advances and billings in excess of contract revenue	$	106.3	$	118.9	$	(12.6)	(10.6)	%
Long-term deferred revenue	0.2		1.9		(1.7)		(89.5)	%

Revenue recognized for the three months ended March 31, 2021 and 2020, that was included in the contract liabilities balance at the beginning of each year was $52.5 and $17.1, respectively. The amount of revenue recognized during the three months ended March 31, 2021 from performance obligations satisfied or partially satisfied in previous periods as a result of changes in the estimates of variable consideration related to long-term contracts, was not significant.

Remaining Performance Obligations

Remaining performance obligations represent the transaction price of firm signed purchase orders or other written contractual commitments from customers for which work has not been performed, or is partially completed, and excludes unexercised contract options and potential orders. As of March 31, 2021, the estimated revenue expected to be recognized in the future related to remaining performance obligations was $934.1. We expect to recognize revenue on approximately 76% of the remaining performance obligations over the next 12 months and with the remaining over the next few years thereafter.

XML

Investments

3 Months Ended

Mar. 31, 2021

Investments, Debt and Equity Securities [Abstract]

Investments

Investments

Investments in equity securities

We measure certain of our investments in equity securities at fair value on a recurring basis. Furthermore, we categorize these investments in equity securities according to the fair value hierarchy as defined in Note 2, “Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended December 31, 2020. Mark-to-market fair value adjustments in these investments in equity securities are classified as unrealized (gain) loss on investments in equity securities in our condensed consolidated statements of income and comprehensive income.

For certain other investments in equity securities that are not measured at fair value on a recurring basis, we measure such investments at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.

The following table summarizes the components of our investments in equity securities:

	Investments in Equity Securities, Level 1 (1)		Investments in Equity Securities, Level 2 (2)		Subtotal		Investments in Equity Securities, All Others (3) (4) (5)		Investments in Equity Securities, Total
Balance at December 31, 2020	$	53.8	$	4.1	$	57.9	$	15.7	$	73.6
New investments	—		—		—		40.0		40.0
(Decrease) increase in fair value of investments in equity securities	(2.6)		5.9		3.3		—		3.3
Foreign currency translation adjustments	(2.4)		—		(2.4)		0.1		(2.3)
Balance at March 31, 2021	$	48.8	$	10.0	$	58.8	$	55.8	$	114.6

_______________

(1)Represents our investment in McPhy (Euronext Paris: MCPHY - ISIN; FR001742329), which was 41.6 million euros ($48.8) and 39.8 million euros ($53.8) at March 31, 2021 and December 31, 2020, respectively. For the three months ended March 31, 2021, we recognized an unrealized loss of $2.6. For additional information see Note 6, “Investments” in our Annual Report on Form 10-K for the year ended December 31, 2020.

(2)Represents our investment in Stabilis Energy, Inc. (“Stabilis”), which was $10.0 and $4.1 at March 31, 2021 and December 31, 2020, respectively. For the three months ended March 31, 2021, we recognized an unrealized gain of $5.9. For additional information see Note 6, “Investments” in our Annual Report on Form 10-K for the year ended December 31, 2020.

(3)Represents our investment in HTEC Hydrogen Technology & Energy Corporation (“HTEC”), which was CAD 20.0 million at both March 31, 2021 and December 31, 2020 (equivalent to $15.8 and $15.7 at March 31, 2021 and December 31, 2020, respectively). For additional information see Note 6, “Investments” in our Annual Report on Form 10-K for the year ended December 31, 2020.

(4)During the first quarter of 2021, we completed an investment in Svante Inc. (“Svante”) in the amount of $15.0 for under 10% of its capital stock on a fully diluted basis. This investment was measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. As of March 31, 2021, the value of the investment was $15.0. Svante offers companies in emissions-intensive industries a commercially viable way to capture large-scale CO2 emissions from existing infrastructure, either for safe storage or to be recycled for further industrial use in a closed loop.

(5)During the first quarter of 2021, we completed an investment in Transform Materials LLC (“Transform Materials”) in the amount of $25.0 for approximately 5% of its equity. This investment was measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. As of March 31, 2021, the value of the investment was $25.0. Transform Materials is a sustainable chemical technology company that uses microwave plasma to convert natural gas into acetylene and hydrogen. Its highly selective, cost-effective, net-carbon-negative process converts the methane in natural gas into high-value products suitable for direct use or downstream reactions.

Equity method accounting investments

Our equity investments accounted for under the equity method of accounting include a 50% ownership interest in a joint venture with Hudson Products de Mexico S.A. de CV which totaled $2.8 at both March 31, 2021 and December 31, 2020. This investment is operated and managed by our joint venture partner and as such, we do not have control over the joint venture and therefore it is not consolidated. Additionally, we have a 25% ownership interest in Liberty LNG, which was valued at $2.2 and $2.1 at March 31, 2021 and December 31, 2020, respectively. Our equity in earnings from these equity method accounting investments were not material for the periods presented.

XML

Leases

3 Months Ended

Mar. 31, 2021

Leases [Abstract]

Leases

Leases

As of March 31, 2021 and December 31, 2020, operating right-of-use (“ROU”) assets and lease liabilities were $28.0 and $27.7 ($5.1 of which was current) and $29.0 and $28.7 ($5.1 of which was current), respectively. The weighted-average remaining term for lease contracts was 5.6 years at March 31, 2021, with maturity dates ranging from April 2021 to February 2029. The weighted-average discount rate was 2.3% at March 31, 2021. ROU assets are classified as property, plant and equipment, net in the condensed consolidated balance sheets.

We incurred $3.0 and $2.9 of rental expense under operating leases for the three months ended March 31, 2021 and 2020, respectively. Certain operating leases contain rent escalation clauses and lease concessions that require additional rental payments in the later years of the term. Rent expense for these types of leases is recognized on a straight-line basis over the minimum lease term. Adjustments for straight-line rental expense for the respective periods was not material and as such, the majority of expense recognized was reflected in cash provided by operating activities for the respective periods. This expense consisted primarily of payments for base rent on building and equipment leases. Payments related to short-term lease costs and taxes and variable service charges on leased properties were immaterial. In addition, we have the right, but no obligation, to renew certain leases for various renewal terms.

The following table summarizes future minimum lease payments for non-cancelable operating leases as of March 31, 2021:

2021	$	5.4
2022	6.2
2023	5.6
2024	5.1
2025	4.3
Thereafter (1)	3.5
Total future minimum lease payments	$	30.1

_______________

(1)     As of March 31, 2021, future minimum lease payments for non-cancelable operating leases for period subsequent to 2024 relate to seven leased facilities.

XML

Inventories

3 Months Ended

Mar. 31, 2021

Inventory Disclosure [Abstract]

Inventories

Inventories

The following table summarizes the components of inventory:

	March 31, 2021		December 31, 2020
Raw materials and supplies	$	140.6	$	124.7
Work in process	57.8		57.8
Finished goods	81.5		65.9
Total inventories, net	$	279.9	$	248.4

The allowance for excess and obsolete inventory balance at both March 31, 2021 and December 31, 2020 was $9.7

XML

Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Goodwill and Intangible Assets

Goodwill

The following table represents the changes in goodwill by segment:

	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Consolidated
Balance at December 31, 2020	$	93.2	$	435.2	$	172.4	$	165.1	$	865.9
Goodwill acquired during the period (1)	—		—		52.1		—		52.1
Foreign currency translation adjustments	(4.8)		(2.6)		—		—		(7.4)
Purchase price adjustment (1)	—		—		0.7		—		0.7
Balance at March 31, 2021	$	88.4	$	432.6	$	225.2	$	165.1	$	911.3

_______________

(1)During the first quarter of 2021, we recorded a purchase price adjustment that increased goodwill by $0.7 in Specialty Products related to the Cryogenic Gas Technologies, Inc. acquisition. For further information regarding goodwill acquired and the purchase price adjustment during the period refer to Note 11, “Business Combinations.”

Amounts included in accumulated goodwill impairment loss at both March 31, 2021 and December 31, 2020 were $129.0 ($23.5 - Cryo Tank Solutions, $49.3 - Heat Transfer Systems, $35.8 - Specialty Products, $20.4 - Repair, Service & Leasing).

Intangible Assets

The following table displays the gross carrying amount and accumulated amortization for finite-lived intangible assets and indefinite-lived intangible assets (exclusive of goodwill) (1):

		March 31, 2021				December 31, 2020
	Weighted-average Estimated Useful Life	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Finite-lived intangible assets:
Customer relationships	13 years	$	300.2	$	(65.0)	$	302.5	$	(59.9)
Unpatented technology	12 years	110.8		(24.2)		110.4		(22.3)
Patents and other	6 years	5.6		(0.4)		8.4		(1.8)
Trademarks and trade names	11 years	3.3		(1.6)		3.6		(1.4)
Land use rights	50 years	11.0		(1.4)		11.1		(1.4)
Total finite-lived intangible assets	13 years	430.9		(92.6)		436.0		(86.8)
Indefinite-lived intangible assets:
Trademarks and trade names		143.1		—		143.9		—
Total intangible assets		$	574.0	$	(92.6)	$	579.9	$	(86.8)

_______________

(1)Amounts include the impact of foreign currency translation. Fully amortized or impaired amounts are written off.

Amortization expense for intangible assets subject to amortization was $8.8 and $14.0 for the three months ended March 31, 2021 and 2020, respectively. We estimate amortization expense to be recognized during the next five years as follows:

For the Year Ending December 31,
2021	$	35.7
2022	34.6
2023	34.4
2024	34.1
2025	33.2

Government Grants

We received certain government grants related to land use rights for capacity expansion in China (“China Government Grants”). China Government Grants are generally recorded in other current liabilities and other long-term liabilities in the unaudited condensed consolidated balance sheets and generally recognized into income over the useful life of the associated assets (10 to 50 years).

China Government Grants are presented in our unaudited condensed consolidated balance sheets as follows:

	March 31, 2021		December 31, 2020
Current	$	0.5	$	0.5
Long-term	7.1		7.3
Total China Government Grants	$	7.6	$	7.8

XML

Debt and Credit Arrangements

3 Months Ended

Mar. 31, 2021

Debt Disclosure [Abstract]

Debt and Credit Arrangements

Debt and Credit Arrangements

Summary of Outstanding Borrowings

The following table represents the components of our borrowings:

	March 31, 2021		December 31, 2020
Senior secured revolving credit facility and term loan:
Term loan due June 2024 (1)	$	103.1	$	103.1
Senior secured revolving credit facility due June 2024 (2) (3)	204.7		123.5
Unamortized debt issuance costs	(4.7)		(5.0)
Senior secured revolving credit facility and term loan, net of debt issuance costs	303.1		221.6
Convertible notes due November 2024:
Principal amount	258.8		258.8
Unamortized discount (4)	—		(34.8)
Unamortized debt issuance costs	(3.6)		(3.1)
Convertible notes due November 2024, net of unamortized discount and debt issuance costs	255.2		220.9
Foreign facilities	—		—
Total debt, net of unamortized discount and debt issuance costs	558.3		442.5
Less: current maturities	255.2		220.9
Long-term debt	$	303.1	$	221.6

_______________

(1)As of March 31, 2021, there were $103.1 in borrowings outstanding under the term loan due June 2024, which is due at maturity, bearing an interest rate of 2.0% (2.5% as of December 31, 2020).

(2)The senior secured revolving credit facility due 2024 includes $100.0 sub limit for letters of credit, a $250.0 sub limit for discretionary letters of credit and $50.0 sub limit for swingline loans. As of March 31, 2021, there were $204.7 in borrowings outstanding under the senior secured revolving credit facility due 2024 bearing a weighted-average interest rate of 1.8% (2.1% as of December 31, 2020) and $53.1 in letters of credit and bank guarantees outstanding supported by the senior secured revolving credit facility due 2024. As of March 31, 2021, the senior secured revolving credit facility due 2024 had availability of $292.2.

(3)A portion of borrowings outstanding under our senior secured revolving credit facility due 2024 are denominated in euros (“EUR Revolver Borrowings”). As of both March 31, 2021 and December 31, 2020, EUR Revolver Borrowings outstanding were EUR 71.5 million (equivalent to $83.8 and $87.7 at March 31, 2021 and December 31, 2020, respectively). During the three months ended March 31, 2021, we recognized an unrealized foreign currency gain of $3.9 relative to the translation of the EUR Revolver Borrowings outstanding during the reporting period. This unrealized foreign currency gain is classified as foreign currency (gain) loss and other in the condensed consolidated statement of income for the three months ended March 31, 2021.

(4)We derecognized the debt discount associated with the convertible notes due November 2024 upon adoption of ASU 2020-06 on January 1, 2021.

Senior Secured Revolving Credit Facility and Term Loan

On June 14, 2019, we entered into the Fourth Amended and Restated Credit Agreement, which includes a senior secured revolving credit facility (the “SSRCF”) and a term loan (together, the “2024 Credit Facilities”). The 2024 Credit Facilities mature on June 14, 2024.

•The SSRCF has a borrowing capacity of $550.0.

•The principal amount of the term loan is $450.0.

•The 2024 Credit Facilities bear interest at a base rate margin determined on a leveraged-based scale which ranges from 25 to 150 basis points for alternative base rate loans and 125 to 250 basis points for LIBOR loans.

•Interest and fees are payable on a quarterly basis (or if earlier, at the end of each interest period for LIBOR loans).

Significant financial covenants for the 2024 Credit Facilities include financial maintenance covenants that, as of the last day of any fiscal quarter ending on and after June 30, 2019, (i) require the ratio of the amount of Chart and its subsidiaries’ consolidated total net indebtedness to consolidated EBITDA to be less than specified maximum ratio levels and (ii) require the ratio of the amount of Chart and its subsidiaries’ consolidated EBITDA to consolidated cash interest expense to be greater than a specified minimum ratio level. The 2024 Credit Facilities include a number of other customary covenants including, but not limited to, restrictions on our ability to incur additional indebtedness, create liens or other encumbrances, sell assets, enter into sale and lease-back transactions, make certain payments, investments, loans, advances or guarantees, make acquisitions and engage in mergers or consolidations and pay dividends or distributions. At March 31, 2021, we were in compliance with all covenants.

The 2024 Credit Facilities also contain customary events of default. If such an event of default occurs, the lenders thereunder would be entitled to take various actions, including the acceleration of amounts due and all actions permitted to be taken by a secured creditor. The 2024 Credit Facilities are guaranteed by Chart and substantially all of its U.S. subsidiaries and secured by substantially all of the assets of Chart and our U.S. subsidiaries and 65% of the capital stock of our material non-U.S. subsidiaries (as defined by the Fourth Amended and Restated Credit Agreement) that are owned by U.S. subsidiaries.

On September 28, 2020 and April 20, 2020, we amended our 2024 Credit Facilities. The amendments, among other things, (i) reduce the LIBO Screen Rate (as defined in the Credit Agreement) floor by half, effectively reducing all interest payable by Chart (ii) provide Chart with further flexibility to complete divestitures at its discretion by changing the “catch-all” permitted divestiture basket from a small annual cap to a more substantial life-of the-facility cap, (iii) adjust the pricing grid in order to accommodate potentially higher leverage ratios, (iv) adjust factoring related definitions and other related provisions to provide Chart with greater flexibility to enter into such arrangements in the future, (v) incorporate a “cash hoarding” prevention covenant and (vi) incorporate various amendments to reflect interest rate floor and other changes to the Loan Syndications and Trading Association and Loan Market Association market standards for credit agreements. The terms and conditions under the 2024 Credit Facilities are otherwise substantially the same as those prior to the amendments. We recorded $1.9 in deferred debt issuance costs related to these amendments which are being amortized over the remaining term of the 2024 Credit Facilities.

We recorded $6.1 in deferred debt issuance costs in conjunction with the 2024 Credit Facilities, which is included in long-term debt in the unaudited condensed consolidated balance sheet at March 31, 2021, associated with the term loan, which is being amortized over its five-year term beginning in July 2019.

We paid $11.9 in deferred debt issuance costs related to the SSRCF. Deferred debt issuance costs are presented in other assets in the unaudited condensed consolidated balance sheets and are being amortized over the term of the SSRCF. At March 31, 2021, unamortized debt issuance costs associated with the SSRCF were $7.3.

The following table summarizes interest expense and financing costs amortization related to the 2024 Credit Facilities:

	Three Months Ended March 31,
	2021		2020
Interest expense, term loan due June 2024	$	0.6	$	4.2
Interest expense, senior secured revolving credit facility due June 2024	0.7		0.6
Interest expense, senior secured revolving credit facility and term loan due June 2024	$	1.3	$	4.8
Financing costs amortization, senior secured revolving credit facility and term loan due 2024	$	1.0	$	0.8

2024 Convertible Notes

On November 6, 2017, we issued 1.00% Convertible Senior Subordinated Notes due November 2024 (the “2024 Notes”) in the aggregate principal amount of $258.8, pursuant to an Indenture, dated as of such date (the “Indenture”). On December 31, 2020, we entered into the First Supplemental Indenture (the “Supplemental Indenture”) to the Indenture, between Chart and Wells Fargo Bank, National Association, as trustee, governing the 2024 Notes. Pursuant to the Supplemental Indenture, Chart irrevocably elected (i) to eliminate Chart’s option to elect Physical Settlement (as defined in the Indenture) on any conversion of 2024 Notes that occurs on or after the date of the Supplemental Indenture and (ii) that, with respect to any Combination Settlement (as defined in the Indenture) for a conversion of 2024 Notes, the Specified Dollar Amount (as defined in the Indenture) that will be settled in cash per $1,000 principal amount of the Notes shall be no lower than $1,000. The 2024 Notes bear interest at an annual rate of 1.00%, payable on May 15 and November 15 of each year, beginning on May 15, 2018, and will mature on November 15, 2024 unless earlier converted or repurchased.

The 2024 Notes are senior subordinated unsecured obligations of the Company and are not guaranteed by any of our subsidiaries. The 2024 Notes are senior in right of payment to our future subordinated debt, equal in right of payment with the Company’s future senior subordinated debt and are subordinated in right of payment to our existing and future senior indebtedness, including indebtedness under our existing credit agreement.

Prior to December 31, 2020, a conversion of the 2024 Notes could have been settled in cash, shares of our common stock or a combination of cash and shares of our common stock, at our election (subject to, and in accordance with, the settlement provisions of the Indenture). After December 31, 2020, a conversion of the 2024 Notes may be settled in either (1) cash or (2) cash for the principal amount of the 2024 Notes and any combination of cash and shares for the excess settlement amount above the principal amount of the 2024 Notes, at our election (subject to, and in accordance with, the settlement provisions of the Indenture and Supplemental Indenture). The initial conversion rate for the 2024 Notes is 17.0285 shares of common stock (subject to adjustment as provided for in the Indenture) per $1,000 principal amount of the 2024 Notes, which is equal to an initial conversion price of approximately $58.725 per share, representing a conversion premium of approximately 35% above the closing price of our common stock of $43.50 per share on October 31, 2017. In addition, following certain corporate events that occur prior to the maturity date as described in the Indenture, we will pay a make-whole premium by increasing the conversion rate for a holder who elects to convert its 2024 Notes in connection with such a corporate event in certain circumstances. For purposes of calculating earnings per share, if the average market price of our common stock exceeds the applicable conversion price during the periods reported, shares contingently issuable under the 2024 Notes will have a dilutive effect with respect to our common stock. Since our closing common stock price of $142.35 at the end of the period exceeded the conversion price of $58.725, the if-converted value exceeded the principal amount of the 2024 Notes by approximately $368.5 at March 31, 2021. As described below, we entered into convertible note hedge transactions, which are expected to reduce the potential dilution with respect to our common stock upon conversion of the 2024 Notes.

Holders of the 2024 Notes may convert their 2024 Notes at their option at any time prior to the close of business on the business day immediately preceding August 15, 2024 only under the following circumstances: (1) during any fiscal quarter commencing after December 31, 2017 (and only during such fiscal quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the applicable conversion price for the 2024 Notes on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the “trading price” (as defined in the Indenture) per one thousand U.S. dollar principal amount of Notes for each trading day of such measurement period was less than 97% of the product of the last reported sale price of our common stock and the applicable conversion rate for the 2024 Notes on each such

trading day; or (3) upon the occurrence of specified corporate events described in the Indenture. On or after August 15, 2024 until the close of business on the second scheduled trading day immediately preceding November 15, 2024, holders may convert their 2024 Notes at the option of the holder regardless of the foregoing circumstances.

As of April 1, 2021, the 2024 Notes continue to be convertible at the option of the shareholders. This conversion right, which will remain available until June 30, 2021, was triggered since the closing price of our common stock was greater than or equal to $76.3425 (130% of the conversion price of the 2024 Notes) for at least 20 trading days during the last 30 trading days ending on March 31, 2021. Since the holders of the 2024 Notes could potentially convert their 2024 Notes at their option during the three month period subsequent to March 31, 2021, the $258.8 principal amount of the 2024 Notes was classified as a current liability in the consolidated balance sheet at March 31, 2021. As of December 31, 2020, the 2024 Notes were convertible at the option of the holders, and the liability component of the 2024 Notes was classified as a current liability. We will reassess the convertibility of the 2024 Notes and the related balance sheet classification on a quarterly basis. There have been no conversions as of the date of this filing.

Prior to the adoption of ASU 2020-06, we allocated the gross proceeds of the 2024 Notes between the liability and equity components of the 2024 Notes. The initial liability component of $200.1, which was recorded as long-term debt, represented the fair value of similar debt instruments that have no conversion rights. The initial equity component of $58.7, which was recorded as additional paid-in capital, represented the debt discount and was calculated as the difference between the fair value of the liability component and gross proceeds of the 2024 Notes. The liability component was recognized at the present value of its associated cash flows using a 4.8% straight-debt rate and was being accreted to interest expense over the term of the 2024 Notes.

After the adoption of ASU 2020-06, our convertible notes due November 2024 are no longer bifurcated into separate liability and equity components in our March 31, 2021 condensed consolidated balance sheet. Rather, the $258.8 principal amount of our convertible notes due November 2024 was classified as a liability only in our March 31, 2021 condensed consolidated balance sheet. Upon adoption of ASU 2020-06 and transition, we recorded an adjustment to the convertible notes liability component, equity component (additional paid-in-capital) and retained earnings. This adjustment was calculated based on the carrying amount of the convertible notes as if it had always been treated as a liability only. Refer to Note 1, “Basis of Preparation” for further discussion.

Prior to the adoption of ASU 2020-06, we recorded $5.3 in deferred debt issuance costs associated with the 2024 Notes, which was being amortized over the term of the 2024 Notes using the effective interest method. We also recorded $1.5 in equity issuance costs, which was recorded as a reduction to additional paid-in capital. After the adoption of ASU 2020-06, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, i.e. as if debt issuance costs had always been treated as a contra liability only. We amortize the adjusted unamortized debt issuance costs balance over the term of the 2024 Notes using the effective interest method. Refer to Note 1, “Basis of Preparation” for further discussion. Furthermore, interest expense related to the accretion of our convertible notes due November 2024 is no longer recognized.

The following table summarizes interest accretion of the 2024 Notes discount, 1.0% contractual interest coupon and financing costs amortization associated with the 2024 Notes:

	Three Months Ended March 31,
	2021		2020
2024 Notes, interest accretion of convertible notes discount	$	—	$	1.9
2024 Notes, 1.0% contractual interest coupon	0.6		0.6
2024 Notes, total interest expense	$	0.6	$	2.5
2024 Notes, financing costs amortization	$	0.2	$	0.2

Convertible Note Hedge and Warrant Transactions Associated with the 2024 Notes

In connection with the pricing of the 2024 Notes, we entered into convertible note hedge transactions (the “Note Hedge Transactions”) with certain parties, including the initial purchasers of the 2024 Notes (the “Option Counterparties”). The Note Hedge Transactions are expected generally to reduce the potential dilution upon any future conversion of the 2024 Notes. Payments for the Note Hedge Transactions totaled approximately $59.5 and were recorded as a reduction to additional paid-in capital in the December 31, 2017 consolidated balance sheet.

We also entered into separate, privately negotiated warrant transactions (the “Warrant Transactions”) with the Option Counterparties to acquire up to 4.41 shares of our common stock. Proceeds received from the issuance of the Warrant Transactions totaled approximately $46.0 and were recorded as an addition to additional paid-in capital in the December 31, 2017 consolidated balance sheet. The strike price of the Warrant Transactions will initially be $71.775 per share (subject to adjustment), which is approximately 65% above the last reported sale price of our common stock on October 31, 2017. The Warrant Transactions could have a dilutive effect to our stockholders to the extent that the market price per share of our common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants.

The Note Hedge Transactions and Warrant Transactions effectively increased the conversion price of the 2024 Notes. The net cost of the Note Hedge Transactions and Warrant Transactions was approximately $13.5.

Foreign Facilities

In various markets where we do business, we have local credit facilities to meet local working capital demands, fund letters of credit and bank guarantees, and support other short-term cash requirements. The facilities generally have variable interest rates and are denominated in local currency but may, in some cases, facilitate borrowings in multiple currencies. We are permitted to borrow up to USD equivalent $80.9 under certain of our foreign facilities. As of March 31, 2021 and December 31, 2020 there were none outstanding in USD equivalent in borrowings outstanding under these facilities. The weighted-average interest rate on foreign facilities was of 1.3% as of March 31, 2021.

Certain of our foreign facilities allow us to request bank guarantees and letters of credit. None of these facilities allow revolving credit borrowings. We have foreign letters of credit and bank guarantees that totaled USD equivalent $51.6 and $47.7 as of March 31, 2021 and December 31, 2020, respectively.

Letters of Credit

Chart Energy & Chemicals, Inc., a wholly-owned subsidiary of the Company, had $1.0 in deposits in a bank outside of the SSRCF to secure letters of credit. The deposits are treated as restricted cash and restricted cash equivalents in the unaudited condensed consolidated balance sheets $1.0 in other assets at both March 31, 2021 and December 31, 2020.

Fair Value Disclosures

The fair value of the 2024 Notes was approximately 242% and 210% of their par value as of March 31, 2021 and December 31, 2020, respectively. The 2024 Notes are actively quoted instruments and, accordingly, the fair value of the 2024 Notes was determined using Level 1 inputs.

XML

Product Warranties

3 Months Ended

Mar. 31, 2021

Product Warranties Disclosures [Abstract]

Product Warranties

Product Warranties

We provide product warranties with varying terms and durations for the majority of our products. We estimate our warranty reserve by considering historical and projected warranty claims, historical and projected cost-per-claim, and knowledge of specific product issues that are outside our typical experience. We record warranty expense in cost of sales in the unaudited condensed consolidated statements of income and comprehensive income. Product warranty claims not expected to occur within one year are included as part of other long-term liabilities in the unaudited condensed consolidated balance sheets.

The following table represents changes in our consolidated warranty reserve:

Balance at December 31, 2020	$	11.9
Issued – warranty expense	(0.9)
Warranty usage	0.3
Balance at March 31, 2021	$	11.3

XML

Business Combinations

3 Months Ended

Mar. 31, 2021

Business Combinations [Abstract]

Business Combinations

Business Combinations

Cryo Technologies Acquisition

On February 16, 2021, we acquired 100% of the equity interests of Cryogenic Gas Technologies, Inc. (“Cryo Technologies”) for approximately $55.0 in cash (subject to certain customary adjustments), net of $0.6 cash acquired. Cryo Technologies is a global leader in custom engineered process systems to separate, purify, refrigerate, liquefy and distribute high value industrial gases such as hydrogen, helium, argon and hydrocarbons with design capabilities for cold boxes for hydrogen

and helium use. The distribution systems Cryo Technologies supplies are located within the helium and hydrogen liquefaction facilities and are inclusive of trailer loading systems, which facilitates the first step in product distribution. The preliminary estimated fair value of the net assets acquired and goodwill at the date of acquisition was $2.9 and $52.1, respectively. Net assets includes $1.8 in intangible assets, which consists of unpatented technology and customer relationships. The acquisition consideration allocation is preliminary and shall be further revised as we finalize third-party valuations and other analyses to include identifiable intangible assets during the remainder of the measurement period, which shall not exceed twelve months from the closing of the acquisition.

Sustainable Energy Solutions, Inc. Acquisition

On December 23, 2020, we completed the acquisition of Sustainable Energy Solutions, Inc. (“SES”). SES’s Cryogenic Carbon Capture™ (CCC) technology eliminates most emissions from fossil fuels while enabling better use of intermittent renewables through grid-scale energy storage. The stock purchase was completed for a closing purchase price of $20.0 in cash at closing, subject to a post-closing working capital adjustment, plus a potential earn-out not to exceed $25.0. The preliminary estimated fair value of the net assets acquired and goodwill at the date of acquisition was $13.4 and $24.0, respectively. Net assets includes $17.3 in intangible assets, which consists of unpatented technology, trade names and non-compete contracts.

BlueInGreen, LLC Acquisition

On November 3, 2020, we completed the acquisition of BlueInGreen, LLC (“BIG”), a leading dissolved-gas expert providing custom-engineered solutions for water treatment and industrial process applications that delivers tangible economic, social and environmental value. The stock purchase was completed for a purchase price of $20.0 in cash at closing (subject to customary adjustments), plus a potential earn-out not to exceed $6.0. The preliminary estimated fair value of the net assets acquired and goodwill at the date of acquisition was $8.8 and $14.8, respectively. The purchase price allocation reported at December 31, 2020 was preliminary and was based on provisional fair values. During the first three months of 2021, we received and analyzed new information about certain intangible assets and subsequently decreased their estimated fair value by $0.7. Net assets includes $6.2 in intangible assets, which consists of non-compete contracts, unpatented technology, trademarks and trade names, certifications and licenses and customer relationships.

Alabama Trailers Acquisition

On October 13, 2020, we completed the acquisition of the Theodore, Alabama cryogenic trailer and hydrogen trailer (transport) assets of Worthington Industries, Inc. (NYSE: WOR) for $10.0 in cash (“Alabama Trailers”). Worthington Industries, Inc. made the decision to exit the hydrogen trailer business and sold the business to Chart at a discount. As a result of the acquisition, we recorded a bargain purchase gain of $5.0. Alabama Trailers designs, manufactures and sells cryogenic trailers and hydrogen trailers used in industrial gas and energy applications.

The purchase price allocations of Cryo Technologies, SES, BIG and Alabama Trailers are preliminary and are based on provisional fair values and subject to revision as we finalize third-party valuations and other analyses. Final determination of the fair values may result in further adjustments to the value of net assets acquired.

Contingent Consideration

The fair value of contingent consideration was $16.9 for SES and $3.2 for BIG at the date of acquisitions and was valued according to a discounted cash flow approach, which included assumptions regarding the probability of achieving certain targets and a discount rate applied to the potential payments. Potential payments are measured between the period commencing April 1, 2021 and ending on December 31, 2028 based on the attainment of certain earnings targets. The potential payments related to both SES and BIG contingent consideration on a combined basis is between $0.0 and $31.0.

Valuations are performed using Level 3 inputs as defined in Note 2, “Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended December 31, 2020 and are evaluated on a quarterly basis based on forecasted sales and earnings targets. Contingent consideration liabilities are classified as other current liabilities and other long-term liabilities in the condensed consolidated balance sheets. Changes in fair value of contingent consideration, including accretion, are recorded as selling, general and administrative expenses in the condensed consolidated statements of income and comprehensive income.

The following table represents the changes to our contingent consideration liabilities:

	SES		BIG		Total
Balance at December 31, 2020	$	16.9	$	3.2	$	20.1
Increase in fair value of contingent consideration liabilities	0.7		0.1		0.8
Balance at March 31, 2021	$	17.6	$	3.3	$	20.9

XML

Accumulated Other Comprehensive (Loss) Income

3 Months Ended

Mar. 31, 2021

Equity [Abstract]

Accumulated Other Comprehensive (Loss) Income

Accumulated Other Comprehensive (Loss) Income

The components of accumulated other comprehensive (loss) income are as follows:

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive income (loss)
Balance at December 31, 2020	$	13.8	$	(11.4)	$	2.4
Other comprehensive loss	(19.6)		—		(19.6)
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes	—		0.4		0.4
Net current-period other comprehensive (loss) income, net of taxes	(19.6)		0.4		(19.2)
Balance at March 31, 2021	$	(5.8)	$	(11.0)	$	(16.8)

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive loss
Balance at December 31, 2019	$	(25.0)	$	(10.9)	$	(35.9)
Other comprehensive loss	(10.2)		—		(10.2)
Amounts reclassified from accumulated other comprehensive loss, net of income taxes	—		0.3		0.3
Net current-period other comprehensive (loss) income, net of taxes	(10.2)		0.3		(9.9)
Balance at March 31, 2020	$	(35.2)	$	(10.6)	$	(45.8)

XML

Earnings Per Share

3 Months Ended

Mar. 31, 2021

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

The following table represents calculations of net earnings per share of common stock:

	Three Months Ended March 31,
	2021		2020
Net income attributable to Chart Industries, Inc.
Income from continuing operations	$	25.6	$	2.1
Income from discontinued operations, net of tax	—		6.4
Net income attributable to Chart Industries, Inc.	$	25.6	$	8.5
Earnings per common share – basic:
Income from continuing operations	$	0.72	$	0.06
Income from discontinued operations	—		0.18
Net income attributable to Chart Industries, Inc.	$	0.72	$	0.24
Earnings per common share – diluted:
Income from continuing operations	$	0.63	$	0.06
Income from discontinued operations	—		0.18
Net income attributable to Chart Industries, Inc.	$	0.63	$	0.24
Weighted average number of common shares outstanding – basic	35.55		35.77
Incremental shares issuable upon assumed conversion and exercise of share-based awards	0.33		0.24
Incremental shares issuable due to dilutive effect of convertible notes	2.57		—
Incremental shares issuable due to dilutive effect of warrants	2.17		—
Weighted average number of common shares outstanding – diluted	40.62		36.01

Diluted earnings per share does not reflect the following potential common shares as the effect would be anti-dilutive:

	Three Months Ended March 31,
	2021	2020
Share-based awards	0.06	0.50
Convertible note hedge and capped call transactions (1)	2.57	—
Warrants	—	4.41
Total anti-dilutive securities	2.63	4.91

 _______________

(1)The convertible note hedge offsets any dilution upon actual conversion of the 2024 Notes up to a common stock price of $71.775 per share. For further information, refer to Note 9, “Debt and Credit Arrangements.”

XML

Income Taxes

3 Months Ended

Mar. 31, 2021

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

Income tax expense of $3.1 and $0.4 for the three months ended March 31, 2021 and 2020, respectively, represents taxes on both U.S. and foreign earnings at a combined effective income tax rate of 10.6% and 16.0%, respectively.

The effective income tax rate of 10.6% for the three months ended March 31, 2021 differed from the U.S. federal statutory rate of 21% primarily due to losses incurred by some of our foreign operations for which no benefit was recorded, partially offset by the effect of income earned by our certain foreign entities being taxed at higher rates than the U.S. federal statutory rate and excess tax benefits associated with share-based compensation.

The effective income tax rate of 16.0% for the three months ended March 31, 2020 differed from the U.S. federal statutory rate of 21% primarily due to losses incurred by certain of our foreign operations for which no benefit was recorded, partially offset by the effect of income earned by certain of our foreign entities being taxed at higher rates than the U.S. federal statutory rate and excess tax benefits associated with share-based compensation.As of both March 31, 2021 and December 31, 2020, we had a liability for gross unrecognized tax benefits of $1.9. This amount includes $1.3 of unrecognized tax benefits as of both March 31, 2021 and December 31, 2020, which, if ultimately recognized, would reduce our annual effective income tax rate. We recognized interest and penalties of $0.3 related to uncertain tax positions in income tax expense as of March 31, 2021.

XML

Share-based Compensation

3 Months Ended

Mar. 31, 2021

Share-based Payment Arrangement, Noncash Expense [Abstract]

Share-based Compensation

Share-based Compensation

During the three months ended March 31, 2021, we granted 0.06 stock options, 0.05 restricted stock units and 0.03 performance units. The total fair value of awards granted to employees during the three months ended March 31, 2021 was $12.5. In addition, our non-employee directors received stock awards with a total fair value of $0.1. During the three months ended March 31, 2021, participants in our stock option plans exercised options to purchase 0.10 shares of our common stock.

Stock options generally have a four-year graded vesting period. Restricted stock and restricted stock units generally vest ratably over a three-year period. Performance units generally vest at the end of a three-year performance period based on the attainment of certain pre-determined performance condition targets. During the three months ended March 31, 2021, 0.07 restricted stock and restricted stock units vested and 0.01 performance units vested.

Share-based compensation expense was $3.4 and $2.9 for the three months ended March 31, 2021 and 2020, respectively. Share-based compensation expense is included in selling, general, and administrative expenses in the unaudited condensed consolidated statements of income and comprehensive income. As of March 31, 2021, total share-based compensation of $18.0 is expected to be recognized over the weighted-average period of approximately 2.4 years.

XML

Commitment and Contingencies

3 Months Ended

Mar. 31, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Environmental

We are subject to federal, state, local, and foreign environmental laws and regulations concerning, among other matters, waste water effluents, air emissions, and handling and disposal of hazardous materials, such as cleaning fluids. We are involved with environmental compliance, investigation, monitoring, and remediation activities at certain of our owned and formerly owned manufacturing facilities and at one owned facility that is leased to a third party, and, except for these continuing remediation efforts, believe we are currently in substantial compliance with all known environmental regulations. At both March 31, 2021 and December 31, 2020, we had undiscounted accrued environmental reserves of $0.3.

Legal Proceedings

Stainless Steel Cryobiological Tank Legal Proceedings

During the second quarter of 2018, Chart was named in lawsuits (including lawsuits filed in the U.S. District Court for the Northern District of California) filed against Chart and other defendants with respect to the alleged failure of a stainless steel cryobiological storage tank (model MVE 808AF-GB) at the Pacific Fertility Center in San Francisco, California.  We continue to evaluate the merits of such claims in light of the information available to date regarding use, maintenance and operation of the tank that was sold to the Pacific Fertility Center through an independent distributor and which has been out of our control for six years prior to the alleged failure.  Accordingly, an accrual related to any damages that may result from the lawsuits has not been recorded because a potential loss is not currently probable or estimable. In connection with the Cryobiological Divestiture, Chart retained certain potential liabilities and claims, including the claims asserted in connection with this litigation.

We have asserted various defenses against the claims in the lawsuits, including a defense that since manufacture, we were not in any way involved with the installation, ongoing maintenance or monitoring of the tank or related fertility center cryogenic systems at any time since the initial delivery of the tank.

We are occasionally subject to various legal claims related to performance under contracts, product liability, taxes, employment matters, environmental matters, intellectual property, and other matters incidental to the normal course of our business. Based on our historical experience in litigating these claims, as well as our current assessment of the underlying

merits of the claims and applicable insurance, if any, management believes that the final resolution of these matters will not have a material adverse effect on our financial position, liquidity, cash flows, or results of operations. Future developments may, however, result in resolution of these legal claims in a way that could have a material adverse effect.

XML

Restructuring Activities

3 Months Ended

Mar. 31, 2021

Restructuring and Related Activities [Abstract]

Restructuring Activities

Restructuring Activities

Restructuring costs of $0.7 for the first three months of 2021 were primarily related to headcount reductions and facility relocation and moving expenses. As previously reported, on July 17, 2020, we announced internally our intention to transfer operations of our heat exchanger leased facility in Tulsa, Oklahoma to our Beasley, Texas location at which we own 260 acres of land. This closure is a cost reduction measure within our Heat Transfer Systems segment to continue to structure the business for profitable growth and capacity efficiency. Total costs related to this closure are expected to be approximately $9.0, of which $2.7 was spent in 2020 and $0.4 has been spent year to date, associated with severance, relocation and moving expenses. We expect this project to be completed by June 30, 2021. We are closely monitoring our end markets and order rates and will continue to take appropriate and timely actions as necessary.

Restructuring costs of $5.2 for the three months ended March 31, 2020 were related to certain cost reduction actions across all segments and corporate to appropriately size our workforce with demand as well as eliminate redundant work. Costs were primarily related to headcount reductions.

The following table summarizes severance and other restructuring costs, which includes employee-related costs, facility rent and exit costs, relocation, recruiting, travel and other:

	Three Months Ended March 31,
	2021		2020
Severance:
Cost of sales	$	—	$	2.3
Selling, general, and administrative expenses	0.3		2.9
Total severance costs	0.3		5.2
Other restructuring:
Cost of sales	0.4		—
Total other restructuring costs	0.4		—
Total restructuring costs	$	0.7	$	5.2

The following tables summarize our restructuring activities:

	Three Months Ended March 31, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at December 31, 2020	$	0.5	$	0.2	$	—	$	—	$	0.1	$	0.8
Restructuring charges	0.3		0.4		—		—		—		0.7
Cash payments and other	(0.3)		(0.6)		—		—		(0.1)		(1.0)
Balance at March 31, 2021	$	0.5	$	—	$	—	$	—	$	—	$	0.5

	Three Months Ended March 31, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at December 30, 2019	$	0.5	$	0.2	$	—	$	—	$	0.2	$	0.9
Restructuring charges	1.8		2.8		—		—		0.6		5.2
Cash payments and other	(0.8)		(2.5)		—		—		—		(3.3)
Balance at March 31, 2020	$	1.5	$	0.5	$	—	$	—	$	0.8	$	2.8

XML

Basis of Preparation (Policies)

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Principles of Consolidation

Principles of Consolidation: The unaudited condensed consolidated financial statements include the accounts of Chart Industries, Inc. and its subsidiaries. Intercompany accounts and transactions are eliminated in consolidation.

Reclassifications: As discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, on October 1, 2020, we closed on the sale of our cryobiological products business to Cryoport, Inc. (CYRX) (refer to Note 2, “Discontinued Operations” for further information). Furthermore, we reorganized our reporting structure such that the composition of our reportable segments changed effective October 1, 2020 (refer to Note 3, “Reportable Segments” for further information). As such, certain reclassifications have been made to the statement of income and comprehensive income for the three months ended March 31, 2020 and certain notes to the unaudited condensed consolidated financial statements in order to conform to the 2021 presentation.

Use of Estimates

Use of Estimates: The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. These estimates may also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions.

Recently Issued and Adopted Accounting Standards

Recently Issued Accounting Standards (Not Yet Adopted): In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” and in January 2021, the FASB subsequently issued ASU 2021-01,

“Reference Rate Reform (Topic 848): Scope.” ASU 2020-04 and the subsequent modifications are identified as Accounting Standards Codification (“ASC”) 848 (“ASC 848”). ASC 848 simplifies the accounting for modifying contracts (including those in hedging relationships) that refer to LIBOR and other interbank offered rates that are expected to be discontinued due to reference rate reform. The amendments in ASC 848 are effective for all entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments for contract modifications by Topic or Industry Subtopic as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020, up to the date that the financial statements are available to be issued. Once elected for a Topic or an Industry Subtopic, the amendments in ASC 848 must be applied prospectively for all eligible contract modifications for that Topic or Industry Subtopic. We expect application of the amendments to impact accounting for our senior secured revolving credit facility due June 2024. We are currently assessing the effect ASC 848 will have on our financial position, results of operations, and disclosures.

Recently Adopted Accounting Standards: In August 2020, the FASB issued ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entities Own Equity (Subtopic 815-40).” This ASU simplifies accounting for convertible instruments by eliminating two of the three models in ASC 470-20 that require separating embedded conversion features from convertible instruments. The guidance is effective for fiscal years beginning after December 15, 2021. We adopted this guidance effective January 1, 2021 under the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods.

As a result of the adoption of ASU 2020-06, our convertible notes due November 2024 are no longer bifurcated into separate liability and equity components in our March 31, 2021 condensed consolidated balance sheet. Rather, the $258.8 principal amount of our convertible notes due November 2024 was classified as a liability only in our March 31, 2021 condensed consolidated balance sheet. Upon adoption of ASU 2020-06, we recorded an adjustment to the convertible notes liability component, equity component (additional paid-in-capital) and retained earnings. This adjustment was calculated based on the carrying amount of the convertible notes as if it had always been treated as a liability only. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, i.e. as if debt issuance costs had always been treated as a contra liability only. Lastly, we derecognized deferred income taxes associated with the convertible notes debt discount and adjusted deferred incomes taxes relative to unamortized debt issuance costs associated with our convertible notes due November 2024.

Interest expense related to the accretion of our convertible notes due November 2024 is no longer recognized. Interest accretion of convertible notes discount and net income from continuing operations attributable to Chart Industries, Inc. for the three months ended March 31, 2021 would have been $2.0 and $24.0, respectively, without the adoption of ASU 2020-06. As such, net income from continuing operations attributable to Chart Industries, Inc. per common share (both basic and diluted) for the three months ended March 31, 2021 is $0.04 higher due to the effect of adoption of ASU 2020-06. As further described in Note 9, “Debt and Credit Arrangements,” on December 31, 2020, we amended the Indenture governing our convertible notes due November 2024 to eliminate share settlement thus leaving us with two settlement options: (1) cash settlement or (2) cash for par and any combination of cash and shares for the excess settlement amount above the $258.8 principal amount of our convertible notes due November 2024. ASU 2020-06 requires usage of the if-converted method to compute diluted earnings per share for our convertible notes due November 2024, however, based on the terms of the amended Indenture and the cessation of interest accretion expense recognition from the transition at adoption, the if-converted method was modified such that interest expense is no longer added to the numerator, and the denominator only includes incremental shares that would be issued upon conversion.

Impacts on Financial Statements

The following table summarizes the cumulative effect of the changes to our condensed consolidated balance sheet as of December 31, 2020 from the adoption of ASU 2020-06:

	Balance at December 31, 2020		Adjustments due to ASU 2020-06 adoption		Balance at January 1, 2021
Liabilities
Accrued income taxes	$	46.5	$	(0.2)	$	46.3
Current convertible notes (1)	220.9		34.0		254.9
Long-term deferred tax liabilities	60.2		(7.6)		52.6
Equity
Additional paid-in-capital	$	780.8	$	(36.9)	$	743.9
Retained earnings	808.4		10.7		819.1

_______________

(1)Current convertible notes is presented net of unamortized discount and debt issuance costs of $34.8 and $3.1, respectively at December 31, 2020. Current convertible notes is presented net of unamortized debt issuance costs of $3.9 at January 1, 2021.

In January 2020, the FASB issued ASU 2020-01, “Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815).” This ASU clarifies the interactions between the measurement alternative in Topic 321, the equity method of accounting in Topic 323 and the application of guidance for certain forward contracts and purchased options that upon settlement or exercise would be accounted for under the equity method of accounting in Topic 815. This guidance is effective for fiscal years ending after December 15, 2020. We adopted this guidance effective January 1, 2021. The adoption of this guidance did not have a material impact on our financial position, results of operations or disclosures.

XML

Basis of Preparation (Tables)

3 Months Ended

Mar. 31, 2021

Accounting Policies [Abstract]

Schedule of Impact on Financial Statements

The following table summarizes the cumulative effect of the changes to our condensed consolidated balance sheet as of December 31, 2020 from the adoption of ASU 2020-06:

	Balance at December 31, 2020		Adjustments due to ASU 2020-06 adoption		Balance at January 1, 2021
Liabilities
Accrued income taxes	$	46.5	$	(0.2)	$	46.3
Current convertible notes (1)	220.9		34.0		254.9
Long-term deferred tax liabilities	60.2		(7.6)		52.6
Equity
Additional paid-in-capital	$	780.8	$	(36.9)	$	743.9
Retained earnings	808.4		10.7		819.1

_______________

(1)Current convertible notes is presented net of unamortized discount and debt issuance costs of $34.8 and $3.1, respectively at December 31, 2020. Current convertible notes is presented net of unamortized debt issuance costs of $3.9 at January 1, 2021.

XML

Discontinued Operations (Tables)

3 Months Ended

Mar. 31, 2021

Discontinued Operations and Disposal Groups [Abstract]

Summarized financial information of discontinued operations

The following table represents income from discontinued operations, net of tax:

	Three Months Ended March 31, 2020
Sales	$	19.2
Cost of sales	10.1
Selling, general and administrative expenses	1.4
Operating income (1)	7.7
Income before income taxes from discontinued operations	7.7
Income tax expense	1.3
Income from discontinued operations, net of tax	$	6.4

________________

(1)Includes depreciation expense of $0.3 for the three months ended March 31, 2020.

The following table represents a summary of cash flows related to discontinued operations:

	Three Months Ended March 31, 2020
Net cash provided by (used in):
Operating activities	$	7.2
Investing activities	(0.1)
Net cash provided by discontinued operations	$	7.1

XML

Reportable Segments (Tables)

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Schedule of reportable and product sales information segments

Segment Financial Information

	Three Months Ended March 31, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	103.9	$	69.2	$	77.3	$	41.4	$	(3.3)	$	—	$	288.5
Depreciation and amortization expense	3.9		9.5		3.1		2.6		—		0.4		19.5
Operating income (loss) (1) (2)	15.6		3.9		17.9		8.3		—		(16.8)		28.9

	Three Months Ended March 31, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Corporate		Consolidated
Sales to external customers	$	98.0	$	112.9	$	52.9	$	40.7	$	(2.6)	$	—	$	301.9
Depreciation and amortization expense	4.4		14.1		1.4		3.3		—		0.4		23.6
Operating income (loss) (1)	11.6		5.5		13.8		4.6		—		(19.7)		15.8

_______________

(1)Restructuring costs for the:

•three months ended March 31, 2021 were $0.7 ($0.3 - Cryo Tank Solutions, $0.4 - Heat Transfer Systems).

•three months ended March 31, 2020 were $5.2 ($1.8 - Cryo Tank Solutions, $2.8 - Heat Transfer Systems, $0.6 - Corporate ).

(2)Includes acquisition-related contingent consideration adjustments of $0.8 in our Specialty Products segment for the three months ended March 31, 2021.

Sales by Geography

	Three Months Ended March 31, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	41.1	$	46.3	$	26.1	$	29.0	$	(1.7)	$	140.8
Europe, Middle East, Africa and India	37.7		7.8		45.6		10.5		(1.0)		100.6
Asia-Pacific	24.2		14.8		5.6		1.8		(0.6)		45.8
Rest of the World	0.9		0.3		—		0.1		—		1.3
Total	$	103.9	$	69.2	$	77.3	$	41.4	$	(3.3)	$	288.5

	Three Months Ended March 31, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
North America	$	40.6	$	82.2	$	24.9	$	32.1	$	(1.3)	$	178.5
Europe, Middle East, Africa and India	34.3		9.5		25.6		6.7		(0.7)		75.4
Asia-Pacific	20.1		20.9		2.2		1.7		(0.5)		44.4
Rest of the World	3.0		0.3		0.2		0.2		(0.1)		3.6
Total	$	98.0	$	112.9	$	52.9	$	40.7	$	(2.6)	$	301.9

Segment assets

	March 31, 2021		December 31, 2020
Cryo Tank Solutions	$	392.0	$	399.2
Heat Transfer Systems	230.1		247.2
Specialty Products	216.3		178.3
Repair, Service & Leasing	145.7		142.6
Total assets of reportable segments	984.1		967.3
Goodwill (1)	911.3		865.9
Identifiable intangible assets, net (1)	481.4		493.1
Corporate	275.5		244.2
Total	$	2,652.3	$	2,570.5

_______________

(1)See Note 8, “Goodwill and Intangible Assets,” for further information related to goodwill and identifiable intangible assets, net.

XML

Revenue (Tables)

3 Months Ended

Mar. 31, 2021

Revenue from Contract with Customer [Abstract]

Disaggregation of revenue by timing

The following tables represent a disaggregation of revenue by timing of revenue along with the reportable segment for each category:

	Three Months Ended March 31, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	98.7	$	5.6	$	61.9	$	26.7	$	(2.9)	$	190.0
Over time	5.2		63.6		15.4		14.7		(0.4)		98.5
Total	$	103.9	$	69.2	$	77.3	$	41.4	$	(3.3)	$	288.5

	Three Months Ended March 31, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Intersegment Eliminations		Consolidated
Point in time	$	89.8	$	7.1	$	38.8	$	28.0	$	(1.5)	$	162.2
Over time	8.2		105.8		14.1		12.7		(1.1)		139.7
Total	$	98.0	$	112.9	$	52.9	$	40.7	$	(2.6)	$	301.9

Changes in contract assets and contract liabilities balances

The following table represents changes in our contract assets and contract liabilities balances:

	March 31, 2021		December 31, 2020		Year-to-date Change ($)		Year-to-date Change (%)
Contract assets
Accounts receivable, net of allowances	$	186.4	$	200.8	$	(14.4)	(7.2)	%
Unbilled contract revenue	74.6		79.4		(4.8)		(6.0)	%
Contract liabilities
Customer advances and billings in excess of contract revenue	$	106.3	$	118.9	$	(12.6)	(10.6)	%
Long-term deferred revenue	0.2		1.9		(1.7)		(89.5)	%

XML

Investments (Tables)

3 Months Ended

Mar. 31, 2021

Investments, Debt and Equity Securities [Abstract]

Investments

The following table summarizes the components of our investments in equity securities:

	Investments in Equity Securities, Level 1 (1)		Investments in Equity Securities, Level 2 (2)		Subtotal		Investments in Equity Securities, All Others (3) (4) (5)		Investments in Equity Securities, Total
Balance at December 31, 2020	$	53.8	$	4.1	$	57.9	$	15.7	$	73.6
New investments	—		—		—		40.0		40.0
(Decrease) increase in fair value of investments in equity securities	(2.6)		5.9		3.3		—		3.3
Foreign currency translation adjustments	(2.4)		—		(2.4)		0.1		(2.3)
Balance at March 31, 2021	$	48.8	$	10.0	$	58.8	$	55.8	$	114.6

_______________

(1)Represents our investment in McPhy (Euronext Paris: MCPHY - ISIN; FR001742329), which was 41.6 million euros ($48.8) and 39.8 million euros ($53.8) at March 31, 2021 and December 31, 2020, respectively. For the three months ended March 31, 2021, we recognized an unrealized loss of $2.6. For additional information see Note 6, “Investments” in our Annual Report on Form 10-K for the year ended December 31, 2020.

(2)Represents our investment in Stabilis Energy, Inc. (“Stabilis”), which was $10.0 and $4.1 at March 31, 2021 and December 31, 2020, respectively. For the three months ended March 31, 2021, we recognized an unrealized gain of $5.9. For additional information see Note 6, “Investments” in our Annual Report on Form 10-K for the year ended December 31, 2020.

(3)Represents our investment in HTEC Hydrogen Technology & Energy Corporation (“HTEC”), which was CAD 20.0 million at both March 31, 2021 and December 31, 2020 (equivalent to $15.8 and $15.7 at March 31, 2021 and December 31, 2020, respectively). For additional information see Note 6, “Investments” in our Annual Report on Form 10-K for the year ended December 31, 2020.

(4)During the first quarter of 2021, we completed an investment in Svante Inc. (“Svante”) in the amount of $15.0 for under 10% of its capital stock on a fully diluted basis. This investment was measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. As of March 31, 2021, the value of the investment was $15.0. Svante offers companies in emissions-intensive industries a commercially viable way to capture large-scale CO2 emissions from existing infrastructure, either for safe storage or to be recycled for further industrial use in a closed loop.

(5)During the first quarter of 2021, we completed an investment in Transform Materials LLC (“Transform Materials”) in the amount of $25.0 for approximately 5% of its equity. This investment was measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. As of March 31, 2021, the value of the investment was $25.0. Transform Materials is a sustainable chemical technology company that uses microwave plasma to convert natural gas into acetylene and hydrogen. Its highly selective, cost-effective, net-carbon-negative process converts the methane in natural gas into high-value products suitable for direct use or downstream reactions.

XML

Leases (Tables)

3 Months Ended

Mar. 31, 2021

Leases [Abstract]

Schedule of operating lease future minimum payments

The following table summarizes future minimum lease payments for non-cancelable operating leases as of March 31, 2021:

2021	$	5.4
2022	6.2
2023	5.6
2024	5.1
2025	4.3
Thereafter (1)	3.5
Total future minimum lease payments	$	30.1

_______________

(1)     As of March 31, 2021, future minimum lease payments for non-cancelable operating leases for period subsequent to 2024 relate to seven leased facilities.

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2021

Inventory Disclosure [Abstract]

Summarized components of inventory

The following table summarizes the components of inventory:

	March 31, 2021		December 31, 2020
Raw materials and supplies	$	140.6	$	124.7
Work in process	57.8		57.8
Finished goods	81.5		65.9
Total inventories, net	$	279.9	$	248.4

XML

Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of goodwill by segment

The following table represents the changes in goodwill by segment:

	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Consolidated
Balance at December 31, 2020	$	93.2	$	435.2	$	172.4	$	165.1	$	865.9
Goodwill acquired during the period (1)	—		—		52.1		—		52.1
Foreign currency translation adjustments	(4.8)		(2.6)		—		—		(7.4)
Purchase price adjustment (1)	—		—		0.7		—		0.7
Balance at March 31, 2021	$	88.4	$	432.6	$	225.2	$	165.1	$	911.3

_______________

(1)During the first quarter of 2021, we recorded a purchase price adjustment that increased goodwill by $0.7 in Specialty Products related to the Cryogenic Gas Technologies, Inc. acquisition. For further information regarding goodwill acquired and the purchase price adjustment during the period refer to Note 11, “Business Combinations.”

Schedule of finite-lived intangible assets

The following table displays the gross carrying amount and accumulated amortization for finite-lived intangible assets and indefinite-lived intangible assets (exclusive of goodwill) (1):

		March 31, 2021				December 31, 2020
	Weighted-average Estimated Useful Life	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Finite-lived intangible assets:
Customer relationships	13 years	$	300.2	$	(65.0)	$	302.5	$	(59.9)
Unpatented technology	12 years	110.8		(24.2)		110.4		(22.3)
Patents and other	6 years	5.6		(0.4)		8.4		(1.8)
Trademarks and trade names	11 years	3.3		(1.6)		3.6		(1.4)
Land use rights	50 years	11.0		(1.4)		11.1		(1.4)
Total finite-lived intangible assets	13 years	430.9		(92.6)		436.0		(86.8)
Indefinite-lived intangible assets:
Trademarks and trade names		143.1		—		143.9		—
Total intangible assets		$	574.0	$	(92.6)	$	579.9	$	(86.8)

_______________

(1)Amounts include the impact of foreign currency translation. Fully amortized or impaired amounts are written off.

Schedule of indefinite-lived intangible assets

The following table displays the gross carrying amount and accumulated amortization for finite-lived intangible assets and indefinite-lived intangible assets (exclusive of goodwill) (1):

		March 31, 2021				December 31, 2020
	Weighted-average Estimated Useful Life	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Finite-lived intangible assets:
Customer relationships	13 years	$	300.2	$	(65.0)	$	302.5	$	(59.9)
Unpatented technology	12 years	110.8		(24.2)		110.4		(22.3)
Patents and other	6 years	5.6		(0.4)		8.4		(1.8)
Trademarks and trade names	11 years	3.3		(1.6)		3.6		(1.4)
Land use rights	50 years	11.0		(1.4)		11.1		(1.4)
Total finite-lived intangible assets	13 years	430.9		(92.6)		436.0		(86.8)
Indefinite-lived intangible assets:
Trademarks and trade names		143.1		—		143.9		—
Total intangible assets		$	574.0	$	(92.6)	$	579.9	$	(86.8)

_______________

(1)Amounts include the impact of foreign currency translation. Fully amortized or impaired amounts are written off.

Schedule of estimated future amortization

We estimate amortization expense to be recognized during the next five years as follows:

For the Year Ending December 31,
2021	$	35.7
2022	34.6
2023	34.4
2024	34.1
2025	33.2

Schedule of government grants

China Government Grants are presented in our unaudited condensed consolidated balance sheets as follows:

	March 31, 2021		December 31, 2020
Current	$	0.5	$	0.5
Long-term	7.1		7.3
Total China Government Grants	$	7.6	$	7.8

XML

Debt and Credit Arrangements (Tables)

3 Months Ended

Mar. 31, 2021

Debt Disclosure [Abstract]

Summary of outstanding borrowings

The following table represents the components of our borrowings:

	March 31, 2021		December 31, 2020
Senior secured revolving credit facility and term loan:
Term loan due June 2024 (1)	$	103.1	$	103.1
Senior secured revolving credit facility due June 2024 (2) (3)	204.7		123.5
Unamortized debt issuance costs	(4.7)		(5.0)
Senior secured revolving credit facility and term loan, net of debt issuance costs	303.1		221.6
Convertible notes due November 2024:
Principal amount	258.8		258.8
Unamortized discount (4)	—		(34.8)
Unamortized debt issuance costs	(3.6)		(3.1)
Convertible notes due November 2024, net of unamortized discount and debt issuance costs	255.2		220.9
Foreign facilities	—		—
Total debt, net of unamortized discount and debt issuance costs	558.3		442.5
Less: current maturities	255.2		220.9
Long-term debt	$	303.1	$	221.6

_______________

(1)As of March 31, 2021, there were $103.1 in borrowings outstanding under the term loan due June 2024, which is due at maturity, bearing an interest rate of 2.0% (2.5% as of December 31, 2020).

(2)The senior secured revolving credit facility due 2024 includes $100.0 sub limit for letters of credit, a $250.0 sub limit for discretionary letters of credit and $50.0 sub limit for swingline loans. As of March 31, 2021, there were $204.7 in borrowings outstanding under the senior secured revolving credit facility due 2024 bearing a weighted-average interest rate of 1.8% (2.1% as of December 31, 2020) and $53.1 in letters of credit and bank guarantees outstanding supported by the senior secured revolving credit facility due 2024. As of March 31, 2021, the senior secured revolving credit facility due 2024 had availability of $292.2.

(3)A portion of borrowings outstanding under our senior secured revolving credit facility due 2024 are denominated in euros (“EUR Revolver Borrowings”). As of both March 31, 2021 and December 31, 2020, EUR Revolver Borrowings outstanding were EUR 71.5 million (equivalent to $83.8 and $87.7 at March 31, 2021 and December 31, 2020, respectively). During the three months ended March 31, 2021, we recognized an unrealized foreign currency gain of $3.9 relative to the translation of the EUR Revolver Borrowings outstanding during the reporting period. This unrealized foreign currency gain is classified as foreign currency (gain) loss and other in the condensed consolidated statement of income for the three months ended March 31, 2021.

(4)We derecognized the debt discount associated with the convertible notes due November 2024 upon adoption of ASU 2020-06 on January 1, 2021.

Schedule of interest expense and financing cost amortization

The following table summarizes interest expense and financing costs amortization related to the 2024 Credit Facilities:

	Three Months Ended March 31,
	2021		2020
Interest expense, term loan due June 2024	$	0.6	$	4.2
Interest expense, senior secured revolving credit facility due June 2024	0.7		0.6
Interest expense, senior secured revolving credit facility and term loan due June 2024	$	1.3	$	4.8
Financing costs amortization, senior secured revolving credit facility and term loan due 2024	$	1.0	$	0.8

Schedule of Interest Accretion

The following table summarizes interest accretion of the 2024 Notes discount, 1.0% contractual interest coupon and financing costs amortization associated with the 2024 Notes:

	Three Months Ended March 31,
	2021		2020
2024 Notes, interest accretion of convertible notes discount	$	—	$	1.9
2024 Notes, 1.0% contractual interest coupon	0.6		0.6
2024 Notes, total interest expense	$	0.6	$	2.5
2024 Notes, financing costs amortization	$	0.2	$	0.2

XML

Product Warranties (Tables)

3 Months Ended

Mar. 31, 2021

Product Warranties Disclosures [Abstract]

Rollforward of consolidated warranty reserve

The following table represents changes in our consolidated warranty reserve:

Balance at December 31, 2020	$	11.9
Issued – warranty expense	(0.9)
Warranty usage	0.3
Balance at March 31, 2021	$	11.3

XML

Business Combinations (Tables)

3 Months Ended

Mar. 31, 2021

Business Combinations [Abstract]

Schedule Of Changes In Contingent Consideration

The following table represents the changes to our contingent consideration liabilities:

	SES		BIG		Total
Balance at December 31, 2020	$	16.9	$	3.2	$	20.1
Increase in fair value of contingent consideration liabilities	0.7		0.1		0.8
Balance at March 31, 2021	$	17.6	$	3.3	$	20.9

XML

Accumulated Other Comprehensive (Loss) Income (Tables)

3 Months Ended

Mar. 31, 2021

Equity [Abstract]

Schedule of changes in accumulated other comprehensive loss

The components of accumulated other comprehensive (loss) income are as follows:

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive income (loss)
Balance at December 31, 2020	$	13.8	$	(11.4)	$	2.4
Other comprehensive loss	(19.6)		—		(19.6)
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes	—		0.4		0.4
Net current-period other comprehensive (loss) income, net of taxes	(19.6)		0.4		(19.2)
Balance at March 31, 2021	$	(5.8)	$	(11.0)	$	(16.8)

	Foreign currency translation adjustments		Pension liability adjustments, net of taxes		Accumulated other comprehensive loss
Balance at December 31, 2019	$	(25.0)	$	(10.9)	$	(35.9)
Other comprehensive loss	(10.2)		—		(10.2)
Amounts reclassified from accumulated other comprehensive loss, net of income taxes	—		0.3		0.3
Net current-period other comprehensive (loss) income, net of taxes	(10.2)		0.3		(9.9)
Balance at March 31, 2020	$	(35.2)	$	(10.6)	$	(45.8)

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2021

Earnings Per Share [Abstract]

Calculation of net income per share

The following table represents calculations of net earnings per share of common stock:

	Three Months Ended March 31,
	2021		2020
Net income attributable to Chart Industries, Inc.
Income from continuing operations	$	25.6	$	2.1
Income from discontinued operations, net of tax	—		6.4
Net income attributable to Chart Industries, Inc.	$	25.6	$	8.5
Earnings per common share – basic:
Income from continuing operations	$	0.72	$	0.06
Income from discontinued operations	—		0.18
Net income attributable to Chart Industries, Inc.	$	0.72	$	0.24
Earnings per common share – diluted:
Income from continuing operations	$	0.63	$	0.06
Income from discontinued operations	—		0.18
Net income attributable to Chart Industries, Inc.	$	0.63	$	0.24
Weighted average number of common shares outstanding – basic	35.55		35.77
Incremental shares issuable upon assumed conversion and exercise of share-based awards	0.33		0.24
Incremental shares issuable due to dilutive effect of convertible notes	2.57		—
Incremental shares issuable due to dilutive effect of warrants	2.17		—
Weighted average number of common shares outstanding – diluted	40.62		36.01

Schedule of antidilutive securities

Diluted earnings per share does not reflect the following potential common shares as the effect would be anti-dilutive:

	Three Months Ended March 31,
	2021	2020
Share-based awards	0.06	0.50
Convertible note hedge and capped call transactions (1)	2.57	—
Warrants	—	4.41
Total anti-dilutive securities	2.63	4.91

 _______________

(1)The convertible note hedge offsets any dilution upon actual conversion of the 2024 Notes up to a common stock price of $71.775 per share. For further information, refer to Note 9, “Debt and Credit Arrangements.”

XML

Restructuring Activities (Tables)

3 Months Ended

Mar. 31, 2021

Restructuring and Related Activities [Abstract]

Summary of severance and other restructuring costs

The following table summarizes severance and other restructuring costs, which includes employee-related costs, facility rent and exit costs, relocation, recruiting, travel and other:

	Three Months Ended March 31,
	2021		2020
Severance:
Cost of sales	$	—	$	2.3
Selling, general, and administrative expenses	0.3		2.9
Total severance costs	0.3		5.2
Other restructuring:
Cost of sales	0.4		—
Total other restructuring costs	0.4		—
Total restructuring costs	$	0.7	$	5.2

Schedule of rollforward of restructuring cost

The following tables summarize our restructuring activities:

	Three Months Ended March 31, 2021
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at December 31, 2020	$	0.5	$	0.2	$	—	$	—	$	0.1	$	0.8
Restructuring charges	0.3		0.4		—		—		—		0.7
Cash payments and other	(0.3)		(0.6)		—		—		(0.1)		(1.0)
Balance at March 31, 2021	$	0.5	$	—	$	—	$	—	$	—	$	0.5

	Three Months Ended March 31, 2020
	Cryo Tank Solutions		Heat Transfer Systems		Specialty Products		Repair, Service & Leasing		Corporate		Consolidated
Balance at December 30, 2019	$	0.5	$	0.2	$	—	$	—	$	0.2	$	0.9
Restructuring charges	1.8		2.8		—		—		0.6		5.2
Cash payments and other	(0.8)		(2.5)		—		—		—		(3.3)
Balance at March 31, 2020	$	1.5	$	0.5	$	—	$	—	$	0.8	$	2.8

XML

Basis of Preparation - Narratives (Details) $ / shares in Units, shares in Thousands		3 Months Ended
		Mar. 31, 2021 USD ($) location $ / shares	Sep. 30, 2020 $ / shares shares	Mar. 31, 2020 USD ($)	Jan. 01, 2021 USD ($)	Dec. 31, 2020 USD ($)	Mar. 11, 2020 USD ($)	Nov. 06, 2017 USD ($)
Debt and Equity Securities, FV-NI
Number of locations (location) | location		25
Shares authorized for repurchase							$ 75,000,000
Shares repurchased during the period (shares) | shares			760
Weighted average share price of shares repurchased (per share) | $ / shares			$ 25.40
Common stock repurchases	[1]			$ 19,300,000
Interest expense, net		$ 2,000,000.0		7,200,000
Income from continuing operations		25,600,000		2,100,000
Scenario, Plan
Debt and Equity Securities, FV-NI
Interest expense, net		2,000,000.0
Income from continuing operations		$ 24,000,000.0
Income from continued operations basic and diluted (usd per share) | $ / shares		$ 0.04
Treasury Stock
Debt and Equity Securities, FV-NI
Common stock repurchases	[1]			19,300,000
Convertible Notes, due 2024 | Convertible Debt
Debt and Equity Securities, FV-NI
Principal amount		$ 258,800,000		258,800,000		$ 258,800,000		$ 258,800,000
Interest expense, net		600,000		$ 600,000
Unamortized discount		0				34,800,000
Unamortized debt issuance costs		$ 3,600,000			$ 3,900,000	$ 3,100,000

[1] Includes $19.3 in shares repurchased through our share repurchase program. On March 11, 2021, the share repurchase program expired with no further repurchases. Refer to Note 1, “Basis of Preparation” for further information.

XML

Basis of Preparation - Impact on Financial Statements (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Liabilities
Accrued income taxes	$ 46.0	$ 46.5
Current convertible notes	255.2	220.9
Long-term deferred tax liabilities	49.9	60.2
Equity
Additional paid-in capital	750.0	780.8
Retained earnings	$ 844.7	808.4
Cumulative Effect, Period of Adoption, Adjustment
Liabilities
Accrued income taxes		(0.2)
Current convertible notes		34.0
Long-term deferred tax liabilities		(7.6)
Equity
Additional paid-in capital		(36.9)
Retained earnings		10.7
Cumulative Effect, Period of Adoption, Adjusted Balance
Liabilities
Accrued income taxes		46.3
Current convertible notes		254.9
Long-term deferred tax liabilities		52.6
Equity
Additional paid-in capital		743.9
Retained earnings		$ 819.1

XML

Discontinued Operations - Income from Discontinued Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Summarized Financial Information of Discontinued Operations
Income from discontinued operations, net of tax	$ 0.0	$ 6.4
Disposed of by held for sale
Summarized Financial Information of Discontinued Operations
Depreciation expense, discontinued operations		0.3
Disposed of by held for sale | Cryobiological products business
Summarized Financial Information of Discontinued Operations
Sales		19.2
Cost of sales		10.1
Selling, general and administrative expenses		1.4
Operating income		7.7
Income before income taxes from discontinued operations		7.7
Income tax expense		$ 1.3
Income from discontinued operations, net of tax	$ 6.4

XML

Discontinued Operations - Cash Flows Related to Discontinued Operations (Details) $ in Millions	3 Months Ended
	Mar. 31, 2020 USD ($)
Net cash provided by (used in):
Operating activities	$ 7.2
Investing activities	(0.1)
Net cash provided by discontinued operations	$ 7.1

XML

Reportable Segments - Narratives (Details)	3 Months Ended
	Mar. 31, 2021 segment
Segment Reporting [Abstract]
Number of reportable segments (segment)	4

XML

Reportable Segments - Segment Income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Segment Reporting Information
Sales to external customers	$ 288.5	$ 301.9
Depreciation and amortization expense	19.5	23.6
Operating income (loss)	28.9	15.8
Restructuring costs	0.7	5.2
Operating Segments | Cryo Tank Solutions
Segment Reporting Information
Sales to external customers	103.9	98.0
Depreciation and amortization expense	3.9	4.4
Operating income (loss)	15.6	11.6
Restructuring costs	0.3	1.8
Operating Segments | Heat Transfer Systems
Segment Reporting Information
Sales to external customers	69.2	112.9
Depreciation and amortization expense	9.5	14.1
Operating income (loss)	3.9	5.5
Restructuring costs	0.4	2.8
Operating Segments | Specialty Products
Segment Reporting Information
Sales to external customers	77.3	52.9
Depreciation and amortization expense	3.1	1.4
Operating income (loss)	17.9	13.8
Restructuring costs	0.0	0.0
Operating Segments | Repair, Service & Leasing
Segment Reporting Information
Sales to external customers	41.4	40.7
Depreciation and amortization expense	2.6	3.3
Operating income (loss)	8.3	4.6
Restructuring costs	0.0	0.0
Intersegment Eliminations
Segment Reporting Information
Sales to external customers	(3.3)	(2.6)
Depreciation and amortization expense	0.0	0.0
Operating income (loss)	0.0	0.0
Corporate
Segment Reporting Information
Sales to external customers	0.0	0.0
Depreciation and amortization expense	0.4	0.4
Operating income (loss)	(16.8)	(19.7)
Restructuring costs	$ 0.0	$ 0.6

XML

Reportable Segments - Product Sales Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Segment Reporting Information
Sales to external customers	$ 288.5	$ 301.9
North America
Segment Reporting Information
Sales to external customers	140.8	178.5
Europe, Middle East, Africa and India
Segment Reporting Information
Sales to external customers	100.6	75.4
Asia-Pacific
Segment Reporting Information
Sales to external customers	45.8	44.4
Rest of the World
Segment Reporting Information
Sales to external customers	1.3	3.6
Operating Segments | Cryo Tank Solutions
Segment Reporting Information
Sales to external customers	103.9	98.0
Operating Segments | Cryo Tank Solutions | North America
Segment Reporting Information
Sales to external customers	41.1	40.6
Operating Segments | Cryo Tank Solutions | Europe, Middle East, Africa and India
Segment Reporting Information
Sales to external customers	37.7	34.3
Operating Segments | Cryo Tank Solutions | Asia-Pacific
Segment Reporting Information
Sales to external customers	24.2	20.1
Operating Segments | Cryo Tank Solutions | Rest of the World
Segment Reporting Information
Sales to external customers	0.9	3.0
Operating Segments | Heat Transfer Systems
Segment Reporting Information
Sales to external customers	69.2	112.9
Operating Segments | Heat Transfer Systems | North America
Segment Reporting Information
Sales to external customers	46.3	82.2
Operating Segments | Heat Transfer Systems | Europe, Middle East, Africa and India
Segment Reporting Information
Sales to external customers	7.8	9.5
Operating Segments | Heat Transfer Systems | Asia-Pacific
Segment Reporting Information
Sales to external customers	14.8	20.9
Operating Segments | Heat Transfer Systems | Rest of the World
Segment Reporting Information
Sales to external customers	0.3	0.3
Operating Segments | Specialty Products
Segment Reporting Information
Sales to external customers	77.3	52.9
Operating Segments | Specialty Products | North America
Segment Reporting Information
Sales to external customers	26.1	24.9
Operating Segments | Specialty Products | Europe, Middle East, Africa and India
Segment Reporting Information
Sales to external customers	45.6	25.6
Operating Segments | Specialty Products | Asia-Pacific
Segment Reporting Information
Sales to external customers	5.6	2.2
Operating Segments | Specialty Products | Rest of the World
Segment Reporting Information
Sales to external customers	0.0	0.2
Operating Segments | Repair, Service & Leasing
Segment Reporting Information
Sales to external customers	41.4	40.7
Operating Segments | Repair, Service & Leasing | North America
Segment Reporting Information
Sales to external customers	29.0	32.1
Operating Segments | Repair, Service & Leasing | Europe, Middle East, Africa and India
Segment Reporting Information
Sales to external customers	10.5	6.7
Operating Segments | Repair, Service & Leasing | Asia-Pacific
Segment Reporting Information
Sales to external customers	1.8	1.7
Operating Segments | Repair, Service & Leasing | Rest of the World
Segment Reporting Information
Sales to external customers	0.1	0.2
Intersegment Eliminations
Segment Reporting Information
Sales to external customers	(3.3)	(2.6)
Intersegment Eliminations | North America
Segment Reporting Information
Sales to external customers	(1.7)	(1.3)
Intersegment Eliminations | Europe, Middle East, Africa and India
Segment Reporting Information
Sales to external customers	(1.0)	(0.7)
Intersegment Eliminations | Asia-Pacific
Segment Reporting Information
Sales to external customers	(0.6)	(0.5)
Intersegment Eliminations | Rest of the World
Segment Reporting Information
Sales to external customers	$ 0.0	$ (0.1)

XML

Reportable Segments - Assets (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Assets
Assets	$ 2,652.3	$ 2,570.5
Goodwill	911.3	865.9
Identifiable intangible assets, net	481.4	493.1
Cryo Tank Solutions
Assets
Goodwill	88.4	93.2
Heat Transfer Systems
Assets
Goodwill	432.6	435.2
Specialty Products
Assets
Goodwill	225.2	172.4
Repair, Service & Leasing
Assets
Goodwill	165.1	165.1
Operating Segments
Assets
Assets	984.1	967.3
Operating Segments | Cryo Tank Solutions
Assets
Assets	392.0	399.2
Operating Segments | Heat Transfer Systems
Assets
Assets	230.1	247.2
Operating Segments | Specialty Products
Assets
Assets	216.3	178.3
Operating Segments | Repair, Service & Leasing
Assets
Assets	145.7	142.6
Corporate
Assets
Assets	$ 275.5	$ 244.2

XML

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Disaggregation of Revenue
Sales to external customers	$ 288.5	$ 301.9
Point in time
Disaggregation of Revenue
Sales to external customers	190.0	162.2
Over time
Disaggregation of Revenue
Sales to external customers	98.5	139.7
Operating Segments | Cryo Tank Solutions
Disaggregation of Revenue
Sales to external customers	103.9	98.0
Operating Segments | Cryo Tank Solutions | Point in time
Disaggregation of Revenue
Sales to external customers	98.7	89.8
Operating Segments | Cryo Tank Solutions | Over time
Disaggregation of Revenue
Sales to external customers	5.2	8.2
Operating Segments | Heat Transfer Systems
Disaggregation of Revenue
Sales to external customers	69.2	112.9
Operating Segments | Heat Transfer Systems | Point in time
Disaggregation of Revenue
Sales to external customers	5.6	7.1
Operating Segments | Heat Transfer Systems | Over time
Disaggregation of Revenue
Sales to external customers	63.6	105.8
Operating Segments | Specialty Products
Disaggregation of Revenue
Sales to external customers	77.3	52.9
Operating Segments | Specialty Products | Point in time
Disaggregation of Revenue
Sales to external customers	61.9	38.8
Operating Segments | Specialty Products | Over time
Disaggregation of Revenue
Sales to external customers	15.4	14.1
Operating Segments | Repair, Service & Leasing
Disaggregation of Revenue
Sales to external customers	41.4	40.7
Operating Segments | Repair, Service & Leasing | Point in time
Disaggregation of Revenue
Sales to external customers	26.7	28.0
Operating Segments | Repair, Service & Leasing | Over time
Disaggregation of Revenue
Sales to external customers	14.7	12.7
Intersegment Eliminations
Disaggregation of Revenue
Sales to external customers	(3.3)	(2.6)
Intersegment Eliminations | Point in time
Disaggregation of Revenue
Sales to external customers	(2.9)	(1.5)
Intersegment Eliminations | Over time
Disaggregation of Revenue
Sales to external customers	$ (0.4)	$ (1.1)

XML

Revenue - Change in Contract Assets and Liabilities (Details) $ in Millions	3 Months Ended
	Mar. 31, 2021 USD ($)
Contract assets
Beginning accounts receivable, net of allowances	$ 200.8
Change in accounts receivable	(14.4)
Ending accounts receivable, net of allowances	186.4
Beginning unbilled contract revenue	79.4
Change in unbilled contract revenue	(4.8)
Ending unbilled contract revenue	$ 74.6
Change in accounts receivable (as a percentage)	(7.20%)
Change in unbilled contract revenue (as a percentage)	(6.00%)
Contract liabilities
Beginning balance customer advances and billings in excess of contract revenue	$ 118.9
Change in customer advances and billings in excess of contract revenue	(12.6)
Ending balance customer advances and billings in excess of contract revenue	106.3
Beginning long-term deferred revenue	1.9
Change in long-term deferred revenue	(1.7)
Ending long-term deferred revenue	$ 0.2
Change in customer advances and billings in excess of contract revenue (as a percentage)	(10.60%)
Change in long-term deferred revenue (as a percentage)	(89.50%)

XML

Revenue - Narratives (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Contract revenue recognized	$ 52.5	$ 17.1
Remaining performance obligation	$ 934.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-04-01
Disaggregation of Revenue
Revenue, remaining performance obligation	76.00%
Performance obligations expected to be satisfied, expected timing	12 months

XML

Investments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Debt and Equity Securities, FV-NI
Balance at December 31, 2020	$ 73.6
New investments	40.0	$ 0.0
(Decrease) increase in fair value of investments in equity securities	3.3
Foreign currency translation adjustments	(2.3)
Balance at March 31, 2021	114.6
Subtotal
Debt and Equity Securities, FV-NI
Balance at December 31, 2020	57.9
New investments	0.0
(Decrease) increase in fair value of investments in equity securities	3.3
Foreign currency translation adjustments	(2.4)
Balance at March 31, 2021	58.8
Investments in Equity Securities Level 1
Debt and Equity Securities, FV-NI
Balance at December 31, 2020	53.8
New investments	0.0
(Decrease) increase in fair value of investments in equity securities	(2.6)
Foreign currency translation adjustments	(2.4)
Balance at March 31, 2021	48.8
Investments in Equity Securities, Level 2
Debt and Equity Securities, FV-NI
Balance at December 31, 2020	4.1
New investments	0.0
(Decrease) increase in fair value of investments in equity securities	5.9
Foreign currency translation adjustments	0.0
Balance at March 31, 2021	10.0
Investments in Equity Securities, All Others
Debt and Equity Securities, FV-NI
Balance at December 31, 2020	15.7
New investments	40.0
(Decrease) increase in fair value of investments in equity securities	0.0
Foreign currency translation adjustments	0.1
Balance at March 31, 2021	$ 55.8

XML

Investments - Narratives (Details) € in Millions, $ in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2021 USD ($)	Mar. 31, 2021 EUR (€)	Mar. 31, 2021 CAD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2020 EUR (€)	Dec. 31, 2020 CAD ($)	Sep. 30, 2019
Debt and Equity Securities, FV-NI
Value of investment	$ 114.6			$ 73.6
HTEC
Debt and Equity Securities, FV-NI
Value of investment			$ 20			$ 20
McPhy
Debt and Equity Securities, FV-NI
Value of investment	48.8	€ 41.6		53.8	€ 39.8
Stabilis Energy, Inc.
Debt and Equity Securities, FV-NI
Equity investment, cost	10.0			4.1
Unrealized gain	5.9
HTEC
Debt and Equity Securities, FV-NI
Value of investment	15.8			15.7
Svante Inc.
Debt and Equity Securities, FV-NI
Value of investment	15.0
Equity investment, cost	$ 15.0
Equity investments, ownership interest (percent)	10.00%	10.00%	10.00%
Transform Materials
Debt and Equity Securities, FV-NI
Value of investment	$ 25.0
Equity investments, ownership interest (percent)	5.00%	5.00%	5.00%
Liberty LNG
Debt and Equity Securities, FV-NI
Equity investments, ownership interest (percent)							25.00%
(Decrease) increase in fair value of investments in equity securities	$ 2.2			$ 2.1
Hudson Products de Mexico S.A. de CV | Investment in Joint Venture
Debt and Equity Securities, FV-NI
Equity investments, ownership interest (percent)				50.00%	50.00%	50.00%
(Decrease) increase in fair value of investments in equity securities	$ 2.8			$ 2.8

XML

Leases - Narratives (Details) $ in Millions	3 Months Ended
	Mar. 31, 2021 USD ($) facility	Mar. 31, 2020 USD ($)	Dec. 31, 2020 USD ($)
Leases [Abstract]
Right of use assets	$ 28.0	$ 29.0
Operating lease liability	27.7	28.7
Operating lease liabilities, current	$ 5.1	5.1	$ 5.1
Weighted average lease term	5 years 7 months 6 days
Operating lease weighted average discount rate (percent)	2.30%
Operating lease rent expense	$ 3.0	$ 2.9
Number of operating contracts | facility	7

XML

Leases - Future Minimum Payments (Details) $ in Millions	Mar. 31, 2021 USD ($)
Future minimum lease payments for non-cancelable operating leases
2021	$ 5.4
2022	6.2
2023	5.6
2024	5.1
2025	4.3
Thereafter	3.5
Total future minimum lease payments	$ 30.1

XML

Inventories (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Raw materials and supplies	$ 140.6	$ 124.7
Work in process	57.8	57.8
Finished goods	81.5	65.9
Total inventories, net	279.9	248.4
Inventory valuation reserve	$ 9.7	$ 9.7

XML

Goodwill and Intangible Assets - Goodwill (Details) $ in Millions	3 Months Ended
	Mar. 31, 2021 USD ($)
Goodwill
Beginning balance, goodwill	$ 865.9
Goodwill acquired during the period	52.1
Foreign currency translation adjustments	(7.4)
Purchase price adjustment	0.7
Ending balance, goodwill	911.3
Cryo Tank Solutions
Goodwill
Beginning balance, goodwill	93.2
Goodwill acquired during the period	0.0
Foreign currency translation adjustments	(4.8)
Purchase price adjustment	0.0
Ending balance, goodwill	88.4
Heat Transfer Systems
Goodwill
Beginning balance, goodwill	435.2
Goodwill acquired during the period	0.0
Foreign currency translation adjustments	(2.6)
Purchase price adjustment	0.0
Ending balance, goodwill	432.6
Specialty Products
Goodwill
Beginning balance, goodwill	172.4
Goodwill acquired during the period	52.1
Foreign currency translation adjustments	0.0
Purchase price adjustment	0.7
Ending balance, goodwill	225.2
Repair, Service & Leasing
Goodwill
Beginning balance, goodwill	165.1
Goodwill acquired during the period	0.0
Foreign currency translation adjustments	0.0
Purchase price adjustment	0.0
Ending balance, goodwill	$ 165.1

XML

Goodwill and Intangible Assets - Narratives (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Finite-Lived Intangible Assets
Accumulated goodwill impairment loss	$ 129.0		$ 129.0
Amortization expense	8.8	$ 14.0
Cryo Tank Solutions
Finite-Lived Intangible Assets
Accumulated goodwill impairment loss	23.5		23.5
Heat Transfer Systems
Finite-Lived Intangible Assets
Accumulated goodwill impairment loss	49.3		49.3
Specialty Products
Finite-Lived Intangible Assets
Accumulated goodwill impairment loss	35.8		35.8
Repair, Service & Leasing
Finite-Lived Intangible Assets
Accumulated goodwill impairment loss	$ 20.4		$ 20.4
Government grants | Minimum
Finite-Lived Intangible Assets
Finite lived intangible assets useful life (in years)	10 years
Government grants | Maximum
Finite-Lived Intangible Assets
Finite lived intangible assets useful life (in years)	50 years

XML

Goodwill and Intangible Assets - Intangible Assets (Excluding Goodwill) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Schedule of Finite-lived and Indefinite-lived Intangible Assets
Weighted Average Useful Life (in years)	13 years
Gross Carrying Amount	$ 430.9	$ 436.0
Accumulated Amortization	(92.6)	(86.8)
Total intangible assets	574.0	579.9
Trademarks and trade names
Schedule of Finite-lived and Indefinite-lived Intangible Assets
Indefinite-lived intangible assets	$ 143.1	143.9
Customer relationships
Schedule of Finite-lived and Indefinite-lived Intangible Assets
Weighted Average Useful Life (in years)	13 years
Gross Carrying Amount	$ 300.2	302.5
Accumulated Amortization	$ (65.0)	(59.9)
Unpatented technology
Schedule of Finite-lived and Indefinite-lived Intangible Assets
Weighted Average Useful Life (in years)	12 years
Gross Carrying Amount	$ 110.8	110.4
Accumulated Amortization	$ (24.2)	(22.3)
Patents and other
Schedule of Finite-lived and Indefinite-lived Intangible Assets
Weighted Average Useful Life (in years)	6 years
Gross Carrying Amount	$ 5.6	8.4
Accumulated Amortization	$ (0.4)	(1.8)
Trademarks and trade names
Schedule of Finite-lived and Indefinite-lived Intangible Assets
Weighted Average Useful Life (in years)	11 years
Gross Carrying Amount	$ 3.3	3.6
Accumulated Amortization	$ (1.6)	(1.4)
Land use rights
Schedule of Finite-lived and Indefinite-lived Intangible Assets
Weighted Average Useful Life (in years)	50 years
Gross Carrying Amount	$ 11.0	11.1
Accumulated Amortization	$ (1.4)	$ (1.4)

XML

Goodwill and Intangible Assets - Future Amortization Expense (Details) $ in Millions	Mar. 31, 2021 USD ($)
Estimated Amortization Expense for Intangible Assets
2021	$ 35.7
2022	34.6
2023	34.4
2024	34.1
2025	$ 33.2

XML

Goodwill and Intangible Assets - Government Grants (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets
Gross carrying amount	$ 430.9	$ 436.0
Government grants
Finite-Lived Intangible Assets
Gross carrying amount	7.6	7.8
Government grants | Current
Finite-Lived Intangible Assets
Gross carrying amount	0.5	0.5
Government grants | Long-term
Finite-Lived Intangible Assets
Gross carrying amount	$ 7.1	$ 7.3

XML

Debt and Credit Arrangements - Summary of Outstanding Borrowings (Details) € in Millions	3 Months Ended
	Mar. 31, 2021 USD ($)	Mar. 31, 2020 USD ($)	Mar. 31, 2021 EUR (€)	Jan. 01, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2020 EUR (€)	Jun. 14, 2019 USD ($)	Nov. 06, 2017 USD ($)
Debt Instrument
Total debt, net of unamortized discount and debt issuance costs	$ 558,300,000				$ 442,500,000
Less: current maturities	255,200,000				220,900,000
Long-term debt	303,100,000				221,600,000
Foreign currency transaction gain	200,000	$ (300,000)
Convertible Notes, due 2024 | Convertible Debt
Debt Instrument
Unamortized debt issuance costs	(3,600,000)			$ (3,900,000)	(3,100,000)
Principal amount	258,800,000	$ 258,800,000			258,800,000			$ 258,800,000
Unamortized discount	0				(34,800,000)
Convertible Debt	255,200,000				220,900,000
Debt instrument stated interest rate (percent)								1.00%
Revolving Credit Facility | Credit Facilities 2019
Debt Instrument
Unamortized debt issuance costs	(4,700,000)				(5,000,000.0)
Senior secured revolving credit facility and term loan, net of debt issuance costs	303,100,000				221,600,000
Revolving Credit Facility | Term loan
Debt Instrument
Long term debt	$ 103,100,000				$ 103,100,000
Principal amount							$ 450,000,000.0
Debt instrument stated interest rate (percent)	2.00%		2.00%		2.50%	2.50%
Revolving Credit Facility | Senior secured revolving credit facility
Debt Instrument
Long term debt	$ 204,700,000				$ 123,500,000
Unamortized debt issuance costs	$ (7,300,000)
Maximum borrowing capacity							$ 550,000,000.0
Weighted average interest rate (percent)	1.80%		1.80%		2.10%	2.10%
Letters of credit outstanding	$ 53,100,000
Line of credit remaining borrowing amount	292,200,000
Revolving Credit Facility | Euro senior secured revolving credit facility
Debt Instrument
Long term debt	83,800,000		€ 71.5		$ 87,700,000	€ 71.5
Foreign currency transaction gain	3,900,000
Revolving Credit Facility | Foreign facilities
Debt Instrument
Foreign facilities	0				$ 0
Maximum borrowing capacity	80,900,000
Weighted average interest rate (percent)					1.30%	1.30%
Letters of credit outstanding	51,600,000				$ 47,700,000
Revolving Credit Facility Sub-limit - Letters of Credit | Senior secured revolving credit facility
Debt Instrument
Maximum borrowing capacity	100,000,000.0
Revolving Credit Facility Sub-limit - Discretionary Letters of Credit | Senior secured revolving credit facility
Debt Instrument
Maximum borrowing capacity	250,000,000.0
Revolving Credit Facility Sub-limit - Swingline | Senior secured revolving credit facility
Debt Instrument
Maximum borrowing capacity	$ 50,000,000.0

XML

Debt and Credit Arrangements - Senior Secured Revolving Credit Facility and Term Loan (Details) - Revolving Credit Facility - USD ($)			3 Months Ended
	Apr. 20, 2020	Jun. 14, 2019	Mar. 31, 2021	Dec. 31, 2020
Credit Facilities 2019
Debt Instrument
Maximum percentage of capital stock guaranteed by company			65.00%
Unamortized debt issuance costs			$ 4,700,000	$ 5,000,000.0
Credit Facilities 2019 | Adjusted Base Rate | Minimum
Debt Instrument
Debt instrument variable interest rate (percent)		0.25%
Credit Facilities 2019 | Adjusted Base Rate | Maximum
Debt Instrument
Debt instrument variable interest rate (percent)		1.50%
Credit Facilities 2019 | LIBOR | Minimum
Debt Instrument
Debt instrument variable interest rate (percent)		1.25%
Credit Facilities 2019 | LIBOR | Maximum
Debt Instrument
Debt instrument variable interest rate (percent)		2.50%
Senior secured revolving credit facility
Debt Instrument
Maximum borrowing capacity		$ 550,000,000.0
Payments for debt issuance costs	$ 1,900,000		11,900,000
Unamortized debt issuance costs			7,300,000
Term loan
Debt Instrument
Principal amount		$ 450,000,000.0
Debt issuance costs			$ 6,100,000
Debt issuance cost, amortization term			5 years

XML

Debt and Credit Arrangements - Interest Expense and Financing Cost Amortization (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Debt Instrument
Interest expense excluding amortization	$ 2.0	$ 7.2
Financing costs amortization	1.2	1.0
Revolving Credit Facility
Debt Instrument
Interest expense excluding amortization	1.3	4.8
Financing costs amortization	1.0	0.8
Revolving Credit Facility | Term loan
Debt Instrument
Interest expense excluding amortization	0.6	4.2
Revolving Credit Facility | Senior secured revolving credit facility
Debt Instrument
Interest expense excluding amortization	$ 0.7	$ 0.6

XML

Debt and Credit Arrangements - 2024 Notes Narratives (Details) $ / shares in Units, shares in Thousands			1 Months Ended	3 Months Ended
	Apr. 01, 2021 day $ / shares	Nov. 06, 2017 USD ($)	Dec. 31, 2017 USD ($) $ / shares	Mar. 31, 2021 USD ($) day $ / shares	Dec. 31, 2020 USD ($)	Mar. 31, 2020 USD ($)	Dec. 31, 2018 shares	Oct. 31, 2017 $ / shares
Debt Instrument
Share price (usd per share) | $ / shares				$ 142.35				$ 43.50
Convertible Debt | Convertible Notes, due 2024
Debt Instrument
Debt instrument stated interest rate (percent)		1.00%
Debt instrument face amount		$ 258,800,000		$ 258,800,000	$ 258,800,000	$ 258,800,000
Share conversion rate(per share)		0.0170285
Debt instrument, conversion price (usd per share) | $ / shares				$ 58.725
Debt instrument, conversion premium				35.00%
Value of securities above principal amount of debt if converted				$ 368,500,000
Debt instrument, threshold for consecutive trading days | day				20
Debt instrument, threshold for consecutive trading days | day				30
Applicable conversion price threshold (as percentage)				130.00%
Maximum days after five trading days				5 days
Applicable conversion price, less than (as percentage)				97.00%
Debt instrument effective interest rate		4.80%
Non cash payment for derivative instrument			$ 59,500,000
Number of shares underlying warrant | shares							4,410
Proceeds from issuances of warrants			$ 46,000,000.0
Percentage above previous sales price								65.00%
Net cost of convertible note hedge and warrant				$ 13,500,000
Convertible Debt | Convertible Notes, due 2024 | Subsequent Event
Debt Instrument
Debt instrument, conversion price (usd per share) | $ / shares	$ 76.3425
Debt instrument, threshold for consecutive trading days | day	20
Applicable conversion price threshold (as percentage)	130.00%
Convertible Debt | Convertible Notes, due 2024 | Maximum
Debt Instrument
Debt instrument, conversion price (usd per share) | $ / shares			$ 71.775
Convertible Debt | Convertible Notes, due 2024 | Liability Component
Debt Instrument
Debt instrument face amount		$ 200,100,000
Debt issuance costs		5,300,000
Convertible Debt | Convertible Notes, due 2024 | Equity Component
Debt Instrument
Debt instrument face amount		58,700,000
Debt issuance costs		$ 1,500,000

XML

Debt and Credit Arrangements - Notes Interest Accretion Schedule (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Nov. 06, 2017
Debt Instrument
Interest accretion of convertible notes discount	$ 0.0	$ 1.9
Interest expense excluding amortization	2.0	7.2
Financing costs amortization	1.2	1.0
Convertible Debt | Convertible Notes, due 2024
Debt Instrument
Interest accretion of convertible notes discount	0.0	1.9
Interest expense excluding amortization	0.6	0.6
Total interest expense	0.6	2.5
Financing costs amortization	$ 0.2	$ 0.2
Debt instrument stated interest rate (percent)			1.00%

XML

Debt and Credit Arrangements - Foreign Facilities (Details) - Foreign facilities - Revolving Credit Facility - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Debt Instrument
Maximum borrowing capacity	$ 80,900,000
Weighted average interest rate (percent)		1.30%
Letters of credit outstanding	$ 51,600,000	$ 47,700,000

XML

Debt and Credit Arrangements - Letters of Credit (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
Restricted cash	$ 1.0
Restricted cash, noncurrent	$ 1.0	$ 1.0

XML

Debt and Credit Arrangements - Fair Value Disclosures about Debt (Details)	Mar. 31, 2021	Dec. 31, 2020
Convertible Debt | Convertible Notes, due 2024
Debt Instrument
Debt instrument percentage over par value	242.00%	210.00%

XML

Product Warranties (Details) $ in Millions	3 Months Ended
	Mar. 31, 2021 USD ($)
Movement in Standard Product Warranty Accrual
Beginning balance standard product warranty accrual	$ 11.9
Issued – warranty expense	(0.9)
Warranty usage	0.3
Ending balance standard product warranty accrual	$ 11.3

XML

Business Combinations - Narratives (Details) - USD ($) $ in Millions					3 Months Ended
	Feb. 16, 2021	Dec. 23, 2020	Nov. 03, 2020	Oct. 13, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Business Acquisition
Payment for acquisition of businesses, net of cash acquired					$ 55.0	$ 0.0
Cash acquired from acquisition	$ 0.6
Goodwill					911.3		$ 865.9
Contingent consideration					20.9		20.1
Cryogenic Technologies
Business Acquisition
Voting percentage acquired	100.00%
Payment for acquisition of businesses, net of cash acquired	$ 55.0
Net assets acquired, excluding goodwill	2.9
Goodwill	52.1
Identifiable intangible assets	$ 1.8
SES
Business Acquisition
Net assets acquired, excluding goodwill		$ 13.4
Goodwill		24.0
Identifiable intangible assets		17.3
Payments for acquisition of business excluding working capital adjustments		20.0
Potential earn-out not to exceed amount		25.0
Contingent consideration		$ 16.9			17.6		16.9
BIG
Business Acquisition
Net assets acquired, excluding goodwill			$ 8.8
Goodwill			14.8
Decrease in estimated fair value of intangibles					0.7
Identifiable intangible assets			6.2
Payments for acquisition of business excluding working capital adjustments			20.0
Potential earn-out not to exceed amount			6.0
Contingent consideration			$ 3.2		3.3		$ 3.2
Alabama Trailers
Business Acquisition
Payments for acquisition of business excluding working capital adjustments				$ 10.0
Gain on bargain purchase				$ 5.0
Sustainable Energy Solutions And Blue In Green LLC | Minimum | Scenario, Plan
Business Acquisition
Contingent consideration					0.0
Sustainable Energy Solutions And Blue In Green LLC | Maximum | Scenario, Plan
Business Acquisition
Contingent consideration					$ 31.0

XML

Business Combinations - Contingent Consideration Rollforward (Details) $ in Millions	3 Months Ended
	Mar. 31, 2021 USD ($)
Contingent Consideration
Balance at December 31, 2020	$ 20.1
Increase in fair value of contingent consideration liabilities	0.8
Balance at March 31, 2021	20.9
SES
Contingent Consideration
Balance at December 31, 2020	16.9
Increase in fair value of contingent consideration liabilities	0.7
Balance at March 31, 2021	17.6
BIG
Contingent Consideration
Balance at December 31, 2020	3.2
Increase in fair value of contingent consideration liabilities	0.1
Balance at March 31, 2021	$ 3.3

XML

Accumulated Other Comprehensive (Loss) Income - Accumulated Other Comprehensive Loss Rollforward (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Accumulated Other Comprehensive Loss
Beginning balance	$ 1,579.3	$ 1,232.4
Ending balance	1,566.0	1,214.9
Accumulated other comprehensive income (loss)
Accumulated Other Comprehensive Loss
Beginning balance	2.4	(35.9)
Other comprehensive income (loss)	(19.6)	(10.2)
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes	0.4	0.3
Net current-period other comprehensive (loss) income, net of taxes	(19.2)	(9.9)
Ending balance	(16.8)	(45.8)
Foreign currency translation adjustments
Accumulated Other Comprehensive Loss
Beginning balance	13.8	(25.0)
Other comprehensive income (loss)	(19.6)	(10.2)
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes	0.0	0.0
Net current-period other comprehensive (loss) income, net of taxes	(19.6)	(10.2)
Ending balance	(5.8)	(35.2)
Pension liability adjustments, net of taxes
Accumulated Other Comprehensive Loss
Beginning balance	(11.4)	(10.9)
Other comprehensive income (loss)	0.0	0.0
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes	0.4	0.3
Net current-period other comprehensive (loss) income, net of taxes	0.4	0.3
Ending balance	$ (11.0)	$ (10.6)

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Net income attributable to Chart Industries, Inc.
Income from continuing operations	$ 25.6	$ 2.1
Income from discontinued operations, net of tax	0.0	6.4
Net income attributable to Chart Industries, Inc.	$ 25.6	$ 8.5
Earnings per common share – basic:
Income from continuing operations (usd per share)	$ 0.72	$ 0.06
Income from discontinued operations (usd per share)	0	0.18
Net income attributable to Chart Industries, Inc. (usd per share)	0.72	0.24
Earnings per common share – diluted:
Income from continuing operations (usd per share)	0.63	0.06
Income from discontinued operations (usd per share)	0	0.18
Net income attributable to Chart Industries, Inc. (usd per share)	$ 0.63	$ 0.24
Weighted average number of common shares outstanding — basic (shares)	35,550	35,770
Incremental shares issuable upon assumed conversion and exercise of share-based awards (shares)	330	240
Incremental shares issuable due to dilutive effect of convertible (shares)	2,570	0
Incremental shares issuable due to dilutive effect of warrants (shares)	2,170	0
Weighted average number of common shares outstanding – diluted (shares)	40,620	36,010

XML

Earnings Per Share - Antidilutive Securities (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share
Total anti-dilutive securities	2,630	4,910
Share-based awards
Antidilutive Securities Excluded from Computation of Earnings Per Share
Total anti-dilutive securities	60	500
Convertible note hedge and capped call transactions
Antidilutive Securities Excluded from Computation of Earnings Per Share
Total anti-dilutive securities	2,570	0
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share
Total anti-dilutive securities	0	4,410

XML

Earnings Per Share - Narratives (Details) - Convertible Notes, due 2024 - Convertible Debt - $ / shares	Mar. 31, 2021	Dec. 31, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share
Debt instrument, conversion price (usd per share)	$ 58.725
Maximum
Antidilutive Securities Excluded from Computation of Earnings Per Share
Debt instrument, conversion price (usd per share)		$ 71.775

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income tax expense	$ 3.1	$ 0.4
Effective income tax rate (percent)	10.60%	16.00%
Unrecognized tax benefits	$ 1.9
Unrecognized tax benefit that would impact effective tax rate			$ 1.3
Income tax penalties and interest accrued	$ 0.3

XML

Share-based Compensation (Details) - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation, fair value of awards granted	$ 12.5
Allocated share-based compensation expense	3.4	$ 2.9
Share based compensation expense not yet recognized	$ 18.0
Period in which unrecognized share based compensation will be recognized (in years)	2 years 4 months 24 days
Director
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation, fair value of restricted shares granted	$ 0.1
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation, shares granted (shares)	60
Share-based compensation, shares exercised (shares)	100
Share-based compensation, vesting period (in years)	4 years
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation, restricted shares granted (shares)	50
Share-based compensation, vesting period (in years)	3 years
Share-based compensation, shares vested other than options (shares)	70
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation, restricted shares granted (shares)	30
Share-based compensation, vesting period (in years)	3 years
Share-based compensation, shares vested other than options (shares)	10
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation, shares vested other than options (shares)	70

XML

Commitment and Contingencies - Narratives (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Accrued environmental reserve	$ 0.3	$ 0.3

XML

Restructuring Activities - Narratives (Details) $ in Millions	3 Months Ended
	Mar. 31, 2021 USD ($)	Mar. 31, 2020 USD ($)	Jul. 17, 2020 a
Restructuring Cost and Reserve
Restructuring costs	$ 0.7	$ 5.2
Facility In Beasley, Texas
Restructuring Cost and Reserve
Area of land (acres) | a			260
Lease facility in Tulsa, Oklahoma | Facility Closing
Restructuring Cost and Reserve
Restructuring costs	2.7
Lease facility in Tulsa, Oklahoma | Facility Closing | Scenario, Plan
Restructuring Cost and Reserve
Restructuring costs	$ 9.0

XML

Restructuring Activities - Restructuring Charges (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Restructuring Cost and Reserve
Severance costs	$ 0.3	$ 5.2
Other restructuring costs	0.4	0.0
Total restructuring costs	0.7	5.2
Cost of sales
Restructuring Cost and Reserve
Severance costs	0.0	2.3
Other restructuring costs	0.4	0.0
Selling, general, and administrative expenses
Restructuring Cost and Reserve
Severance costs	$ 0.3	$ 2.9

XML

Restructuring Activities - Rollforward (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Restructuring Reserve
Beginning balance, restructuring accrual	$ 0.8	$ 0.9
Restructuring charges	0.7	5.2
Cash payments and other	(1.0)	(3.3)
Ending balance, restructuring accrual	0.5	2.8
Operating Segments | Cryo Tank Solutions
Restructuring Reserve
Beginning balance, restructuring accrual	0.5	0.5
Restructuring charges	0.3	1.8
Cash payments and other	(0.3)	(0.8)
Ending balance, restructuring accrual	0.5	1.5
Operating Segments | Heat Transfer Systems
Restructuring Reserve
Beginning balance, restructuring accrual	0.2	0.2
Restructuring charges	0.4	2.8
Cash payments and other	(0.6)	(2.5)
Ending balance, restructuring accrual	0.0	0.5
Operating Segments | Specialty Products
Restructuring Reserve
Beginning balance, restructuring accrual	0.0	0.0
Restructuring charges	0.0	0.0
Cash payments and other	0.0	0.0
Ending balance, restructuring accrual	0.0	0.0
Operating Segments | Repair, Service & Leasing
Restructuring Reserve
Beginning balance, restructuring accrual	0.0	0.0
Restructuring charges	0.0	0.0
Cash payments and other	0.0	0.0
Ending balance, restructuring accrual	0.0	0.0
Corporate
Restructuring Reserve
Beginning balance, restructuring accrual	0.1	0.2
Restructuring charges	0.0	0.6
Cash payments and other	(0.1)	0.0
Ending balance, restructuring accrual	$ 0.0	$ 0.8